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RNA interference (RNAi) is a phenomenon in which RNA molecules elicit 
potent and sequence-specific post-transcriptional gene silencing.  Nucleic acid chemical 
modifications have been incorporated to improve their pharmacological properties.  
Despite numerous developments in chemical modifications for increased stability, 
safety, and efficiency of these therapeutic agents, they still face challenges of spatial 
and temporal targeting.  One potential targeting strategy uses photocaging techniques, 
which involves the covalent attachment of photolabile compounds to the effector NA 
species that blocks bioactivity until exposed to near UV-light.  This work demonstrates 
that fully-2’-fluorinated nucleic acids (FNAs) can elicit RNAi and that these effectors are 
resistant to sugar-specific enzymatic digestion.  1-(4,5-dimethoxy-2-
nitrophenyl)diazoethane (DMNPE) was used to cage NA oligonucleotides, including 
FNAs for controlling RNAi.  Photo-control over RNAi was demonstrated in cell culture 
and developing zebrafish embryos.  Caging also afforded additional protection against 
nuclease digestion.  High doses of siFNAs were toxic to fish embryos, as characterized 
by a developmental delay and increased mortality rate.  Caging siFNAs rendered the 
effectors inert and eliminated the observed toxicity in the developing embryos.  Building 
on the success of caging chemically-modified siFNAs through random phosphate 
alkylation, a strategy for the site-specific incorporation of an amine-based cage post-
synthetically was developed.  To demonstrate the feasibility of directed post-synthetic 
base caging, a base-caged ATP was generated and tested for photo-activation 
capacity.  A novel cage group, 4,5-dimethoxy-2-nitrobenzylamine, was synthesized and 
used for the conversion of chloropurine riboside triphosphate and the corresponding 
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free nucleoside.  Base-caged ATPs were inactive until photoexposure to 365nm light.  
Additionally, these compounds did not demonstrate competitive inhibition of protein-ATP 
interactions, as previously described for γ-phosphate caged ATP.  For the site-specific 
incorporation of caged nucleobase derivatives, a strategy relying on amine-reactive 
convertible nucleotides was developed for positional substitution using 2-nitrobenzyl 
amine cage compounds.  These convertible nucleotides can be incorporated during 
custom solid-phase synthesis, and may provide a reactive target for the presented 
amine-based cage compounds.  Caging RNAi effectors will allow for spatial and 
temporal targeting of a controlled dose release of gene silencing agents, which has 
potential applications for wet-bench assays, probing developing biological systems, and 






1.1 Purpose and Significance 
 The primary aim of this work was to develop a method to induce RNAi 
activity with an external trigger.  To achieve this goal, photo-caging technology was 
applied to RNAi effectors to control gene silencing activity using light.  Photo-caging 
refers to the attachment of photosensitive compounds to a biomolecule to transiently 
alter its activity until the caged biomolecule is exposed to light of an appropriate 
wavelength and intensity to remove the adducts (further defined in section 1.3.1).  It 
was originally hypothesized that caging various forms of dsRNA would be adequate to 
control their activity.  However, phosphate backbone photo-caging was found to be 
chemically incompatible with stabile RNA polymers (see section 2.3).  Therefore, it was 
necessary to develop 100% chemically modified RNA mimics that successfully elicit 
RNAi and are compatible with the caging strategy for controlling activity.  This body of 
work demonstrates that these chemically modified siRNAs function as potent RNAi 
effectors, and the attachment of multiple cage compounds on each strand results in 
transiently inert small interfering duplexes.  Exposure to light of the appropriate 
wavelength and sufficient energy restores the biological response to these compounds 
in vitro, in cell culture, and in vivo.  These results demonstrate the potential utility of 
caged RNAi effectors by incorporating several simultaneous modes of control for gene 
silencing.  Using the caging strategy, the inert RNAi effector can be delivered globally 
to a biological system of interest without eliciting a response.  In this scenario, a photo-
trigger can be used to induce gene silencing in a desired region of three-dimensional 
space and/or at a specific time interval, post delivery.  In addition to this spatial-
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temporal control, the extent of activity can be controlled using assorted doses of light 
energy.  This level of control has potential future applications in the areas of 
developmental knockdown investigations, tissue specific gene silencing, and single cell 
gene silencing for experimental and therapeutic modeling purposes.  
 A secondary aim of this work was to explore chemical means of 
incorporating a caging group into an RNAi effector in a site-specific manner.  The 
method described above uses a reactive intermediate for covalent attachment to the 
nucleic acid in a batch-style reaction, resulting in caging at random sites on the 
effector.  Towards the aim of site-specific incorporation, a caging group with modified 
attachment chemistry was generated and tested for its ability to bind an adenosine 
residue on the nucleobase.  Nucleoside model studies indicate that this attachment 
scheme is possible through a nucleophilic substitution of chlorine on 6-chloropurine 
riboside (see chapter 5).  This scheme was expanded to generate base-caged ATP, 
which unlike γ-phosphate caged ATP, does not act as a competitive inhibitor for 
proteins that associate with ATP.  Future studies will attempt to use this caging 
strategy for incorporating an amine-attached caging compound on an internal 
nucleobase through substitution utilizing a convertible nucleoside.  Caging at a site-
directed location may allow for complete inhibition of activity using a single cage 
compound and a more efficient photo-activation of the RNAi effectors, resulting in a 
binary on-off behavior profile.  Caging offers the ability to modulate RNAi activity in 
terms of spatial and temporal resolution and as a means for light-dependant dosing of 
RNAi intensity, which has applications in developmental investigations of biological 
systems and therapeutic targeting 
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1.2 RNA Interference  
RNA interference (RNAi) refers to a highly specific, potent, and naturally 
occurring post-transcriptional silencing of protein expression initiated by RNA.  The first 
evidence of this mechanism emerged from studies attempting to genetically enhance 
the violet pigmentation in petunias (Napoli, Lemieux et al. 1990; van der Krol, Mur et 
al. 1990).  The overexpression of the pigment gene unexpectedly resulted in a null 
phenotype.  A related observation was seen in fungal systems where an over-
expressed transgene retarded gene expression at the post-transcriptional level 
(Romano and Macino 1992).  However, it took nearly a decade to discover that dsRNA 
is the foundation of this post-transcriptional gene silencing (PTGS) mechanism (Fire, 
Xu et al. 1998).  The breakthrough experiment showed that the introduction of dsRNA 
was far more efficient in silencing a complementary target gene than either sense or 
antisense strands individually.  This dsRNA-induced PTGS mechanism was coined 
RNAi.  RNAi and its discovery have received a series of highly-acclaimed recognitions 
including Science magazine’s 2002 Breakthrough of the Year, Fortune Magazine’s 
2003 Biotech’s Billion Dollar Breakthrough, and has earned Andrew Fire and Craig 
Mello the 2006 Nobel Prize in Physiology or Medicine.  This praise is well-deserved as 
the field of RNAi matures and the significance of this discovery in being realized.  
However, the use of RNAi for therapeutics still faces several hurdles that are 
discussed in the following sections.  A detailed review of the RNAi mechanism along 
with advancements in RNA chemical modifications and current therapeutic 
development is given in the following sections to adequately identify these obstacles, 
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describe current technologies to improve the pharmacological effectiveness of RNAi, 
and to identify candidate positions for optimal photo-caging of RNAi effectors. 
 
1.2.1 Known Mechanism of RNA Interference 
The RNAi pathway has been extensively studied in various eukaryotic 
organisms.  It is an active process which requires ATP at several stages to induce 
gene silencing.  Although there are numerous differences in these pathways across 
various plants and animals, the basic mechanism seems to be well conserved.  For 
this universal model, small double stranded RNAs (dsRNAs) act as the crucial 
substrate for the initiation of RNAi.  The sources of these dsRNAs can vary widely, 
which is discussed in the following paragraph.  Once introduced to the cytoplasm, 
these small RNAs associate with several proteins to form the RNA-Induced Silencing 
Complex (RISC) (Hammond, Bernstein et al. 2000).  The nucleoprotein complex is 
then activated by one or several ATP-dependant processes that are not yet well 
understood.  It is theorized that this activation process includes the unwinding of the 
siRNA for target recognition.  However, to date a conserved ATP-dependant helicase 
has not been identified.  Once activated, RISC recognizes the mRNA target and either 
clips it at a specific location, physically blocks its translation, or sequesters it to a 
processing body (p-Body) organelle.  Although the general process can be described 
in a relatively straightforward manner, the full process is complex due to a high number 
of variations, unidentified factors, and downstream processes.  For simplicity, the 
entire mechanism with an emphasis on the siRNA pathway will be broken down into 1) 
siRNA generation, 2) RISC assembly, 3) RISC maturation, 4) RISC targeting 
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interaction and mRNA degradation, and 5) downstream chromatin remodeling.  Each 
















Figure 1.1:  RNAi mechanism.  RISC components illustrate how RNA 
and proteins associate with each other.  Stages include siRNA 
generation, siRNA recognition and RISC assembly, RISC maturation, 
and target mRNA cleavage 
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1.2.1.1  Small Interfering RNA Generation 
SiRNAs can be generated through several natural and synthetic methods.  
As was done in this work, siRNAs can be generated synthetically or enzymatically in 
vitro and then delivered to the cells or embryos in an active form.  In most organisms, 
the introduction of long double-stranded RNA (dsRNA) prompts the enzymatic 
digestion of the RNA into 21-30nt length siRNAs.  The highly conserved enzyme that 
performs this digestion was named Dicer and belongs to the RNAse III family of 
enzymes (Hammond, Bernstein et al. 2000; Bernstein, Caudy et al. 2001; Elbashir, 
Lendeckel et al. 2001).  This pathway is not utilized for RNAi in mammalian cells 
because they mount a global protein kinase response as a viral protection mechanism, 
which results in cellular apoptosis (Williams 1997; Gil and Esteban 2000).  However, 
Dicer is still a critical component to the RISC pathway and is present in mammalian 
systems.  In addition to linearized dsRNA, Dicer can process stem-loop structures to 
produce siRNAs.  This has enabled the ability to introduce transgenic short hairpin 
RNAs (shRNAs) that are processed by Dicer to induce RNAi.  One of the more 
profound discoveries that arose from RNAi studies was the existence of hundreds of 
endogenous stem-loop RNAs called microRNAs (miRNAs), which are theorized to play 
a major role in genetic regulation (Lee, Feinbaum et al. 1993; Ruvkun 2001).  These 
miRNAs originate from non-coding regions of the genome in the form of a long primary 
transcript known as pri-miRNA.  These are processed in the nucleus into the shorter 
stem-loop structures (pre-miRNA) and exported to the cytoplasm where they are 
processed into their mature form.   Although siRNAs and miRNAs are functionally 
similar, small structural differences of these effectors elicit different RNAi pathways.   
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1.2.1.2  RISC Assembly 
 Once in the cytoplasm, small RNAs are assembled into RISC.  This is a 
process in which siRNAs or miRNAs interact with a series of cellular proteins to form 
active complexes for target recognition and regulation.  The most important factor for 
active RISC is the assembly of siRNAs with the argonate (AGO) family of proteins.  
These are the only small binding proteins which have been found in all variations of 
functional RISC to date.  Several studies have shown that when some AGO proteins 
are complexed with siRNA a functional core RISC can be formed, which drives mRNA 
degradation in vitro and in vivo (Martinez, Patkaniowska et al. 2002; Liu, Carmell et al. 
2004; Rand, Ginalski et al. 2004).  AGO proteins contain several conserved domains, 
that are critical for siRNA binding and RISC activity.  The PAZ domain is located within 
a hydrophobic cleft and contains a series of aromatic and positively charged residues 
that enable a strong recognition of the negative charges on the siRNA 3’-end 2nt 
overhangs (Song, Liu et al. 2003).  AGO proteins also contain a Mid domain, which is 
characterized by a deep basic pocket.  Studies have suggested that this domain 
interacts with the 5’-end monophosphate of the guide RNA (Parker, Roe et al. 2004; 
Song, Smith et al. 2004; Ma, Yuan et al. 2005; Rivas, Tolia et al. 2005; Yuan, Pei et al. 
2005).  The final region of interest is the conserved PIWI domain, which is between the 
Mid and PAZ domains.  This section contains a motif that is similar to those found in 
the RNAse H family of endonucleases, suggesting that AGO proteins possess catalytic 
activity (Yang and Steitz 1995; Parker, Roe et al. 2004; Ma, Yuan et al. 2005; Parker, 
Roe et al. 2005; Yuan, Pei et al. 2005).  However, not all AGO proteins contain a 
catalytically active PIWI motif.  For instance, 8 AGO proteins have been discovered in 
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humans, which are evenly split into 2 subfamilies: PIWI and eIF2C containing AGOs 
(Sasaki, Shiohama et al. 2003).  Among the non-PIWI containing proteins, only one, 
hAGO2, demonstrates catalytic ability (Liu, Carmell et al. 2004; Meister, Landthaler et 
al. 2004; Rivas, Tolia et al. 2005).  An understanding of this family of proteins may 
allow for the design of siRNAs that can enter functionally different RNAi pathways.  
Additionally conserved requirements among all AGO variants may provide insight into 
potential caging sites that will disrupt all RNAi processes. 
 In some RISC systems, other protein factors are required for RISC assembly 
and RNAi activity.  Not only are there variations among different organism species but 
there are various pathways within single organisms.  One example comes from 
Drosophila melanogaster, one of the most extensively studied systems, where two 
dicer proteins (Dcr-1 and Dcr-2) have distinct functions (Bernstein, Caudy et al. 2001; 
Liu, Rand et al. 2003; Lee, Nakahara et al. 2004; Okamura, Ishizuka et al. 2004; 
Pham, Pellino et al. 2004).  Dcr-1 is responsible for miRNA production while Dcr-2 is 
required only for siRNA production and therefore it is not required for normal fly 
development (Lee, Nakahara et al. 2004; Okamura, Ishizuka et al. 2004).  In this 
system, siRNAs are loaded into a RISC loading complex (RLC) which is comprised of 
Dcr-2 and a double-stranded RNA binding protein, R2D2, before associating with 
AGO2  (Pham, Pellino et al. 2004; Tomari, Du et al. 2004; Tomari, Matranga et al. 
2004; Tomari and Zamore 2005).  One interesting phenomenon is that R2D2 and Dcr-
2 bind asymmetrically to the siRNA, where R2D2 associates to the more stable end 
(Tomari, Matranga et al. 2004).  This could be taken into account when designing 
siRNAs to ensure that the antisense strand is preferentially retained in RISC.  The RLC 
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factors are gradually displaced once AGO2 has been recruited, leaving behind only the 
core RISC components, AGO2 and siRNA.  Observations in the human system of 
siRNA-based RISC assembly seem to share many similarities with Drosophila.  It has 
been shown that human Dicer forms a complex with TAR RNA binding protein (TRBP) 
(Chendrimada, Gregory et al. 2005; Haase, Jaskiewicz et al. 2005).  Following this 
binding, siRNA is added to the assembly forming a Dicer-TRBP-siRNA complex.  In 
this system, TRBP is required for recruiting hAGO2 to the complex for RISC formation.     
 
1.2.1.3  RISC Maturation 
 The process of generating a mature RISC containing the single-stranded 
RNA effector is not yet well understood.  It is known that the maturation process 
requires ATP in vitro (Nykanen, Haley et al. 2001).  Initial models rely on an 
unidentified ATP-dependant helicase in the immature RISC or RLC to remove the 
carrier strand.  This theory is supported by the fact that several DEAD-box RNA 
helicases, which are ATP dependant, are involved in the RNA pathway in different 
organisms (Dalmay, Horsefield et al. 2001; Tabara, Yigit et al. 2002; Yan, Mouillet et 
al. 2003; Cook, Koppetsch et al. 2004; Tomari, Du et al. 2004; Kim, Gabel et al. 2005).  
In this proposed mechanism it is unclear whether helicase unwinding occurs in the 
RLC or simultaneously with AGO protein displacement of the RLC cofactors.   More 
recent models suggest the RLC transfers the siRNA to the AGO protein, and in a 
process that is analogous to mRNA enzymatic processing, the passenger strand is 
cleaved.  Once cleaved, the two halves of the passenger strand are ejected so that 
RISC is free to repeat the processed on another mRNA target (Matranga, Tomari et al. 
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2005; Miyoshi, Tsukumo et al. 2005; Leuschner, Ameres et al. 2006).  The ejecting 
process is likely an ATP dependant process that is equivalent to releasing digested 
target mRNA and recycling of RISC.  Additionally, if ATP is required for strand 
separation, there is nothing to suggest that this is a helicase independent process. 
 
1.2.1.4  RISC Targeting and mRNA Degradation 
 There are two functional categories of mature RISC: those that initiate 
cleavage of the target and those that only participate in translational arrest.  Cleavage 
the mRNA target by RISC is determined by three factors.  First, only an AGO protein 
that contains an active endonuclease motif in the PIWI domain can cleave target 
mRNA (Liu, Carmell et al. 2004; Parker, Roe et al. 2004; Baumberger and Baulcombe 
2005; Parker, Roe et al. 2005).  If a non-catalytically active AGO protein is used, a 
non-cleaving RISC is formed.  Secondly, a high degree of complementarity is needed 
between the incorporated strand of siRNA with the target (Chiu and Rana 2002).  
Lastly, the scissile phosphodiester bond of the mRNA must be directly accessible to 
the active endonuclease motif in the PIWI domain (Parker, Roe et al. 2004; Parker, 
Roe et al. 2005; Yuan, Pei et al. 2005).  Only a fraction of all the AGO proteins 
identified contain a catalytically active motif, such as the human hAGO2 (Liu, Carmell 
et al. 2004; Meister, Landthaler et al. 2004; Meister and Tuschl 2004; Rivas, Tolia et al. 
2005) or dAGO1 and dAGO2 in Drosophila (Meister and Tuschl 2004).  The catalysis 
of AGO “slicer” activity is dependant on divalent cations such as Mg2+ and Ca2+ 
(Schwarz, Tomari et al. 2004; Rivas, Tolia et al. 2005).  The location of cleavage is 
predetermined by RISC at the phosphodiester bond on the mRNA across from the 
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location between the nucleotides 10 and 11 from the 5’-end of the guide RNA, 
regardless of siRNA size (Elbashir, Lendeckel et al. 2001; Elbashir, Martinez et al. 
2001; Haley, Tang et al. 2003; Rivas, Tolia et al. 2005).  The hydrolysis of this 
phosphodiester linkage yields 3’-hydroxyl and 5’-phosphate termini on the cleavage 
products (Elbashir, Martinez et al. 2001; Martinez and Tuschl 2004).   
 Proper base-pairing is not only important for target recognition but is critical 
for RISC-directed cleavage.  A strong association between the guide RNA strand and 
the target mRNA seems to correlate to more efficient target cleavage (Chiu and Rana 
2003; Tang, Reinhart et al. 2003; Martinez and Tuschl 2004; Yang, Li et al. 2005). 
However, there does seem to be some mismatch tolerance as certain locations of 
partial complementarities can lead to mRNA cleavage.  In nearly all cases of base 
mismatching, target cleavage is reduced.  The exception to this rule is the first base on 
the 5’end.  A point mismatch at this location increases the observed target cleavage in 
vitro (Rhoades, Reinhart et al. 2002; Haley, Tang et al. 2003; Lewis, Shih et al. 2003; 
Tang and Zamore 2004; Ma, Yuan et al. 2005), presumably by facilitating release of 
the processed target.  Other than this location, mismatches on the 5’-half of the guide 
strand are less tolerated than those on the 3’-half (Haley, Tang et al. 2003; Martinez 
and Tuschl 2004).  It has also been suggested that the A-form RNA helix is required 
for RISC activity (Chiu and Rana 2002; Chiu and Rana 2003).  Since there are 11 
base-pairs per turn in the A-form helix, a mismatch in the first 9 or 10 nucleotides of 
the guide strand may disrupt the helix and cause the resulting loss of activity. 
 The preferred association between the AGO protein with the guide RNA 
occurs with the 5’-end phosphate anchored in the basic pocket motif of the Mid-PIWI 
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domain and the 3’-end bound to the PAZ-domain (Parker, Roe et al. 2004; Ma, Yuan et 
al. 2005; Yuan, Pei et al. 2005).  This directs the region containing the active slicer 
motif between the Mid-PIWI and PAZ domains, and the interaction with the guide 
strand likely restricts this region so that the hydrophilic side of this domain is positioned 
toward the solution (Ma, Yuan et al. 2005).  Once bound to the target, a conformational 
change occurs to bring the scissile phosphodiester bond of the target into the 
catalytically active region (Ma, Yuan et al. 2005; Parker, Roe et al. 2005).  The actual 
cutting of the target mRNA is not ATP dependant, but the release of the cleaved 
products does require ATP and likely also requires an ATPase/RNA helicase (Hunter 
2000; Nykanen, Haley et al. 2001; Haley, Tang et al. 2003; Rivas, Tolia et al. 2005).  In 
the circumstance of a non-catalytic RISC, knockdown may occur either through 
blockade of protein translation or by sequestering mRNA targets to cytoplasmic 
processing bodies (P-bodies) that are sometimes co-localized with mRNA decapping 
and degradation proteins (Bagga, Bracht et al. 2005; Ding, Spencer et al. 2005; 
Fillman and Lykke-Andersen 2005; Jabri 2005; Liu, Valencia-Sanchez et al. 2005; 
Pillai, Bhattacharyya et al. 2005; Rehwinkel, Behm-Ansmant et al. 2005; Sen and Blau 
2005).  
 
1.2.1.5  Downstream RNAi Processes 
 RNA-dependant epigenetic chromatin remodeling was first discovered in 
1994 in a plant system (Wassenegger, Heimes et al. 1994).  This phenomenon 
occurred in response to the integration of viral cDNA into the host genome.  It was 
observed that the replicating foreign sequence triggered methylation of homologous 
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DNA copies.  It was later shown that this process is dependant on short RNA strands 
that are generated from processing the replicated dsRNA, suggesting Dicer activity 
(Zilberman, Cao et al. 2004).  This RNA-dependant DNA-methylation was found to be 
highly specific in that methylation is limited to the region of RNA-DNA complementarity 
(Wassenegger 2000; Aufsatz, Mette et al. 2002).  In addition to plants, RNAi mediated 
chromatin remodeling was also studied in S. Pombe, a species of yeast.  It was 
observed that small RNAs, which were generated from the centromeric repeat regions 
of chromosomes, eventually caused a silencing of these regions (Reinhart and Bartel 
2002).  The existence of a nucleus RISC that contains small RNAs and the AGO1 
protein provided the first biochemical evidence of RNAi activity in the nucleus 
(Motamedi, Verdel et al. 2004; Noma, Sugiyama et al. 2004).  It was subsequently 
found that Dicer, RNA-dependant RNA-polymerase, and a specific histone methyl 
transferase are also required to establish heterochromatin in S. Pombe centromeres 
(Volpe, Kidner et al. 2002; Hall, Noma et al. 2003; Volpe, Schramke et al. 2003).  
Unlike the plant system, chromatin methylation in yeast spreads several kilobases from 
the initially targeted region (Hall, Shankaranarayana et al. 2002; Schramke and 
Allshire 2003).  Although more extensively studied in the plant and yeast systems, 
RNAi-related chromatin remodeling has been identified in human cells (Bayne and 
Allshire 2005).  The phenomenon of RNA-mediated epigenetic genome modification 
demonstrates the utility of RNAi as an intrinsic defense mechanism to foreign genetic 
material from viral or transposable element sources, as well as suggesting a potential 
RNAi role in developmental processes. 
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1.2.2 Chemical Modifications to siRNAs 
Although siRNAs utilizing chemical modifications have been used determine 
intramolecular RNA structural requirements that are necessary to elicit RNAi and to 
elucidate certain protein nucleic acid interactions, most of these studies aim to improve 
the pharmacological properties of siRNAs.  For in vitro, cell culture, and some in vivo 
models, the efficacy of unmodified siRNAs is sufficient.  However, the development of 
robust RNAi drugs faces several challenges including; chemical stability in 
physiological environments, improved bio-distribution, improved cellular delivery, and 
targeting of disease tissues.  This section reviews the current literature on siRNA 
chemical modifications.  Several excellent reviews are also available (Dorsett and 
Tuschl 2004; Manoharan 2004; Zhang, Du et al. 2006). 
 
1.2.2.1  Terminal Modifications 
The termini of siRNAs have different structural requirements related to how 
they interact with RISC components (refer to section 10.2.1 for a detailed description).  
The structural studies of the interactions between the PAZ and MID domains of AGO 
proteins with siRNAs complement studies in which terminally-modified RNAi effectors 
were tested for silencing ability.  For example, it is known that a 5’-phosphate on the 
antisense, or guide strand, is required for siRNA recognition and RISC formation from 
both crystallography studies of AGO proteins and from incorporating modifications on 
siRNAs to disrupt the RNAi pathway (Nykanen, Haley et al. 2001; Martinez, 
Patkaniowska et al. 2002; Schwarz, Hutvagner et al. 2002; Parker, Roe et al. 2004; 
Song, Smith et al. 2004; Ma, Yuan et al. 2005; Rivas, Tolia et al. 2005; Yuan, Pei et al. 
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2005).  Despite the progress made in the understanding of the RNAi pathway, different 
studies relating to terminal modification of siRNA often yields varying results.  One of 
the modified termini that yields the most inconsistent reports with respect to RNAi 
tolerance is the 3’-antisense end.  Structural studies of siRNA recognition by AGO 
proteins suggests that the 2-nt 3’-antisense over hang is necessary for proper RISC 
formation and stability (Lingel, Simon et al. 2003; Song, Liu et al. 2003; Yan, Yan et al. 
2003; Ma, Ye et al. 2004).  Therefore, modifications to this location should reduce 
RNAi activity.  Indeed, both 2-hydroxylethylphosphate and 2’-O,4’-C-ethylene 
thymidine modifications to this location abolished all RNAi activity (Hamada, Ohtsuka 
et al. 2002).  Other siRNA chemical modification examples, however, have 
demonstrated that silencing activity is retained when this terminal is modified with 
larger substitutions such as 3’phosphate-aminopropyl, 3’-puromycin, 3’biotin, or 
fluorescent chromophores (Chiu and Rana 2002; Schwarz, Hutvagner et al. 2002; 
Harborth, Elbashir et al. 2003).  There is even a case in which the 3’-2nt overhang of 
the antisense strand was eliminated and the resulting blunt ended siRNA that exhibited 
RNAi activity in mammalian cell culture (Czauderna, Fechtner et al. 2003) 
siRNAs tolerate terminal modifications on both ends of the sense strand 
(Chiu and Rana 2003; Czauderna, Fechtner et al. 2003; Harborth, Elbashir et al. 2003; 
Davidson, Harel et al. 2004; Lorenz, Hadwiger et al. 2004; Muratovska and Eccles 
2004; Morrissey, Blanchard et al. 2005).  This is expected since this strand is not 
retained in the active RISC effector, and as long as the siRNA forms a proper duplex 
structure for RISC formation, RNAi will likely be uninterrupted.  These locations are the 
most exploited with respect to improving cellular delivery.  For example, cholesterol 
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and lipid conjugates to the sense strand 5’-terminal nucleotide allow increased delivery 
to liver cells (Lorenz, Hadwiger et al. 2004; Soutschek, Akinc et al. 2004).  In a similar 
strategy, end-conjugation to proteins that promote endocytosis has also demonstrated 
successful siRNA delivery and effective RNAi (Davidson, Harel et al. 2004; Muratovska 
and Eccles 2004).  Another example employs an acid-labile linker to generate siRNA 
micelle complexes that are transported by triggering cell-surface receptors and 
subsequently released into the intracellular environment through pH-dependent 
breakdown (Oishi, Nagasaki et al. 2005).  Although this end-conjugation strategy 
addresses increased delivery of siRNAs to cells, this technique has primarily been 
evaluated in liver cells when applied to in vivo models since the RNAi effectors are 
localized in this tissue after being introduced systemically. 
Modification of the 5’-end of the antisense strand is the least tolerated by the 
RNAi pathway.  It has been consistently demonstrated the phosphate at this location is 
required for RNAi.  More specifically, the 5’-phosphoester bond must not be disturbed 
if silencing is to occur (Nykanen, Haley et al. 2001).  An unmodified hydroxyl can be 
phosphorylated, but if this location is blocked by any conjugate attached the oxygen, 
RNAi will be abolished (Elbashir, Martinez et al. 2001; Martinez, Patkaniowska et al. 
2002; Schwarz, Hutvagner et al. 2002).  Conjugation that retains 5’-phosphate does 
not eliminate the necessary phosphoester and is generally tolerated.  Several studies 
have demonstrated that silencing ability is retained after conjugation of a bulky linker to 
the phosphate (Schwarz, Hutvagner et al. 2002; Harborth, Elbashir et al. 2003).  In 
fact, a photolabile linker at this location has shown to decrease but not eliminate RNAi 
activity (Nguyen, Chavli et al. 2006; Shah and Friedman 2007).  The residual activity 
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was explained by an isomer that partially exposes the negative charge of the 
phosphate to the MID domain of the AGO protein (Shah and Friedman 2007).  This 
allows for RISC recognition of the 5’-end, even when a large conjugate is attached to 
the phosphate. 
 
1.2.2.2  Backbone Modifications  
Backbone modifications have a history in providing NA stability and chemical 
resistance to degradation and enzymatic digestion that predates RNAi.  This review is 
limited to the use of these chemical substitutions for synthetic siRNA knockdown.  A 
recent review of chemical modifications to antisense and ribozyme therapies provides 
a more detailed record of these applications (Kurreck 2003).  Since a great deal of 
knowledge was generated studying the effects of backbone modifications on DNA 
antisense therapies, only the most successful candidates have been investigated for 
RNAi.  The most widely used phosphate modification in siRNA is the phosphorothioate 
(PS).  The PS modification consists of a sulfur substitution in place of one of the 
nonbridging oxygen within the phosphate backbone.   
PS substitutions were first used in siRNAs in 2000 (Parrish, Fleenor et al. 
2000), shortly after the discovery of RNAi.  Studies on RNAs with PS substitutions 
used sparingly do not report adverse affects on silencing ability (Padilla and Sousa 
2002; Braasch, Jensen et al. 2003; Holen, Amarzguioui et al. 2003), but extensive 
modification can result in cytotoxicity (Amarzguioui, Holen et al. 2003; Holen, 
Amarzguioui et al. 2003).  One of the more heavily cited studies also showed a 
decreased silencing ability of phosphorothioated compared to unmodified siRNA 
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independent of cytotoxicity (Chiu and Rana 2003).  Alternatively one study reported 
that if certain locations were modified, RNAi activity would actually increase (Li, Mao et 
al. 2005).  In addition to the aforementioned research, several incidences of the PS 
modification being used in conjunction with other types of chemical modifications and 
conjugations have been reported (reviewed by (Manoharan 2004; Zhang, Du et al. 
2006)). 
Another, less common, modification that has generated some recent 
enthusiasm is the boranophosphate substitution.  These modifications consist of BH3 
substitutions of one of the non-bridging oxygen molecules of the phosphate backbone.  
NAs with these modifications have demonstrated nuclease stability (Hall, Wan et al. 
2004; Hall, Wan et al. 2006), increased hydrophobicity (Shaw, Sergueev et al. 2000), 
and minimal toxicity (Hall, Burnham et al. 1993).  Relative to PS modified siRNAs of 
the same sequence, boranophosphates used for partial modification showed the ability 
to increase the level of silencing activity (Hall, Wan et al. 2004).  Single-stranded 
boranophophate-siRNAs were also able to enter the RNAi pathway and not operate 
under a translational arrest pathway alone (Hall, Wan et al. 2006).  This is appealing 
as it is demonstrated in chapter 2 that fully modified 2’-fluoro RNAs were unable to 
elicit single-stranded RNAi.  This suggests that single-stranded RNA recognition by 
RISC components may involve an intermediate factor that requires the 2’-hydroxyl 
instead of identifying the negative charge of the phosphate.  Although this modification 
shows promise, it should be noted that all boranophosphate RNAi studies have been 








































































Figure 1.2: Sugar and backbone chemical modifications used for RNAi 
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1.2.2.3 Base Modifications 
 Surprisingly, nucleobase chemical modifications have not been extensively 
studied in siRNAs.  Base modifications that have been attempted thus far include 5’-
bromo uracil, 5’-iodo uracil, 2,6-diaminopurine, N3-methyl-uridine, inosine, and 5-(3-
aminoallyl) (Parrish, Fleenor et al. 2000; Chiu and Rana 2003).  In general, each of 
these substitutions reduced RNAi activity to varying degrees.  To complement reports 
on nucleobase substitution are studies that have investigated single base 
mismatching.  A recent comprehensive investigation was carried out by systematically 
inserting a single base mutation at all locations of the siRNA target site (Du, Thonberg 
et al. 2005).  This study provides insight into which locations are most sensitive to 
mismatches.  Additionally, it was discovered that the identity of the mismatch also 
influenced silencing ability.  Reduction in silencing activity caused by single base 
mismatches varied depending on which nucleobase was inserted as the mismatch.  
This study differed from others which inserted point mutations into the siRNA rather 
than the target (Boutla, Delidakis et al. 2001; Holen, Amarzguioui et al. 2002; 
Amarzguioui, Holen et al. 2003).  However, the results of these two substitution 
techniques were consistent.  Together, these studies suggest that complementarity in 
the central region of the siRNA is the most critical for efficient RNAi activity, whereas 
mismatches at the terminal ends are better tolerated.   
 
1.2.2.4  2’  Modifications 
Modifications to the 2’-hydroxyl of RNA have been widely utilized in siRNAs.  
These substitutions are generally well tolerated by the RNAi pathway because the 2’-
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hydroxyl is not necessary for RISC recognition or target cleavage (Chiu and Rana 
2003).  Additionally these modifications increase the chemical and enzymatic stability 
of the NAs, relative to unmodified RNA.  For these reasons, many chemical 
substitutions at this location have been evaluated for RNAi activity and improved 
resistance to nuclease degradation. 
2’-O-Methoxyethyl (2’-MOE) modifications had previously shown promise for 
antisense applications due to their enhanced blood stability and adequate retention of 
activity (reviewed by (Kurreck 2003)).  Therefore, they seemed likely candidates for 
introduction into siRNAs.  However, pervasive use of this modification is not well 
tolerated by the RNAi pathway, suggesting that the cumbersome side chain interferes 
with the process.  In the central region of the duplex across from the cleavage site, it 
appears that the size of a 2’-substitution is inversely proportional to the level of RNAi 
activity of the effector (Chiu and Rana 2003; Prakash, Allerson et al. 2005).  The 2’-
MOE modification was also not tolerated on the on either end of the antisense strand, 
but RNAi activity was maintained surprisingly well when this modification was used on 
either end of the sense strand (Prakash, Allerson et al. 2005).  Another study showed 
favorable results by increasing end duplex stability with several 2’-MOE modifications 
on each side of the siRNA (Vickers, Koo et al. 2003).  Despite the potential for 
improved stability, these studies suggest that this modification reduces RNAi efficiency 
and can only be used sparingly. 
Initial studies using 2’-O-methyl (2’-OME) substitutions demonstrated 
unfavorable results with respect to maintaining RNAi efficiency (Elbashir, Martinez et 
al. 2001; Chiu and Rana 2003).  However, the use of this modification has 
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subsequently been studied in great detail (reviewed by (Manoharan 2004; Zhang, Du 
et al. 2006)).  Like other bulky modifications, 2’-OME nucleotides can only be used 
sparingly.  Heavy utilization results in a decrease in silencing activity, presumably 
through disruption of the major groove of the RNA A-type helix (Chiu and Rana 2003).  
This study that gradually increased the number of 2’-OME substitutions determined 
that four nucleotide substitutions per strand are well tolerated.  Additionally, limited use 
of this substitution appears to increase RNAi ability, presumably through increase 
duplex stability and/or improved resistance to enzymatic digestion (Czauderna, 
Fechtner et al. 2003).  The benefits obtained by using a small number of the 2’-OME 
modification in a siRNA have made this substitution popular for use in siRNAs with 
combinations of various chemical modifications. 
Locked nucleic acids (LNA) are a family of ribose modified compounds in 
which the 2’-oxygen is bridged to the 4’-carbon, locking the ribose in the C3’-endo 
conformation.  LNAs have been studied in detail to determine their nuclease 
resistance, duplex stability, and RNAi functionality (Braasch, Jensen et al. 2003; 
Jepsen and Wengel 2004; Elmen, Thonberg et al. 2005).  End-modification using 
LNAs is tolerated well on all but the 5’-end of the antisense strand.  In another example 
of a comprehensive evaluation, a single LNA substitution was evaluated at each 
location of the antisense strand of an otherwise active siRNA (Elmen, Thonberg et al. 
2005).  This study identified four locations that resulted in a significant loss of silencing 
activity, which comprised of the 5’-end, nucleotide 10, nucleotide 12, and nucleotide 
14.  However, these positional effects were only tested on a single siRNA sequence.  
As with other bulky modifications, extensive use of these modifications results in a loss 
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of RNAi activity.  It was proposed that this decrease might be a result of increased 
thermal stability and a reduction in helicase unwinding ability (Elmen, Thonberg et al. 
2005).  However, 2’-fluoro substitutions result in a similar thermal stability without 
diminishing silencing capacity (see chapter 2).  Even with the limitations of LNAs, 
careful placement of this modification can improve the properties of the resulting 
siRNAs for use in in vivo systems. 
Of all the chemical modifications tested, deoxy-2’-fluoro (2’-F) modifications 
seem to be the best-tolerated alteration with respect to retaining the silencing activity 
of unmodified siRNAs.  These substitutions have several characteristics that make 
them ideal for RNAi applications.  Fluorine is small enough to fit within the minor 
groove without inhibiting duplex recognition by certain proteins, and the 
electronegativity of the halide reinforces the A-type helix through the preferred C3’-
endo ribose pucker conformation (Guschlbauer and Jankowski 1980; Chiu and Rana 
2003).  In addition to not disrupting the global structure of a RNA duplex, 2’-F 
substitutions increase thermal stability of the modified NAs when annealed to DNA or 
RNA (Kawasaki, Casper et al. 1993; Yazbeck, Min et al. 2002).  2’-F modified 
oligonucleotides and siRNAs have also demonstrated improved resistance to 
enzymatic degradation relative to their unmodified counterparts (reviewed by 
(Manoharan 2004; Zhang, Du et al. 2006)).  Several studies have shown similar levels 
of RNAi elicited between unmodified siRNA and these synthetic counterparts that 
contain fluorine on every pyrimidine (Braasch, Jensen et al. 2003; Chiu and Rana 
2003; Harborth, Elbashir et al. 2003; Layzer, McCaffrey et al. 2004; Manoharan 2004; 
Soutschek, Akinc et al. 2004).  Sullenger and colleagues showed that 2’-F pyrimidine-
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modified siRNAs and unmodified siRNAs have similar activity over a range of 
concentrations and silencing durations (Layzer, McCaffrey et al. 2004).  Chiu and 
Rana compared silencing potency of various siRNA modifications and found that 
siRNA completely modified with 2’-F pyrimidines and 2’-H purines showed only a 50% 
decrease in knockdown ability relative to an unaltered siRNA counterpart (Chiu and 
Rana 2003).  In addition to improving resistance to enzymatic degradation while 
maintaining silencing efficiency, 2’-modifications have been shown to reduce off-target 
effects normally observed following siRNA delivery (Jackson, Burchard et al. 2006; 
Cekaite, Furset et al. 2007).  Until recently, 2’-F modified purine phosphoramidite 
building-blocks for solid phase synthesis were unavailable.  Therefore, the 
aforementioned studies investigated pyrimidine only 2’-F NAs.  Chapter 2 
demonstrates the first use of fully-modified 2’-F siRNAs generated through synthetic 
and enzymatic methods. Alternatively, 2’-deoxy-2’fluoro-β-D-arabinonucleic acid 
modifications, in which the 2’-flouro is inverted, have been used to partially modify 
siRNA and successfully induce RNAi (Dowler, Bergeron et al. 2006).  The combination 
of these results suggests that the 2’-OH is not necessary for RNAi, but changes at this 
location that either alter the global duplex structure or disrupt the minor groove can 
abolish interference.  Therefore, this modification is ideal for either global 2’-F 
substitution or for use in conjunction with other chemical modifications for the 
development of efficient and persistent RNAi effectors. 
The combination of several types of chemical modifications into a single 
siRNA molecule is becoming increasingly common in efforts to improve the 
pharmacological efficacy of RNAi.  Bhat and colleagues demonstrated that fully-
modified duplexes which included 2’-F pyrimidine nucleotides and 2’-O-methyl purine 
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nucleotides actually increased RNAi efficiency, and in one case they achieved a 500-
fold increase in silencing ability (Allerson, Sioufi et al.).  The grouping of these two 
modifications is popular in studies that utilized more than one type of chemical 
substitution (Allerson, Sioufi et al. 2005; Morrissey, Blanchard et al. 2005; Morrissey, 
Lockridge et al. 2005; Prakash, Allerson et al. 2005; Kraynack and Baker 2006).  In 
one of the more heavily modified examples, Morrissey and colleagues (Morrissey, 
Blanchard et al. 2005) created a siRNA targeting hepatitis B that contained 2’-deoxy, 
2’-F, 2’-O-ME, PS, and 3’-5’-inverted deoxy-abasic substitutions. Combining these 
types of modifications may improve efficacy and effector half-life, but it may also 
provide means to achieve targeted delivery or inducible activity with the use of 
alternative modifications such as receptor ligands or caging compounds conjugated to 
the stabilized siRNAs. 
 
1.2.3 Current RNAi Therapeutic Developments 
RNAi has demonstrated potent gene silencing in laboratory studies, making 
it an exciting alternative approach for treating a wide variety of medical conditions.  
The strategy of repressing protein translation with NAs has several advantages over 
small molecule pharmaceuticals.  Most notably is the flexibility and ease of targeting 
the specific gene that is causing a pathological state.  There are a whole host of 
diseases in which the protein responsible has been identified, but no compound has 
been developed for effective treatment.  Using RNAi and antisense techniques, several 
sequences could be developed for the specific disease-causing gene or allele, and 
candidate effectors could be generated in sufficient quantities for evaluation in a matter 
of days once the problem gene is identified.  Despite these benefits and general 
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optimism surrounding this technology, few examples exist of siRNA being tested 
clinically in humans.  In addition to the fact that RNAi is still a relatively young 
technology, the primary reason that RNAi drugs are rare is the inability to overcome 
the problems of biodistribution, siRNA stability, cellular delivery, and tissue targeting, 
as discussed in the prior sections.  For this reason, all clinical trials to date rely on 
localized delivery of the siRNA-based drugs. 
Three companies are currently in the process of conducting clinical trials of 
RNAi drugs.  Acuity Pharmaceuticals (recently merged with Froptix Corp. and 
eXegenics, Inc.) was the first to begin a phase I clinical trial for a siRNA drug in 
November of 2004.  This siRNA targets the gene for vascular endothelial growth factor 
(VEGF) to halt angiogenesis in the macula.  Up-regulation of this gene is one of the 
major factors in causing wet age-related macular degeneration (AMD).  The drug, 
called bevasiranib, is delivered intra-ocularly to stop the progression of the disease.  
This drug was also the first to reach the milestone of a double-blinded phase II study in 
July of 2005.  Although it is not yet on the market, Acuity has reported positive results 
relating to halting the disease progression and maintaining safety.  SiRNA 
Therapeutics (recently acquired by Merck & Co.) has also completed phase I trials 
using a siRNA drug, Sirna-027, targeting wet AMD.  In addition, they are moving 
rapidly toward clinical trials of a hepatitis C targeting siRNA, Sirna-034.  Lastly, 
Alnylam Pharmaceuticals have developed a siRNA drug, ALN-RSV01, which targets 
nucleocapsid protein to prevent viral replication against respiratory syncytial virus 
(RSV).  Phase I clinical trials for this compound began in December of 2005, and a 
human experimental infection model was initiated in November of 2006.  However, to 
achieve RNAi by systemic delivery, some of the technologies discussed in the prior 
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section will need to be applied.  Indeed, many of these techniques have been adopted 
outside of academia.  A strong commercial contingent is actively pursuing techniques 
that will improve the pharmacological potential of siRNAs. 
The development of delivery systems is of paramount importance to the 
successful generation of RNAi therapeutics.  Several companies have adopted a lipid-
mediated approach to this problem.  Silence Therapeutics (formerly SR Pharma) has 
developed siRNA-lipoplexes that function very similar to cationic liposomes that are 
used to transfect cell culture.  In addition to complexing the NAs with a lipid delivery 
system, this company has developed a siRNA structure that is blunt-ended and 
contains alternating 2’-modifications to impart enzymatic stability.  A similar lipid 
approach has been adopted by SiRNA Therapeutics in which lipid nanoparticles are 
used to physically encase the effector for delivery.  For both of these cases, the siRNA 
complexes are endocytosed and then released intracellularly.  A more tissue-specific 
version of this strategy was developed by Calando Pharmaceuticals.  In their strategy, 
siRNAs are end-conjugated to a polymer, which are complexed into nanoparticle 
structures.  These polymers have the ability to target specific cell surface receptors 
and induce endocytosis.  Nastech Pharmaceutical Company Inc., has taken this 
cellular targeting strategy one step further to promote siRNA delivery specifically at 
tight junctions of epithelial and endothelial cells.  High-throughput screening is used to 
identify compounds that interact with these tight junctions and then candidate 
compounds are used as carriers for delivery of siRNAs.  Nastech also uses siRNA 
sequences that are screened for natural enzyme resistance and replaces ribouracil 
with ribothymine to reduce off-target silencing through improved hybridization 
properties.  Due to the known enzyme susceptibility of siRNAs and the complications 
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associated with global and specific cellular delivery, it is reasonable to assume that 
systemic application of RNAi drugs will require the combination of several 
technological advancements. 
If the hurdles associated RNAi drugs are overcome, the therapeutic 
applications are nearly limitless.  Three of the most important areas of RNAi potential 
applications include antivirals, treatments for neurodegenerative disorders, and cancer 
therapies.  For example, the development of vaccines is severally limited when the 
virus of interest proves to be highly mutagenic.  RNAi offers the alternative of targeting 
highly conserved regions of the genome, as opposed to targeting viral surface 
antigens.  Examples of viruses that may one day be treatable with RNAi drugs include 
influenza, hepatitis C, and HIV.  As aforementioned, Alnylam has already completed 
phase I clinical trials with a siRNA against RSV, a viral target.  Alnylam is also working 
with Medtronic toward a technology that would allow for local delivery of siRNAs to 
treat neurodegenerative diseases via an implantable infusion pump.  As a final 
example, Calando is expected to file a new drug application for a cancer targeting 
siRNA, CALAA-01.  Despite the guarded optimism for RNAi drugs, they are 
fundamentally untested in therapeutic applications.  In order to truly estimate the 
impact of RNAi, more validation in human trials are necessary.  
 
1.3:  Caging  
1.3.1: Definition and Historical Perspective 
Traditional chemical modulators of biological processes are unable to 
achieve the necessary spatiotemporal control required for some experimental 
investigations and targeting for therapeutics.  One strategy to achieve this control is to 
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develop compounds whose activity is dependant on a conditional trigger.  Light 
exemplifies an ideal external trigger for inducing mechanisms with extraordinary spatial 
and temporal resolution.  Light-induced activation of biological molecules is typically 
accomplished by first rendering the molecule of interest inert through conjugation of a 
photoprotecting group, or “caging”, which can later be removed by exposure to an 
appropriate light source.  Caging is very specific term, which describes the use of a 
photolytic chromophore for the rapid release of a biologically active substrate (Kaplan, 
Forbush et al. 1978).  The covalent attachment of a photosensitive compound 
produces a photo-caged compound when the attachment of this group blocks native 
biochemical or biological activity and the blocked activity can be restored by light 
treatment.  Therefore, the term “caged,” in this context, is descriptive of the photo-
activation property and does not refer to physical trapping of the inactivated substance 
within a crystal lattice or shell.  For the purposes of this work, the term caging is more 
narrowly defined.  Caging refers to the covalent attachment of one or multiple 
chromophores to a biomolecule, and the attachment of the caging compound(s) must 
alter the normal biological activity of the substrate.  In nearly all cases, it is desired that 
the caged molecule is functionally inert.  Attachment of the cage and inactivation of the 
biomolecule must be transient and reversible in the presence of the appropriate 
incident light.  This restriction eliminates stable photo-responsive elements, such as 
biological photoswitches (Reviewed by (Mayer and Heckel 2006)).  Finally, the photo-
responsive biomolecule must not be naturally occurring.  Although the definition of 
caging requires that the photochemistry be used to release a biochemically active 
substrate, the initial findings by Kaplan and colleges was inspired by earlier reports in 
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which photolabile residues were used as protecting groups in synthetic chemistry for 
carboxylic acids, alcohols, amines, ketones, or phosphates (reviewed by (Pillai 1980)). 
 
Classically, caged compounds have been used to study the time course of 
cellular responses induced by a millisecond step increase in the intracellular 
concentration of a bioactive compound of interest. As aforementioned, Kaplan et al. 
(Kaplan, Forbush et al. 1978) was the first to apply this type of photochemistry to 
release an inducer to a biological system, the Na:K ion pump from erythrocytes (e.g. 
ATP, Fig. 1.3).  Time course experiments using caged compounds have been used to 
study a wide range of biological processes in vitro and in vivo, including studies of cell 
motility, muscle fibers, active transport proteins, biological membranes and other 
intracellular responses (reviewed by (McCray and Trentham 1989; Pelliccioli and Wirz 
2002; Mayer and Heckel 2006; Ellis-Davies 2007)).  Applications of cage groups have 
expanded beyond their beginnings in organic synthesis and step increases in 
concentration of biological inducers to play an important role in the inactivation of 
macro-biomolecules.  While the early biochemical studies were limited to evaluating 
the time course of brief biological responses in vitro and in situ, caged macromolecules 
afford control to a broad range of wet-bench and potentially therapeutic applications.  







































Released ATPg-phosphate caged ATP
hn +
 
Figure 1.3: 2-Nitrobenzyl γ -phosphate caged ATP and photolytic release 
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lipids, and nucleic acids (Mayer and Heckel 2006; Ellis-Davies 2007).  Photoprotected 
species can be dispersed throughout the biological target without eliciting the normal 
bioactivity, which is a major advantage over conventional methods for substrate 
release.  Additional benefits of this strategy include control over the local concentration 
and spatial distribution, and the temporal release of the effector can be varied from 
seconds to nanoseconds (Givens, Weber et al. 1998). 
In order to be effective in biological systems, cage compounds must exhibit 
various characteristics to achieve the desired response while avoiding unwanted-
effects (reviewed by (Mayer and Heckel 2006; Ellis-Davies 2007; Tang and 
Dmochowski 2007)).  The chromatic properties of the caged species must allow for 
efficient and non-toxic substrate release.  Therefore the cage should have both a high 
extinction coefficient at non-damaging wavelengths, corresponding to strong light 
absorption characteristics, as well as a high quantum yield, which dictates energy 
conversion efficiency.  For applications in which a rapid biological response is being 
measured, the rate at which the product is released through dark-reaction 
intermediates may also be a significant factor.  The caged molecule should be water 
soluble and resistant to hydrolysis in order to be properly utilized under aqueous 
conditions in physiological pH ranges.  Additionally, the caged molecule and the 
released byproduct(s) should be physiologically inert to avoid potentially toxic side-
responses.  Lastly, in order to progress beyond proof-of-concept studies, the mode of 
covalent attachment between the cage and biomolecule should be relatively simple, 
reproducible, and cost efficient.  Although many caging systems adequately adhere to 
these characteristics, no single cage exhibits the ideal properties for all categories.   
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Many types of caging groups have been developed in efforts to improve the 
aforementioned properties.  However, most of these are simple conjugations to already 
known photoprotecting groups.  For instance, nitrobenzyl derivatives are often adorned 
with electron donating functional moieties to achieve a hyperchromatic absorbance 
shift into the near UV-light range (Aujard, Benbrahim et al. 2006).  Nitrobenzyl 
derivatives are the most extensively studied of all the caging groups and were selected 
for this study.  A review of caging groups for nucleic acids is presented in the following 
section.  
 
1.3.2   Common Cage Groups 
The number of incidences in which photoprotection groups have been used 
to cage biomolecules has been rapidly expanding since ATP was first caged by Kaplan 
in 1978.  For the purposes of this study, emphasis is placed a general review of 
various categories of cage compounds while providing periodic examples of 
applications.  Although the experimental section of this work only utilizes one of these 
caging groups, an understanding of available alternatives is paramount to future works 
that may improve upon this body of work.   
 
1.3.2.1 2-Nitrobenzyl Caging Group 
The 2-nitrobenzyl (2-NB) caging group and its derivatives are the most 
widely utilized cage molecules to date, and therefore are the best characterized 
(Goeldner and Givens 2006).  The pervasiveness in the literature in not necessarily an 
indicator that this caging group has ideal photochemical properties or is the easiest to 
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use via synthetic or biochemical methods, but rather its’ widespread use first type of 
cage compound applied to biological systems.  Kaplan’s pioneering work using caged 
ATP for controlling the NA:K pump utilized 2-NB cages from this category (Kaplan, 
Forbush et al. 1978).  They were also the first used to study millisecond time-scale 
induction of the actin-myosin response to photolysed caged ATP (McCray, Herbette et 
al. 1980; Goldman, Hibberd et al. 1982).  The basic structure that defines the group is 
a benzyl structure with an ortho-located nitro substitution.  Variants of this structure 
commonly include substitutions directly on the carbon ring and/or alternative 
attachment chemistry on the methyl group (fig. 1.4a). 
 
 
Cage compounds in the 2-NB family of can be further subdivided based on 
different substitutions at positions 4 and 5 as well as the exocyclic linker, as illustrated 
in figure 1.4a.  Common subdivisions include 2-nitrobenzyl (NB) (fig. 1.4b), 4,5-
































Figure 1.4: 2-nitrobenzyl derivatives 
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(4,5-dimethoxy-2-nitrophenyl)ethyl (DMNPE) (fig. 1.4e), and α-carboxy-2-nitrobenzyl 
(CNB) (fig. 1.4f).  The driving motivation for developing derivatized forms of the cage 
compound is to improve either the rate or efficiency of photolysis.  Generally, electron 
donating ring substitutions result a hyperchromatic absorbance shift, allowing 
photolysis at longer wavelengths that are less damaging to biological systems.  
However, these substitutions often significantly reduce the efficiency of photolysis 
(Aujard, Benbrahim et al. 2006; Goeldner and Givens 2006).  Benzylic carbon α-
substitutions presumably affect the C-H bond at the site of attachment in the excited 
state, which may affect the rate of hydrogen transfer that forms the aci-nitro 
intermediate, illustrated below (Goeldner and Givens 2006).   However, the decay 
process of 2-NB photo-cleavage is complex, and the rate constants at each stage 
depend heavily on pH, make up of the media or buffer, the nature of the substrate, as 
well as derivations to the cage compound (Il'ichev, Schworer et al. 2004).  
The currently theorized mechanism of 2-NB photolysis begins with the 
delivery of a photon that can be absorbed by the chromophore and induces an excited 
state.  Both singlet and triplet excited states have been identified and either state may 
cause the hydrogen transfer to form the Z-nitronic acid (aci-nitro), which is converted to 
the E-isomeric form (Yip, Sharma et al. 1985; Yip, Wen et al. 1991; 2006).  The 
resulting aci-nitro compound is a long-lived intermediate and with several possible 
isomeric forms, as aforementioned.  It is the E,E isomer that spontaneously forms the 
cyclic benzisoxazole that will ultimately lead to substrate release.  This structure is 
converted to hemi-acetyl intermediate, which is then further hydrolyzed to the 2-
nitrosobenzylcarbonyl and the released biomolecule (Walker, Reid et al. 1988; Corrie, 
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Barth et al. 2003; Il'ichev, Schworer et al. 2004) (Goeldner and Givens 2006).  The 
nitroso byproduct has historically been theorized to be potentially reactive and toxic to 
biological systems.  However, there are only a few incidences of complications related 
to this byproduct reported in the literature (Kaplan, Forbush et al. 1978; Zhang, Buchet 
et al. 2004) and subsequent work suggests that the conclusions of these studies were 
not accurate (Goeldner and Givens 2006). 
 
1.3.2.2  p-Hydroxyphenacyl Caging Group 
The p-hydroxyphenacyl group (pHP) is a relatively new category of caging 
compounds.  Although it was first utilized in photo-reactions in 1962 (Anderson and 
Reese 1962) and identified as a potential photolabile protecting group by releasing 
glycine in 1973 (Sheehan and Umezawa 1973), it was only about a decade ago that 
this family of compounds was utilized as a caging group for biomolecules.  Much like 





































Figure 1.5: Proposed photolytic mechanism of 2-nitrobenzyl  
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Givens and Park to generate photo-released ATP (Givens and Park 1996; Park and 
Givens 1997).  Despite their recent entry into the caging field, these compounds have 
been met with enthusiasm and are often included in biocaging review articles 
(Pelliccioli and Wirz 2002; 2006; Mayer and Heckel 2006). 
As dictated in the name, the general structure of the pHP group consists a 
phenyl ring with an acyl attachment chemistry and a hydroxyl in the para-position.  The 
acyl functional group attachment allows for several attachment schemes such as 
carbonyls, acyl halides, esters, and more.  Other substitutions can be made at the 
meta-positions on the phenyl ring.  Electron donating groups at these positions cause 
a hyperchromatic shift, but they also drastically reduce the quantum yield of the photo-
reaction (Conrad, Givens et al. 2000).  In contrast, electron-withdrawing ring 
substitutions tend to increase the quantum yield (Goeldner and Givens 2006).  
Interestingly, the withdrawing substitutions have little affect on the absorption spectra.  
Figure 1.6 illustrates the basic structure of the pHP cage group.  
The photo-release mechanism of the pHP cage is not as well understood as 
the 2-NB group, but a general proposed chemical pathway has been proposed.  The 











Figure 1.6: p-hydroxyphenacyl cage group 
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This is then converted to a triplet state prior to substrate release (Conrad, Givens et al. 
2000).  Deprotonation of the excited compounds results in an anion oxide intermediate.  
The proton transfer from the caged species to the solvent is supported by a strong 
dependence on solution pH for uncaging (Goeldner and Givens 2006).  The anion form 
of the caged species is believed to undergo substrate release as the rate limiting step 
as illustrated in figure 1.7 (Goeldner and Givens 2006).  However, this process is 
currently considered to be speculative.  The resulting intermediate is believed to 
undergo hydrolysis and reprotonization to form p-hydroxyphenylacetic acid (pHPA).  
Other proposed mechanisms hypothesize direct substrate cleavage from the triplet 
excited state (not shown) (Goeldner and Givens 2006).  These mechanisms would 
allow for O-methyl or alkylether groups at the para-position, since deprotonization is 
not required.  In addition, the cage intermediate following substrate release may be in 
equilibrium with an anion oxide isomer.  Other exceptions to the proposed mechanism 
include an example in which caged carboxylic esters photo-released directly from the 
singlet state (Zhang, Corrie et al. 1999; Zhang and Taylor 1999) and that an attempt to 
identify the spirodienedione intermediate through TRIR were unsuccessful (Pelliccioli 
and Wirz 2002). 
Substrates caged by pHP include but are not limited to ATP (Givens and 
Park 1996; Park and Givens 1997), phosphates (Park and Givens 1997; Conrad, 
Givens et al. 2000), and various amino acid based structures (Givens, Jung et al. 
1997).  These studies indicate that the pHP cage group is capable of desirable 
quantum yields, rapid photo-release, acceptable solubility and stability in aqueous 
conditions, and non-toxic photo products.  In addition to the favorable aspects of these 
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compounds, several drawbacks were also identified.  Most notably, these compounds 
do not absorb well for wavelengths above 320 nm (Pelliccioli and Wirz 2002).  As 
aforementioned, derivations on the ring structure can improve the absorption 
properties, but this causes in a drastic decrease in quantum yield. 
 
 
1.3.2.3 Coumarinyl Caging Group 
The coumarinyl group was first recognized as a potential photoprotection 






















































Figure 1.8: The coumarinyl cage group 
(Givens and Matuszewski 1984).  It was nearly a decade later before this chemical 
group was evaluated as alternative cage compounds for the 2-NB group (Furuta, 
Torigai et al. 1993).  These compounds typically possess high absorption coefficients, 
fast photo-release kinetics, and large two-photon excitation cross-sections (Pelliccioli 
and Wirz 2002; 2006).  The strong absorption properties of these compounds (εmax 
typically from 4,000 to 20,000 M-1cm-1) make up for relatively poor quantum yields of 
photo-release (Goeldner and Givens 2006).  Another property of these cage 
compounds is a strong fluorescence signal.  The emission spectra may overlap with 
common fluorescent probes, which limits the use of coumarin derivatives in certain 
biochemical assays.  Despite this minor limitation, the coumarinyl group has 
demonstrated practical photochemical properties along with a wide diversity of 
derivatization possibilities. 
The base structure of this group is a derivatized coumarin, as the name 
indicates.  Coumarins consist of two fused six-member rings, one of which is an 
oxygen containing heterocyclic ring with an adjacent carbonyl group (figure 1.8).  
Attachment is in the meta-position in reference to the ring-bound oxygen.  A methyl
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functionality lies between the bound substrate and the coumarin.  Ring-substitutions at 
C6 and C7 are commonly used to red-shift the absorption maxima.  Ring 
derivatizations can also be used to improve membrane permeability and water 
solubility.  In addition to these substitutions, the nature of the bound substrate can 
have a significant effect on the photochemical properties of cage release.  The 
coumarinyl group can be subdivided into several groups consisting of; 7-alkoxy, 6,7-
dialkoxy, 6-bromo-7-alkoxy, and 7-dialkylamino (reviewed by (Goeldner and Givens 













































Figure 1.9: Coumarinyl proposed photolytic mechanisms 
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A photo-release mechanism was proposed from the studies of various 
coumaryl-caged phosphates (Schade, Hagen et al. 1999; Eckardt, Hagen et al. 2002; 
Hagen, Frings et al. 2003).  In this scheme, photo-activation results in an excited 
singlet state, followed by heterolysis or homolysis and subsequent electron transfer at 
the site of substrate attachment.  The unstable cationic released cage is then trapped 
by the solvent.  Figure 1.9 demonstrates this mechanism.  Alternatively, studies of 
coumarinyl-caged amines suggested a slightly different mode of photo-release, shown 
in figure 1.9b (Sarker, Kaneko et al. 1997; Sarker, Kaneko et al. 1998; Schoenleber 
and Giese 2003).  Photo-excitation results in electron-donor dependent homolytic 
cleavage and the formation of a radical anion intermediate. 
The coumarinyl group has successfully been used to cage phosphates, 
carboxylates, carbonyls, alcohols, amines, and sulfonates (reviewed by (Goeldner and 
Givens 2006)).  Generally, the photo-kinetic properties of these compounds and the 
flexibility for creating various coumarin derivatives are desirable.  Despite the success 
of this group used for in vitro assays, only a few examples in biological systems exist.  
However, these studies have also yielded positive results.  In fact, one of the first 
examples of a coumarinyl-caged macromolecule used in a biological system was a 
Bhc-caged mRNA for photo-induction of gene expression (Ando, Furuta et al. 2001; 
Ando, Furuta et al. 2004). 
  
1.3.2.4 Benzoin Caging Group 
The benzoin group was first reported in 1971, where 3’,5’-dimethoxybenzoin 
caged acetate was released upon photoexposure (Sheehan and Umezawa 1973).  
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This study reported a clean photolysis reaction yielding acetate and 
dimethoxybenzofuran at an exceptionally high quantum efficiency (Φ = 0.64).  
Although various other derivatives have been tested, the two most common forms 
include the unsubstituted and the 3’,5’-dimethoxy benzoins (reviewed by (Pelliccioli 
and Wirz 2002)).  The general structure of these compounds is depicted in figure 1.10, 
along with the general photo-release scheme.  A detailed figure on the photo-release 
mechanism is not shown do to the high degree of disagreement in several proposed 
mechanisms.  It is likely that the nature of the substrate and the attachment chemistry 
have a profound effect on the mode of photo-release.  Several studies demonstrate  
quenching of photo-release by the addition of piperylene or naphthalene, indicating 
that photolysis occurs through the excited triplet state (Sheehan and Umezawa 1973; 
Rajesh, Givens et al. 2000).  These quenchers facilitate vibration relaxation of the 
excited state, and they function through the triplet state since it is less energetic.  
However, studies of different benzoin-caged substrates demonstrated a lack of 
susceptibility to quenching(Sheehan and Umezawa 1973; Pirrung and Shuey 1994), 
suggesting different photolytic pathways.  Proposed mechanisms of photolysis include 
heterolytic dissociation and cation formation through the singlet state (Rajesh, Givens 
et al. 2000), formation of a strained bicyclic intermediate that breaks down to release 










Figure 1.10:  The benzoin cage group 
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form an ion pair followed by elimination through ring closure (Cameron, Willson et al. 
1996). 
Benzoin cage compounds typically exhibit high quantum yields and fast 
release kinetics, (Sheehan, Wilson et al. 1971; Corrie and Trentham 1992; Givens, 
Athey et al. 1993; Pelliccioli and Wirz 2002).  However, there are several drawbacks to 
this cage group.  It has a strong absorption coefficient, but this occurs in the 300 nm 
range (Pelliccioli and Wirz 2002).  Radiation of this wavelength is not tolerated by 
biological systems.  Additionally, these compounds exhibit strong fluorescence, limiting 
their use for some fluorescence-based in vitro assays (Pirrung and Shuey 1994).  
Finally, these compounds are highly hydrophobic and reduce the solubility of the 
bounds substrate in physiological conditions.  An attempt to develop a water soluble 
derivative using bis(carboxymethoxy) substitutions reduced the photolytic yield (Rock 
and Chan 1998).    
 
1.3.3   Caging of Nucleic Acids 
Examples of caged nucleic acids (NAs) are much less abundant and more 
recent when compared to other categories of caged compounds, such as small-
molecule metabolites and proteins.  This is surprising given that the original model for 
caged biomolecules was based on nucleotides such as caged-ATP (Kaplan, Forbush 
et al. 1978).  Additionally, the potential utility of caging NAs is readily apparent since 
they participate in a variety of biochemical reactions that are inherently dependent on 
structure.  Although earlier examples of caged NAs exist, the first study in which caged 
DNA was used in a cellular system did not occur until 1999 (Monroe, McQuain et al. 
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1999; Monroe, McQuain et al. 1999).  In this work, plasmids encoding for GFP or 
luciferase were caged with DMNPE-groups in bulk based on diazo attachment to 
nucleotide phosphates.  Using this strategy, the authors were able to demonstrate 
photo-induced transgene expression.  Despite this three-decade gap from caged ATP 
to caged DNA use in biological systems, this study ignited interest in the field by 
demonstrating the utility of caging NAs. 
Prior to the 1999 study by Haselton and colleagues, there were several 
examples of caged NAs being used for chemical or enzymatic applications in vitro.  
Photoprotection groups offer alternatives for NA synthesis.  Caging has been used for 
microarray oligonucleotide synthesis (McGall, Labadie et al. 1996) and as an 
alternative nucleobase protection for solid-phase synthesis (Alvarez, Vasseur et al. 
1999).  This technique has also been used to control the self annealing of a hairpin 
(Ordoukhanian and Taylor 1995) and the hybridization of an oligonucleotide to its 
complement (Ghosn, Haselton et al. 2005).  Caging compounds have also been 
employed by Meldrum et al. to study DNA repair kinetics (Meldrum, Chittock et al. 
1998).  This study was an extension of their earlier work in which radiolabeled caged-
ATP was used to study the same phenomenon (Meldrum, Shall et al. 1990).  The first 
example of a nucleic acid with a caged compound inserted at a precise location was 
demonstrated by Chaulk and Macmillian (Chaulk and MacMillan 1998).  In this study 
the authors prepared a 2’-O-caged phosphoramidite for insertion into a full-length RNA 
oligonucleotide.  They prepared a ribozyme target that was caged at the site of 
catalytic cleavage and demonstrated protection of the RNA substrate until 
photoexposure.  These authors expanded on this original work to disrupt splicesome 
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and polymerase activity using the site-specifically caged NA strategy (Chaulk and 
MacMillan 2001).  Responding to requests from the scientific community, Chaulk and 
MacMillian have recently published detailed protocols for their technique (Chaulk and 
MacMillan 2007).  This 2’-hydroxyl caging strategy was later adopted by Pitsch for the 
development of alternative conditions for synthesizing RNA (Pitsch, Weiss et al. 1999).  
In addition to these early studies, there is a large body of literature relating to photo-
induction of strand breaks using photosensitive adducts (Reviewed by (Mayer and 
Heckel 2006)). 
Chaulk and MacMillian used a de novo synthetic process to cage RNA on 
the 2’-hydroxyl while Monroe et al. used a batch-style reaction to achieve random 
attachment to the phosphate backbone, or “statistical caging”.  The latter was also 
adopted to cage mRNA and plasmid DNA using a derivatized coumarin caging group 
(Ando, Furuta et al. 2001; Ando and Okamoto 2003).  Through this strategy, Ando et 
al. were able to control transcription of the mRNA in a zebrafish model.  Interestingly, 
the caged mRNA appeared to be surprisingly stabile.  This contrasts with our results, 
in which caging of double-stranded RNA resulted in fragmentation of the target (see 
section 1.4), presumably through a 2’-hydroxyl attack at the phosphotriester (Breslow 
and Xu).  The same approach which caused hydrolysis of the dsRNA was used to 
produce 1-(4,5-dimethoxy-2-nitropheynl)ether (DMNPE) caged siRNAs (Shah, 
Rangarajan et al. 2005).  In both incidences of statistical RNA backbone caging 
reported in the literature, the caged RNA effectors demonstrated reduced activity 
relative to their respective controls, which was partially restored by exposure to 350-
365nm light.  In an effort to reduce the leak activity, improve the efficiency of photo-
 46
induction, and avoid RNA hydrolysis, two groups have separately expanded on caged 
siRNA by incorporating a single photolabile group onto the 5’ terminal phosphate of the 
siRNA antisense strand (Nguyen, Chavli et al. 2006; Shah and Friedman 2007).  
These studies are discussed in further detail in chapter 3.  Briefly, Nguyen et al. 
demonstrated that these caged siRNA had very little activity until silencing was 
efficiently restored with light.  Small leak activities were explained by N-1 contaminants 
from the synthesis process, in which the cage-containing terminal nucleotide was 
missing.  Shah and Friedman disputed this interpretation since their data shows a 
significant higher leak RNAi activity in the caged state.  Their interpretation was that 
the RISC components have the ability to interact with the remaining non-bridging 
phosphate-bound oxygen, allowing some RNAi to proceed.   
Significant progress has been made in recent years toward site-specific 
caging of nucleic acids.  A review of the studies above suggests that in order to 
achieve a binary, “on-off behavior”, for caged NAs, control over positioning of the 
caging group is necessary.  The original work by Chaulk and MacMillian was limited to 
only adenosine residues that are caged on the 2’-hydroxyl.  However, the design of a 
caged NA for various effectors will require more flexibility.  Pitsch and colleagues 
expanded the 2’-O-caging to include the other bases.  However, other work has 
attempted to include the caging species on the nucleobases.  The first example of a 
caged nucleobase appeared in 1992, where a caged adenosine derivative was used 
for self-replication but was not incorporated into an oligonucleotide (Hong, Feng et al. 
1992).  The first example of a caged base within an oligonucleotide came in 2004 and 
was also an adenosine derivative (Ting, Lermer et al. 2004).  This study used a non-
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traditional photoactive C8 thioether-linkage to control DNAzyme activity.  Shortly after 
this study, the 2-nitrobenzyl caging moiety was used for all bases.  A 2-nitrobenzyl 
group to cage the O4-position of thymine and the resulting NAs were used to disrupt 
T7 polymerase (Krock and Heckel 2005) and control aptamer activity (Heckel and 
Mayer 2005).  This same team also caged the guanine nucleobase in order to control 
aptamer activity by controlling G-quadruplex structure formation (Mayer, Krock et al. 
2005).  At nearly the same time, another group presented NPE caged guanine to study 
tertiary folding kinetics of RNA (Wenter, Furtig et al. 2005).  Almost immediately 
following these studies, Höbartner and Silverman produced a complete set of NPE 
base-caged RNA residues (Hobartner and Silverman 2005).  This offers a great deal of 
design flexibility to researched developing caged oligonucleotide effectors.  However, 
these compounds are still significantly limited in two ways.  First, generation of the 
caged precursors requires considerable chemical expertise and is a limiting factor for 
many biologists.  Second, since the caging groups are non-substituted 2-nitrobenzyl 
cage groups, uncaging requires photoexposure in a range of wavelengths that is 
damaging to biological systems.  One final example of base caging comes from 
Dmochowski and colleagues.  This group has created a 25nt oligonucleotide 
containing a cytosine with a nitrobenzyl linker that is further conjugated to a 
fluorescence quencher (Tang and Dmochowski 2005).  An adjacent nucleotide 
contains a fluorophore, which emits a fluorescent signal upon photo-release of the 
quencher.  They used this cage attachment chemistry to control RNAse H mediated 
digestion through hairpin loop caging (Tang and Dmochowski 2006).    
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1.3.4 Special Considerations 
1.3.4.1 Two-Photon Excitation
One of the newest frontiers in caging technology is the application of the 
two-photon excitation (TPE) strategy, first applied by Webb and colleagues (Denk, 
Strickler et al. 1990).  The time required to produce an excited electron state when a 
chromophore absorbs a single photon is on the order of 10-15 s-1 (Ellis-Davies 2007).  
TPE occurs when two photons of half the necessary energy are absorbed within this 
time-frame, or “simultaneous” absorption.  The probability for the simultaneous 
absorption of two photons is proportional to the square of the incident light intensity 
and the two-photon absorption cross-section, measured in units of Göppert-Mayer (1 
GM = 10-50 cm4·s·photon-1) (Göppert-Mayer 1931; Pelliccioli and Wirz 2002).  This 
strategy has several advantages over single-photon uncaging.  Since the excitation is 
exponentially dependent on the incident light intensity, much greater three-dimensional 






Figure 1.11: One versus two-photon uncaging.  Brackets and shading depict the 
region of efficient uncaging. 
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confined to a very small region near the focal point of the excitation laser.  It has been 
demonstrated that the spatial resolution of TPE can reach sub-femtoliter volumes 
[Brown, 1999 #334; Brown, 1996 #335].  Another benefit of TPE is that it relies on IR 
radiation for excitation.  Light in this wavelength range is capable of deeper tissue 
penetration and is less likely to cause damage to biological systems.  Nevertheless, 
photo-toxicity is response to TPE has been observed in biological systems when the 
power of the incident laser exceeds 5 to 10 mW (Hopt and Neher 2001). 
 
1.3.4.2 Convertible Nucleoside Approach 
An alternative to generating phosphoramidites containing photolabile 
protecting groups on the nucleobase or the ribose 2’-hydroxyl is post-synthesis 
substitution of the oligonucleotide.  For this technique to be affective, the protecting 
groups used need to be stabile under the conditions of RNA solid-phase synthesis, but 
they must also susceptible to some form of substitution for post-synthetic placement of 
the cage compound.  In an effort to generate cross-linked nucleic acid duplexes to 
study DNA-protein interactions, a group led by Verdine developed a method for 
incorporating reactive nucleotide analogs for post-synthetic substitution of NAs.  They 
named their technique “the convertible nucleotide approach” (Ferentz and Verdine 
1992; Ferentz, Keating et al. 1993).  Building on the foundation of successful post-
synthetic modification, this group developed a complete set of convertible nucleotide 
analogues for site-specific incorporation into DNA (Macmillan and Verdine 1990; 
Macmillan and Verdine 1991; Erlanson, Chen et al. 1993; Ferentz, Keating et al. 1993) 
and RNA (Allerson and Verdine 1995; Allerson 1996; Allerson, Chen et al. 1997).  The 
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conversion reaction requires a primary amine that is nucleophilic in nature and is 
performed following oligonucleotide synthesis.  In the case of convertible RNA, this 
reaction is performed prior to 2’-deprotection.  If a suitable cage compound containing 
a nucleophilic amine is available, this process would be practical for biologists and 
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Figure 1.12.   Convertible nucleotide approach. Benzylamine used as a model for 2-
nitrobenzylamine mediated caging. A = convertible adenosine reaction, B = 
convertible cytosine reaction, and C = convertible guanine reaction 
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Although a number of amines were tested by Verdine’s group, the 
attachment of a 2-nitrobenzyl group through the convertible nucleotide approach was 
not attempted.  However this group did successfully demonstrate the conversion 
reaction using benzyl amine (fig 1.12) (Allerson 1996).  Recently, this same chemistry 
was used to generate site-specifically modified siRNAs by reacting benzyl amine with 
an internal convertible G (Puthenveetil, Whitby et al. 2006).  Although the authors of 
the latter study were using this technique to probe the cytokine response induced by 
small RNA duplexes, this serves as a foundation for the use of this approach for site-
specifically modified siRNAs.  This work demonstrates the use of this approach to 





Initial Feasibility Studies for Caging RNA 
 
2.1 Determination of Caging Efficiency 
Before experimental conditions of cage attachment to oligonucleotides could 
be varied for optimization (described below), it was necessary to determine spectral 
properties of the dimethoxy-2-nitorbenzyl product.  The hypothesized position of cage 
attachment for the reactive diazo-intermediate is on the negatively charged phosphate 
of the NA.  This theory is based on common use of diazo chemistry to alkylate 
phosphate groups in addition to previous caged nucleic acid examples (reviewed by 
(Monroe and Haselton 2004)).  Therefore, the expected product would be a phosphate, 
which would likely have little effect on the absorbance spectrum of the NA.  A simple 
experiment was performed to determine the spectral properties of DMNPE-phosphate. 
2-nitrobenzyl hydrazone cage precursor (5 mg) was activated in DMF (1 mL) 
and filtered according to the protocol discussed below.  A control was simultaneously 
processed without the addition of the 2-nitrobenzyl hydrazone.  Both the activated 
diazo cage and process control (0.1 mL) were added to an excess of concentrated 
phosphoric acid (15 mL).  The process control was used to obtain baseline spectra at 
various dilutions in deionized water.  Absorbance spectra for several dilutions of 
reacted cage were obtained in triplicate, and extinction coefficients were determined 
for A260, A355, and A500.  The results (ε260 = 3064, ε355 = 4512, ε500 = 0 M-1cm-1), 
were in agreement with previous studies (reviewed by (Monroe and Haselton 2004)). 
Following a caging reaction, the isolated caged oligonucleotide products 
were analyzed through spectroscopy to determine caging efficiency.  Briefly, the 
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absorbance spectra of a caged products were measured from 230 to 500 nm.  A500 
was utilized as a standard to zero each measurement.  A355 was used to calculate the 
molar concentration of attached DMNPE.  Once this concentration was known, the 
absorbance at 260 nm due to this DMNPE was subtracted from the measured value.  
The corrected A260 was used to calculate the molar concentration of the nucleic acid.  
The degree of phosphate alkylation is reported as “caging efficiency”.  This term is 
descriptive of the percentage of the phosphate groups has reacted with the diazo 2-
nitrobenzyl.  For instance, an oligonucleotide with 20 monomers would have 19 
phosphate groups, assuming the 5’-end is not phosphorylated.  For this sample 
scenario, a 100% caged product would require a 19:1 molar ratio of oligonucleotide to 
cage group in solution.  
 
After UVA light exposure, the quantum yield (Φ) can be calculated for the 
photolysis event.  In this case, Φ refers to the number of photo-release events for each 
photon absorbed by the cage molecule.  Measuring this property requires an additional 









Equation 2.1:  Equation used to calculate the caging efficiency following removal of 
all unreacted diazo cage compound.  The numerator is used to determine the molar 
concentration of attached cage.  The denominator is used to calculate the molar 
concentration of free phosphates using a corrected absorbance. 
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proper product purification and characterization of the incident light, Φ can be 
calculated from analysis of the post-UVA light treated caged species and the pre-
determine absorbance properties of the cage molecule. 
 
2.2 Determination and Optimization of Caging Protocol  
The cage attachment procedure was modeled after previous examples in the 
literature (Monroe, McQuain et al. 1999; Ghosn, Haselton et al. 2005; Shah, 
Rangarajan et al. 2005).  Dimethoxy-2-nitorbenzyl hydrazone (5 mg) was dissolved in 
an organic solvent and converted to the diazo-form using MnO2 (50 mg) for 20 minutes 
at room temperature under agitation.  The MnO2 was pelleted through centrifugation 
and the supernatant was filtered through a prewetted diatomaceous earth column.  
The resulting active cage solution was added to an aqueous solution of NA, buffered to 
a desired pH.  The reaction was shielded from light, and typically allowed to react at 
4oC for 18 hours. Once complete, the unreacted cage was removed through size 
exclusion chromatography using solvent resistant LH-20 sephadex (GE Healthcare 
Bio-Sciences Corp., Piscataway, NJ).  The product solution was then dried in vacuo 
until most of the solvent was removed.  Deionized water was used to bring the 
LOG-1(ε355DMNPE · CDMNPE · L)
A355Caged - A355Caged
Quantum Yield (Φ) =
(ε355DMNPE) · L
Light Dose (J/cm2)
h · C(speed of light)
λ
Area ·
Equation 2.2:  Equation used to calculate Φ following photo-release.  The numerator 
is used to determine the molar amount of DMNPE removed by light treatment.  The 
denominator is used to calculate the number of photons absorbed by the caged 
species. 
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concentrated solution to 500 μL.  All remaining organic solvents, by products, and 
unreacted cage molecules were removed through a nitrocellulose spin filter (YM3, 
Microcon). 
 
In an effort to obtain purified products through a range of caging efficiencies, 
several variables of the caging reaction were investigated.  The following variables 
were examined to determine their effect on the caging reaction: nucleic acid type 
(DNA, RNA, PS, 2’-fluoro substituted NAs, morpholino), nucleobase composition, 
concentration and molar excess of active diazo-cage, reaction duration, reaction 
temperature, organic solvent, and pH of the aqueous buffer.  Variables which affected 
the efficiency of the cage reaction included pH, relative molar excess of active cage, 
and type of nucleic acid target.  PS NAs experienced the highest alkylation rate among 
the samples tested.  Morpholino oligonucleotides, which lack a phosphate backbone, 
also showed cage attachment, albeit at a lesser rate.  Since these polymers do not 
contain any phosphates, this suggests that either a minimal degree of nucleobase 
alkylation is possible or that a more specific reaction is occurring with the specialized 
Table 1.1 
Caging Efficiencies of Various NA Targets. 







5.5DNA mixed sequence 46.7 13.4 
8.0DNA mixed sequence 4.0 1.6 
5.5DNA oligo dT 41.5 9.3 
8.0DNA oligo dT 6.4 1.4 
5.5FNA mixed sequence 36.2 12.4 
5.5Morpholino mixed sequence 18.3 4.3 
8.0Morpholino mixed sequence 7.2 4.9 
 i  effi i i  f v ri   targets.  
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backbone of this NA.  Reaction with the backbone morpholinos is unlikely as they are 
comprised of stable 6-membered morpholino rings bound by phosphorodiamidate 
linkages.  Sugar-modifications seemed to have little effect on the caging process, and 
therefore DNA, RNA, and FNA all yielded equivalent efficiencies.  Reaction 
temperature and reaction duration also had little effect on the outcome of the reactions.  
This is likely because these reactions proceeded to completion in the timeframes that 
were tested, even at 19oC.  The organic solvent used to activate the cage hydrazone 
also had little effect on caging reaction outcome.  However, different organic solvents 
required optimization of the purification process to prevent loss of the product and poor 
reaction yields.  Altering base composition yielded somewhat inconsistent results.  

















Figure 2.1: Caging efficiency by cage concentration and reaction temperature 
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nucleic acid may have an unexpectedly robust influence on caging efficiency.  Below 
are results from two sample experiments that tested some of these variables.   
 In addition to developing a protocol to adjust the caging efficiencies for 
various NA targets, improvements to caged product purification were also required.  
Previous studies that utilized this caging technique targeted larger NAs such as 
plasmid DNA or mRNA (Monroe, McQuain et al. 1999; Ando, Furuta et al. 2001).  This 
required fewer caging molecules to render the biomolecules inert, which allows for the 
purification through phase separation.  For hybridization disruption, oligonucleotides 
seem to require a higher percentage of caged phosphates, which reduces the 
hydrophillicity of the molecule and results in inefficient liquid-liquid extraction.  Since 
caging of the oligonucleotides alters the hydrophillicity and eliminates backbone 
charge, separation based on these principles is challenging.  Size-exclusion 
chromatography and filtration, two techniques based on molecular size, provided the 
most reasonable alternative.  However, organic solvent contamination is often 
incompatible with the materials used for these separation techniques.  Additionally, the 
crude product can not simply be dried to remove the organic solvents because the 
unattached caging material will partially precipitate from the remaining aqueous 
solution.  Therefore, a solvent-resistant size-exclusion chromatography material, LH-20 
sephadex, was used.  The separation capabilities were tested for each organic solvent 
used in the reaction (DMF, DMSO, acetonitrile).  Figure 2.2 illustrates that separation 
occurs well for solutions containing 30% or less acetonitrile in aqueous buffer.  Any 
new solvent system must be tested in this manner to ensure proper cage removal.  
Once the solvent conditions were determined for adequate separation from the free 
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cage, the system was also tested using spin filters at a relative centrifugal force of 
500g.  Preswollen LH-20 sephadex could be used in either a gravity or spin column, 
and each technique had benefits and drawbacks.  Gravity columns could handle a 
larger load of material, but the process was slower and generated larger volumes that 
required longer drying steps.  Spin columns were very fast, but only a limited volume 
could be added to the column bed.  Additionally, the fixed angle rotor found in many 
microtube centrifuges sometimes caused uneven elution of the product solution.  
Following size-exclusion, the solutions were dried in vacuo until less than 25 μL of 
solvent remained in order to remove most of the organic component.  This solution 
was brought to a volume of 500 μL with deionized water and applied to the cellulose 
filtration system, YM3 amicon spin filters (Millipore, Billerica, MA).  The product was 
filtered several times by adding water to the filter and spinning to elute the unwanted 
          
 
Figure 2.2: LH-20 sephadex resolution.  Size-exclusion separation as a function of 
% organic solvent.  From left to right, loaded LH-20 sephadex was washed with 
100%, 80%, 60%, 40%, 20%, and 0% organic solvent (acetonitrile).  The panel on 
the right illustrates the resolution of a spin filter eluted at 400Xg at 30% organic 
solvent.
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material.  This step removed any remaining organic solvents, removed any remaining 
free cage contamination, and desalted the product.  However, this step was particularly 
sensitive to organic contamination, and improper handling before this step resulted in 
poor yields.  When performed properly, this cleaning protocol would consistently result 
in caged NA recovery yields greater than 90%. 
 
The final reaction conditions used to generate caged oligonucleotides that 
were unmodified on the phosphate or the nucleobase are as follows.  Dimethoxy-2-
nitorbenzyl hydrazone (5 mg) was dissolved in 1 mL of acetonitrile and activated using 
MnO2 (50 mg) for 20 minutes at room temperature.  If less efficiently caged products 
were desired, several dilutions of the active diazo-cage were made following MnO2 
removal.  The nucleic acid was diluted to 500 ng/μL in BisTris buffer (50 mM Bis-Tris-
HCl, 1 mM EDTA, pH 5.5), and the active cage was added to achieve a final solution of 
2:1 acetonitrile:water.  The reaction was agitated at 4oC for 18 hours in the dark.  At 
this time, water was added to the reaction solution to obtain a 3:10 acetonitrile:water 
concentration.  A gravity column was packed with prewetted LH-20 sephadex and 
washed with three column volumes using the appropriate solvent.  The entire reaction 
was added to the column and the eluent was collected.   The column was washed with 
3 X 200 μL using deionzed water to ensure all nucleic acid was eluted from the 
column.  The collected product was dried in a vacuum centrifuge until less than 25 μL 
remained.  This was added to 500 μL of water in a YM3 amicon spin filter, which was 
spun at 12,000Xg for 100 minutes.  Water was added (500 μL) twice and the spinning 
elution was repeated each time.  All eluents from this step were kept until the product 
recovery was verified, and then they were discarded.  YM3 filtration would typically 
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yield 50 μL of an aqueous solution of the purified product.  The product was measured 
by spectroscopy to determine caging efficiency and product yield. 
 
2.3 Caging of 700bp dsRNA 
 Initially it was proposed that caging of long double-stranded RNA would be a 
feasible means to control RNAi by light.  This has several benefits over caging small 
RNAs.  First, these targets can be generated more easily through in vitro enzymatic 
methods.  Secondly, this technique did not require the screening for active siRNA 
sequences, as Dicer acts to digest these products into a pool of siRNAs.  This process 
can be carried out in vitro using a recombinant Dicer enzyme to generate siRNAs for 
use in mammalian cell culture.  Finally, caging at this stage offers another level of 
control since the processing by Dicer is an additional protein-NA interaction that may 
be disrupted.  However, this preliminary experiment allowed the identification of a 
major design flaw in the original proposal.  
 The Dicer siRNA Generation Kit (Genelantis, San Diego, CA) provided all 
the necessary materials for the initial experiment including: the dicer enzyme, a control 
GFP reporter plasmid, T7 polymerase, and the appropriate PCR primers.  PCR was 
carried out according to the manufacturer instructions to generate a 700bp RNA 
transcript.  This dsRNA was subjected to the caging reaction using DMF as the organic 
solvent.  The product was analyzed by spectroscopy and DMNPE attachment was 
verified.  These products were further analyzed by capillary electrophoresis using the 
Agilent 2100 Bioanalyzer lab-on-a-chip platform and the accompanying DNA 1000 
reagent system [Agilent, Clara, CA], according to the manufacturer protocol.  Figure 
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2.3 shows the electropherograms of the resulting products as they relate to the 15bp 
and 1500bp internal standard peaks.  The process control RNA is detected at around 
90 seconds, which corresponds to the expected migration time for a 700bp NA.  
However, the caged sample elutes much sooner, at around 50 seconds.  This shift 
direction was unexpected since cage attachment should increase the migration time 
through standard principles of electrophoresis.  Indeed, photoexposure increased the 
mobility of the caged species, suggesting removal of the cage groups.   
 These results indicate that caging RNA using phosphate alkylating diazo 
cage compounds is possible, but it also results in fragmentation.  RNA is known to be 
susceptible to self-hydrolysis due to the presence of the 2’-hydroxyl on the ribose 
moiety.  Additionally, RNA phosphotriesters have been shown to be particularly 
Caged
Control + LightC ntrol
Caged + Light
Cage + LightControl + Light
 
Figure 2.3:  Capillary electrophoresis of caged 700bp dsRNA.  Faster elution of caged RNA 
indicated strand cleavage from the caging process.   
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unstable in aqueous solutions (Breslow and Xu).  This aqueous instability is due to the 
2’-hydroxyl attack and cyclization of the 2’-3’ positions of the ribose, creating an 
unstable intermediate.  Therefore internally caged nucleotides might be very 
susceptible to scissile bond cleavage and degradation of the RNA.  Alternatively, 
hydrolytic release of the cage molecule is a possibility. This experiment prompted a 
search for a chemically stabilized RNA mimic and is the subject of Chapter 3. 
 
2.4 Design of the siRNA for the pAcGFP Reporter System  
Established siRNA design requirements were followed, such as maintaining 
approximately 50% GC content of 21nt sense and antisense strands which hybridize to 
yield 2nt, 3’ overhangs (Elbashir, Lendeckel et al. 2001).  The overhangs were 
designed as UU on both strands, and a sequence was chosen so that the antisense 
overhang was still homologous to the target gene.  Additionally, the first nucleotide of 
both the sense and the antisense transcripts was guanine since it is typically the first 
addition by T7 polymerase (Donze and Picard 2002).  This required the 19th nucleotide 
of each transcript to be cytosine.  Additionally, several sequence requirements were 
necessary for endeavors into the site-specific incorporation of a cage species.  The 
most likely base for this site specific incorporation is adenosine because of its stability, 
history of ATP experiments, possession of an exocyclic primary amine, and previous 
caging of this nucleotide in the literature.  Therefore, one adenosine was placed within 
the first 5 nucleotides from the 5’-end and one was placed at the 11th nucleotide from 
this end.  These are considered as important sites for RISC recognition and mRNA 
processed.  The sequence of the GFP plasmid, pAcGFP-N1 (Clontech, Carlsbad, CA), 
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used in knockdown experiments was searched for an appropriate target, which was 
also subjected to a BLAST search to ensure no cross-reactivity with other known 
genes.   
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CHAPTER 3 
2’-Fluoro Nucleic Acids Induce RNA Interference 
 
3.1 Introduction 
RNA interference refers to a highly specific, very potent, and naturally-
occurring post-transcriptional silencing of protein expression initiated by RNA (for 
review, see (Tomari and Zamore 2005)).  Since its discovery in 1998 (Fire, Xu et al. 
1998), RNAi has drastically altered our understanding of gene regulation by 
introducing a plethora of small regulatory RNA molecules.  These molecules are 
termed small-interfering RNAs (siRNAs), small-hairpin RNAs (shRNAs), or microRNAs 
(miRNAs), depending on their origin and specific structure (Elbashir, Lendeckel et al. 
2001; Matzke and Matzke 2003).  In addition to these variations, recent works show 
that single-stranded RNA molecules (antisense siRNA) can elicit RNAi in mammals 
(Martinez, Patkaniowska et al. 2002; Schwarz, Hutvagner et al. 2002; Amarzguioui, 
Holen et al. 2003; Holen, Amarzguioui et al. 2003).  A collection of proteins known as 
the RNA-induced silencing compound (RISC) incorporate the siRNAs, which act as a 
guide for sequence recognition and enzymatic degradation of target mRNAs in the 
cytoplasm.  Some intramolecular RNA structural requirements that are necessary to 
elicit these various pathways and consequences with respect to siRNA design have 
been described in recent studies.  A common focus of these works is chemical 
modification of siRNAs to improve pharmacological efficacy.  In order to develop useful 
RNAi drugs, the siRNA must be efficiently delivered systemically, exhibit highly specific 
knockdown of the target gene, and maximize the duration of silencing.  For these 
reasons, modifications have been made which optimize the lipophilicity of RNA, 
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increase the stability of the duplex, and impart resistance to RNAses, respectively.  
The relative successes and failures of these modifications have helped to identify 
useful alterations that may be well-tolerated by the RNAi pathway.   
Phosphate backbone and ribose modifications are widely used to increase 
resistance of RNA to enzymatic degradation ((Elbashir, Lendeckel et al. 2001; 
Amarzguioui, Holen et al. 2003; Braasch, Jensen et al. 2003; Chiu and Rana 2003; 
Czauderna, Fechtner et al. 2003; Harborth, Elbashir et al. 2003; Dowler, Bergeron et 
al. 2006) reviewed by (Manoharan 2004; Zhang, Du et al. 2006)).  In addition to 
nucleases resistance other such modifications impart other desired characteristics 
such as preference for a certain helix formation or increased thermal stability (Kurreck 
2003; Manoharan 2003; Manoharan 2004).  For this reason, many types of modified 
siRNAs have been evaluated for their ability to elicit target mRNA degradation and 
subsequent gene knockdown with highly variable results between studies.  Other than 
halide substitutions, modifications at the 2’ site have been problematic.  O-methyls, 
locked nucleic acids (LNAs), or other bulky substitutions can be used only sparingly 
and are thought to protrude into the minor groove and disrupt RISC recognition of the 
duplex (Braasch, Jensen et al. 2003; Chiu and Rana 2003; Czauderna, Fechtner et al. 
2003).  Complete 2’-deoxy substitution, results in a conformational change of the 
duplex to a B-type helix and does not exhibit RNAi activity (Chiu and Rana 2003).  2’-
Deoxy-2’-fluoro modifications seem to be the best-tolerated alteration with respect to 
maintaining silencing activity (Manoharan 2003; Manoharan 2004).  Unfortunately, 2’-F 
substituted purines have been unavailable commercially until recently, so only 
pyrimidine-modified siRNA mediated gene silencing has been attempted to date.  
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Several studies have shown similar levels of RNAi elicited between wild-type siRNA 
and these synthetic counterparts that contain fluorine on every pyrimidine (Braasch, 
Jensen et al. 2003; Chiu and Rana 2003; Harborth, Elbashir et al. 2003; Manoharan 
2003; Layzer, McCaffrey et al. 2004; Manoharan 2004; Soutschek, Akinc et al. 2004).  
Sullenger and colleagues showed that 2’-F pyrimidine-modified siRNAs and 
unmodified siRNAs have similar activity over a range of concentrations and silencing 
durations (Layzer, McCaffrey et al. 2004).  Chiu and Rana compared silencing potency 
of various siRNA modifications and found that siRNA completely modified with 2’-F 
pyrimidines and 2’-H purines showed only a 50% decrease in knockdown ability 
relative to an unaltered siRNA counterpart (Chiu and Rana 2003).  Interestingly, Bhat 
and colleagues demonstrated that fully-modified duplexes which included 2’-F 
pyrimidine nucleotides and 2’-O-methyl purine nucleotides actually increased RNAi 
efficiency, and in one case they achieved a 500-fold increase in silencing ability 
(Allerson, Sioufi et al. 2005).  The combination of several types of chemical 
modifications into a single siRNA molecule are becoming increasingly common as 
illustrated by a recent work by Morrissey and colleagues (Morrissey, Blanchard et al. 
2005). Alternatively, 2’-deoxy-2’fluoro-β-D-arabinonucleic acid  modifications, in which 
the 2’-flouro is inverted, have been used to partially modify siRNA and successfully 
induce RNAi (Dowler, Bergeron et al. 2006).  The combination of these results 
suggests that the 2’-OH is not necessary for RNAi, but changes at this location that 
alter either the global duplex structure or disrupt the minor groove can abolish 
interference.  In addition to improving resistance to enzymatic degradation while 
maintaining silencing efficiency, 2’-modifications have been shown to reduce off-target 
 67
effects normally observed following siRNA delivery (Jackson, Burchard et al. 2006; 
Cekaite, Furset et al. 2007).  Since halide substitutions are thought to maintain the A-
type helical structure by enforcing a C3’-endo sugar pucker confirmation (Guschlbauer 
and Jankowski 1980; Chiu and Rana 2003) and they are not large enough to disrupt 
the minor groove, siRNAs that contain 2’-F functional groups at every location may still 
elicit potent RNAi.  Although fully 2’F-modified nucleic acids have been generated and 
evaluated for several characteristics which are crucial in antisense applications, these 
compounds have not been evaluated for gene silencing in cells or in vivo (Kawasaki, 
Casper et al. 1993).  Replacing the hydroxyl at every location may also provide further 
resistance to enzymatic degradation by nucleases and eliminate RNA degradation 
through 2’-OH nucleophilic hydrolysis. 
A mutated polymerase, originally developed for the ability to incorporate both 
rNTPs and deoxy-counterparts, may provide a cost-effective method to generate fully-
fluorinated siRNAs.  Specifically, T7 with a mutation of tyrosine to phenylalanine at 
position 639 (Y639F) eliminates discrimination at the 2’-location of the NTP substrate 
by abolishing hydrogen bonding requirements (Sousa and Padilla 1995).  Eliminating 
the requirement for 2’-recognition might allow the polymerase to incorporate any 2’-
functional group that is not limited by steric hindrance.  NTPs with small functional 
group modifications at this location, such as amines and halides, are incorporated into 
full length transcripts at differing efficiencies dependant on these steric limitations 
(Padilla and Sousa 1999).  Given that this enzyme has been used to incorporate 2’-F 
modified pyrimidine NTPs at every location in full-length transcripts, its use may be 
extended to generate a fully-fluorinated product. 
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The potential benefits of fluorinated RNA with respect to RNAi stability have 
prompted us to generate fully 2’-deoxy-2’-fluoro substituted nucleic acid (FNA) through 
solid phase synthetic and in vitro transcription methods.  Nuclease digestion assays 
were performed to evaluate resistance to degradation compared to native RNA.  We 
have evaluated the ability of small interfering fluoronucleic acid (siFNA) to initiate 
knockdown of a target gene in mammalian cell cultures.  Additionally, these siFNAs 
were evaluated for their silencing ability in both their duplex and single-stranded 
antisense forms.   
 
3.2  Materials and Methods 
3.2.1 siRNA Design 
 Established siRNA design requirements were followed, such as 
maintaining approximately 50% GC content of 21nt sense and antisense strands which 
hybridize to yield 2nt, 3’ overhangs (Elbashir, Lendeckel et al. 2001).  The overhangs 
were designed as UU on both strands, and a sequence was chosen so that the 
antisense overhang was still homologous to the target gene.  Additionally, the first 
nucleotide of both the sense and the antisense transcripts was guanine since it is 
typically the first addition by T7 polymerase (Donze and Picard 2002).  This required 
the 19th nucleotide of each transcript to be cytosine.  Using these design criteria, runoff 
trasciption could be used to generate each strand in vitro. The sequence of the GFP 
plasmid, pAcGFP-N1 (Clontech, Carlsbad, CA), used in knockdown experiments was 
searched for an appropriate target, which was also subjected to a BLAST search to 
ensure no cross-reactivity with other known genes.   
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3.2.2 siRNA and siFNA Preparation 
RNAs were generated in vitro using a T7 polymerase (Donze and Picard 
2002) and using partial duplexes designed for run-off transcription.  DNA templates 
(Sense: 5’-AAGCGGATCTTGAAGTTCACCTATAGTGAGTCGTATTA-3’, Antisense: 
5’-AAGGTGAACTTCAAGATCCGCTATAGTGAGTCGTATTA-3’, T7 Primer: 5’-
TAATACGACT-CACTATAG-3’) were synthesized, desalted, and HPLC purified from 
Alpha DNA (Montreal, Quebec, Canada).  Equal molar ratios (75pMoles/μl) of each 
template and the T7 primer oligonucleotide were annealed by bringing the solution to 
95oC and slowly cooling to 4oC over 20 minutes.  The RNAMaxx® in vitro transcription 
kit (Stratagene, Cedar Creek, TX) was used according to manufacturer instructions to 
generate each strand of RNA individually.  FNA strands were generated using 2’F-
NTPs (purines from Trilink Biotechnologies, San Diego, CA, pyrimidines from 
Epicentre, Madison, WI) and an alternate in vitro transcription kit, Durascribe® 
(Epicentre, Madison, WI), which utilized a Y639F mutant T7 polymerase, R&DNA 
Polymerase™ (Sousa and Padilla 1995; Padilla and Sousa 1999).  Final 
concentrations of templates and NTPs were 50 ng/μl and 5 mM, respectively.  
Transcription incubation times were extended from 8 hours for native unmodified RNA 
generation to 48 hours for FNA generation.  The transcription mixtures were treated 
with DNAse I at a final concentration of 0.5units/ul overnight at 37°C to completely 
digest the DNA template. The RNA/FNA products were then precipitated with sodium 
acetate and ethanol, washed three times, and resuspended in nuclease-free water.  
Additional purification of fluorinated products was carried out using Microcon YM-3 
cellulose spin filters (Millipore, Billerica, MA) to remove possible early termination 
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products under approximately 10nts in length.  Product concentrations were 
determined by UV/VIS absorbance spectroscopy.  The 21-nt FNAs were also 
chemically synthesized by University of Calgary Core DNA & Protein Services 
(Calgary, AB, Canada).  Synthetic FNAs were PAGE purified and verified through 
matrix-assisted laser desorption/ionization (MALDI) mass spectrometry.  Homologous 
strands at equal molar ratios were annealed as aforementioned to generate duplex 
siRNA or siFNA. 
 
3.2.3  Hybridization Analysis  
Melting curves were measured for FNA duplexes, DNA duplexes, and 
FNA/DNA hybrids to compare transcribed and synthetic FNA oligonucleotide 
hybridization to the same target.  For each case, complementary strands were brought 
to equal molar concentrations of 4μM in a medium-salt buffer (100 mM NaCl, 10 mM 
sodium phosphate, 0.1 mM EDTA, pH 7.5).  The samples were annealed by heating to 
95oC for 5 minutes and cooling to 4oC over 10 minutes, degassed under vacuum, 
transferred to a quartz cuvette, and covered with 100μl of dimethylsiloxane to prevent 
evaporation.  Melting experiments were conducted using an AVIV model 14DS 
spectrophotometer (Lakewood, NJ).  OD260 was measured as a function of 
temperature from 15oC to 90oC with a 2.5oC step.  The samples were held at each 
temperature for 2 minutes before absorbance reading were recorded.  Melting 
temperature (Tm) values were calculated by determining the local maximum of each 
melting curve’s first derivative.  
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3.2.4 Nuclease Digestions 
RNAse One™, an E. Coli derived RNAse, and an accompanying buffer 
(Promega Corporation, Madison, WI) were used to evaluate nuclease resistance to 
FNAs.  Equal molar ratios of single-stranded or duplex RNAs and FNAs were 
suspended in optimal buffer and pH conditions as described by the manufacturer.  
RNAse One™ was added to each solution to a final concentration of 0.5 unit/μl.  The 
digestion reactions were incubated overnight at 37oC.  The products were evaluated 
qualitatively by capillary electrophoresis on the Bioanalyzer 2100 Lab-Chip system 
(Agilent Technologies, Wilmington, DE) using a custom protocol designed to evaluate 
small oligonucleotides.  The manufacturer loading buffer was replaced with a solution 
of 200 nM N-Tris(hydroxymethyl)methyl-3-aminopropane sulfonic acid (TAPS) and 2 
mM EDTA at pH 8.0-8.5 to eliminate the 15bp markers, which have similar mobility to 
the experimental samples.  With the exception of the loading buffer, a DNA 500/1000 
electrophoresis chip was loaded according to the manufacturer protocol, but the chip 
was run under the mRNA Nano programming conditions (provided within the 
manufacturer’s software package) to obtain data within a useful range of short 
migration times (<40 sec).  The intensities for each electropherogram were normalized 
to baseline fluorescence and are presented as a composite gel image.  
 
3.2.5 Cell Culture and Transfection 
BHK-21 (Baby Hamster Kidney) cells were cultured in reduced serum 
Dulbecco’s Modified Eagle’s Medium (DMEM-RS) (HyClone, Logan, UT) 
supplemented with 3% heat inactivated fetal bovine serum (HyClone, Logan, UT) at 
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37oC under 5% CO2 in a humidified chamber and regularly passaged at 
subconfluence.  Cells were seeded on 12 well plates (BD Biosciences, Franklin Lakes, 
NJ) 18 hours prior to transfection at approximately 20K cells/cm2.  Cotransfections of 
pAcGFP-N1, and siRNA or siFNA were mediated with lipofectamine (Invitrogen, 
Carlsbad, CA).  Transfection mixtures containing 0.1 μg of pAcGFP-N1, varying 
amounts of siRNA or siFNA, and lipid (3:1 ratio of lipid with respect to total nucleic 
acid) were assembled in 100 μl of reduced protein medium (OPTI-MEM®, Invitrogen, 
Carlsbad, CA) and incubated at room temperature for 30 minutes.  The plated cells 
were rinsed with OPTI-MEM and 500 μl of OPTI-MEM was added to each well.  The 
transfection mixtures were added to the appropriate wells and the cells were incubated 
at 37oC under 5% CO2 for 6 hours.  The transfection media was then replaced with cell 
culture media and the plates were incubated for 48 hours and harvested for expression 
analysis.     
 
3.2.6 Flow Cytometry RNAi Analysis 
Transfected and control cell culture samples were harvested and fixed in 
PBS suspension with 1% or 0.5% paraformaldehyde prior to GFP expression analysis 
via flow cytometry.  GFP fluorescence was collected at 530±15 nm (FL1), and cellular 
auto-fluorescence was collected at a wavelength greater than or equal to 650 nm (FL3) 
on a fluorescence activated cell sorter (FASC-Scan) cytometer (Becton Dickinson, San 
Jose, CA) equipped with 488 nm excitation.  For each sample, a maximum of 30,000 
events were collected.  Intact cells were gated on a FSC (forward angle light scatter) 
versus SSC (90 degrees light scatter) dot plot.  An FL1 versus an FL3 display of a 
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GFP-negative control was gated and applied to all samples and analyzed to yield a 
percentage of cell events in the GFP-positive region.  This GFP-positive percentage for 
each sample was normalized to an average of GFP-positive controls for the specific 
set of experiments and expressed as a mean value ± standard error.  In addition to 
gating analysis, the linear mean of GFP fluorescence intensity was calculated using all 
measured cell events.     
 
3.2.7 Semiquantitative PCR Analysis 
BHK-21 cells were co-transfected with 100ng of pAcGFP plasmid and the 
aforementioned siRNAs or siFNAs as previously described.  Each sample type: siRNA 
(13.3 nM), two concentrations of siFNA (13.3 and 33.3 nM), positive control, and 
negative control was generated in triplicate.  At 48hrs post-transfection, the cells were 
harvested and washed with PBS.  Approximately 100,000 cells were fixed in 0.5% PFA 
in PBS and evaluated by flow cytometry to determine GFP expression levels.  Total 
RNA was isolated from the remaining cells (approximately 400,000) using TRI Reagent 
(Sigma, St. Louis, MO).  The RNA isolate was treated with Turbo DNA-free (Ambion, 
Austin, TX) to eliminate genomic and plasmid DNA contamination.  The yield of 
isolated RNA was evaluated by OD260 and purity by OD260/OD280 using a Bio-Tek 
Synergy HT multi-detection microplate reader (Bio-Tek Instruments, Inc., Winooski, 
VT).  The integrity of the RNA was evaluated by electrophoresis in a denaturing 0.8% 
agarose slab gel and stained with SYBR GOLD (Invitrogen Molecular Probes, 
Carlsbad, California).  Each RNA isolate (500ng) was reverse transcribed with BD 
Sprint PowerScript Pre-Primed Random Hexamer primers RT-PCR Kit (BD 
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Biosciences, Palo Alto, CA), divided into single-use aliquots, and stored at -20oC.  
Desalted primers for the knockdown target (GFP: forward primer, 5’-TAC AAC TAC 
AAC GCC CAC AAT GT-3’; reverse primer, 5’-CAC GCT GCC ATC CTC GAT-3’) and 
a control gene (GAPDH, glyceraldehyde-3-phosphate dehydrogenase: forward primer, 
5’-TGG CAA AGT GGA TAT TGT CG-3’; reverse primer, 5’-AGA TGG ACT TCC CGT 
TGA TG-3’) were synthesized (Integrated DNA Technologies, Coralville, IA).  For real-
time PCR, the following components were mixed: 12.5uL iTaq Sybr green supermix 
with ROX (BioRad, Hercules, CA, USA), 3.5uL of PCR grade water, 2uL of both 
forward and reverse primers at 10uM and 2.5uM for GAPDH and GFP, respectively, 
and 5uL template cDNA diluted 100-fold.  Non-template controls and a standard curve 
(beginning with a non-diluted mixture of all cDNAs and including 5-serial 10-fold 
dilutions of this mixture) were simultaneously run in conjunction with the experimental 
samples using both primer sets.  PCR was carried out using a Chromo4 Real-Time 
PCR Detection System (Bio-Rad, Hercules, CA, USA).  For all samples and primer 
sets, the following thermal cycling conditions were used: incubation (50oC for 2 mins), 
denaturation (95oC for 5 mins), 45 cycles of amplification and fluorescence 
quantification (95oC for 15 secs followed by 60oC for 60 secs), and melting 
fluorescence quantification (heating from 55oC to 95oC and measuring at 0.2oC step-
intervals after holding for 0.02 secs).  Both GAPDH message levels and PCR 
efficiencies (calculated via amplification slopes with Opticon Monitor 3 software) were 
used to ensure the results for each sample were suitable for analysis.  Following 
amplification, a representative GFP product was sequenced to ensure the correct 
amplicon was generated. 
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3.3 Results  
3.3.1 FNA Generation 
Synthetic sense and antisense FNA oligonucleotides were successfully 
generated through solid phase synthesis at a 250nMole yield and verified by MALDI 
and further purified by PAGE separation.  Mass spectroscopy of these products prior to 
PAGE purification gave primary peaks of 6693m/z and 6715m/z for the antisense and 
sense strands, respectively.  These values agree with the expected mass calculated 
for each product.  Extra peaks, which were only slightly discernable above background 
noise, corresponded to base depurinations that occur as a result of MALDI, or the 
presence of residual monovalent cations.  UV/VIS absorbance spectroscopy was used 
to determine the total amount of FNA generated for each transcription reaction.  An 
extinction coefficient was calculated for each product based on the sequence and 
standard absorbance profiles for nucleic acids.  Since 2’-Fluoro-2’deoxy-NTPs have 
absorbance properties comparable to native NTPs (2’F-dATP, ε = 15,400 M-1cm-1, 2’F-
dGTP, ε = 13,600 M-1cm-1, Trilink Biotechnologies), the same extinction coefficients 
were used for the RNA and FNA products.  At 48 hours, an average of 83.9±7.4 μg 
(n=8) of total product was generated in a typical 20 μl reaction volume.  This was 
comparable to manufacturer’s estimated yield of unmodified RNA generation using this 
enzyme, which was 40-60μg for an equivalent reaction held for 4 hours.  PAGE 
separation of the products followed by nucleic acid staining and comparison to 
included standards indicated that full-length transcripts were present in addition to 
some early termination products.  An average of 28.7±8.9% (n=4) sample recovery 
was obtained from Microcon spin filter purification.  PAGE results showed little 
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difference between single stranded and duplex FNA products (figure 3.2).  The 
average yield of unmodified RNA using the RNAMaxx® in vitro transcription was 
approximately 92±6.9 μg (n=6) for an 8 hour reaction of the same volume.  This 
amount was in agreement with the manufacturer’s estimated yield.   
     
2.3.2 Hybridization Analysis  
Melting curves shown in figure 3.1 were measured to calculate the Tm of 
various duplexes to assess the purity and accuracy of the transcribed products and 
synthesized FNA.  Synthetic FNAs exhibited the highest melting temperatures, with a 
FNA:FNA duplex Tm of  89oC and a FNA:DNA duplex Tm of 72.4oC.  This increase in 
melting temperature relative to the DNA duplex (Tm = 65oC) agrees with earlier findings 
 
Figure 3.1:  Melt-curve analysis of FNA hydridization.  Nucleic acid hybridization 
measured by absorbance as a function of temperature.  The black line represents 
the absorbance measurements at temperatures from 15oC to 95oC normalized to 
the lowest reading of each sample.  The dF/dT of these curves gives a local 
maximum, representing the Tm of the duplex.   The nucleic acid hybridization Tm 
values are show as follows: A) DNA/DNA duplex (Tm = 65oC), B) DNA/Synthetic 
FNA duplex (Tm = 72.4oC), C) Synthetic FNA/Synthetic FNA duplex (Tm = 89oC), 
and D) DNA/Transcribed FNA duplex (Tm = 35oC). 
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that these modifications act to improve duplex stability (Kawasaki, Casper et al. 1993; 
Yazbeck, Min et al. 2002).  Conversely, when the transcribed FNA is hybridized with its 
DNA complement, the duplex dissociates at approximately 35oC.  This reduction in Tm 
suggests that transcription products contain base incorporation errors and/or early 
termination products.        
 
3.3.3 Nuclease Digestions 
Products of double-stranded and single-stranded synthetic FNAs following 
digestion by both DNAse I and RNAse One® were analyzed by electrophoresis (figure 
3.2) to qualitatively evaluate nuclease resistance.  Comparison of the digestion 
products to the associated controls, which were not exposed to RNAse One® but 
 
Figure 3.2:  Capillary electrophoresis of nuclease treated RNAs and FNAs.  All 
species were originally treated with DNAse I following synthesis.  Digested products 
were treated with RNAse One® for 18 hours. Control samples were treated to 
similar buffer and heating conditions in the absence of the ribonuclease.  Lane L: 
10bp Ladder, Lane 1: single-stranded transcribed FNA, Lane2: single-stranded RNA 
control, Lane 3: single-stranded RNA digested, Lane 4: double-stranded RNA 
control, Lane 5: double-stranded RNA digested, Lane 6: single-stranded FNA 
control, Lane 7: single-stranded FNA digested, Lane 8: double-stranded FNA 
control, Lane 9: double-stranded FNA digested 
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otherwise processed identically to test samples, shows a striking difference between 
native RNA and fluoro-modified species.  Unmodified single-stranded RNAs were 
completely digested by nuclease treatment.  Although duplex RNA is thought to be 
considerably more resistant to nuclease digestion than single-stranded RNA, these 
samples show a similar pattern in figure 3.2, which illustrates that siRNA was also 
completely digested under the aforementioned conditions.  Both the single-stranded 
and the double-stranded digested FNAs were nearly indistinguishable from their 
processed controls, suggesting that no nuclease degradation occurred.  
 
 
3.3.4 RNAi of GFP Expression in Cell Cultures 
GFP expression levels were normalized to the positive controls in the same 
experimental plate for both the percent of cells gated and the fluorescence linear 
mean.  The siRNAs designed in this study were effective silencing agents, reducing 
GFP expression at low concentrations.  Native RNA that was synthesized through a 
similar transcription reaction did not require purification, and knockdown of GFP was 
evident at the lowest concentration evaluated (21.8±3.3% at 3.3 nM siRNA).  SiFNAs 
from custom synthesis were also able to reduce target gene expression at 3.3 nM.  
Expression of GFP relative to the corresponding positive controls were 35.8±8.0%, 
19.9±3.8%, 14.9±2.8%, 11.0±2.0%, and 8.1±0.8% for 3.3 nM, 13.3 nM, 33.3 nM, 66.7 
nM, and 133.3 nM, respectively (figure 3.4 A).  These levels were only slightly higher 
than those for siRNA knockdown, indicating efficient silencing.  Preliminary 
experiments with transcribed siFNAs were used to define a concentration range where 
treatment effects were responsive to concentration and not due to non-specific toxicity 
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phenomena.  While these initial experiments spanned a concentration range of 3.3 nM 
to 333.3 nM, the appropriate concentration range for evaluating effective transcribed 
siFNA mediated GFP suppression was narrowed to 33.3 nM to 133.3 nM.  The 
concentrations in this range were evaluated in triplicate.  Since siRNA and synthetic 
siFNA were effective at lower concentrations, a single set of transcribed siFNA 
knockdown experiments incorporating the full range from 3.3 nM to 333.3 nM was 
 
 
Figure 3.3:  Brightfield and fluorescent images microscopy of cell cultures.  
Transfected BHK-21 cells at 48 hours following transfection: A,B) Positive control, 
C,D) siRNA knockdown, and E,F) siFNA knockdown. 
 
 80
included to illustrate trends for comparative analysis.  Expression levels relative to 
positive controls were 70.4±3.0%, 36.2±2.7%, and 24.8±0.3% following filtered 
transcribed siFNA knockdown at concentrations of 33.3 nM, 66.7 nM, and 133.3 nM, 
respectively.  The FL1 (530±15 nm) fluorescence linear mean also suggests a 
reduction in GFP levels following siRNA and siFNA treatment.  Figure 3.4B illustrates 
this reduction and the trend that synthetic siFNA is nearly equivalent to siRNA in 
reducing total protein content, even at the lowest levels of effector concentration.   
Since the enzymatic RNAi pathway can be elicited using single-stranded 
antisense RNA in mammalian cells (Martinez, Patkaniowska et al. 2002; Schwarz, 
Hutvagner et al. 2002; Amarzguioui, Holen et al. 2003; Holen, Amarzguioui et al. 
2003), antisense FNA was evaluated for its silencing ability in the 33.3 nM to 133.3 nM 
range.  The single-stranded synthetic antisense FNA showed minimal silencing ability, 
yielding approximately 88.2±1.3%, 81.0±1.6%, and 51.7±0.8% GFP expression levels 
for 33.3 nM, 66.7 nM, and 133.3 nM, respectively. The single-stranded transcribed 
antisense FNA has a similar silencing ability that is indistinguishable from the synthetic 
FNA, yielding approximately 74.1±15.7%, 84.1±4.4%, and 62.5±0.7% GFP expression 
levels for 33.3 nM, 66.7 nM, and 133.3 nM, respectively.  In contrast, native antisense 
RNA exhibited a lower level of GFP activity (approximately 32%) at the lowest 
concentration studied (3.3nM, not shown) and then maintained between 15-20% 
expression for the concentrations shown in figure 3.5.  
Expression analysis was also supported by decreased mRNA levels following 






Figure 3.4: RNAi analysis of siRNA and siFNA in cell culture.  A: Gated analysis of 
cell population for GFP expression.  Bars from light to dark represent scrambled 
siRNA, transcribed siFNA, synthetic siFNA, and siRNA.  Expression was normalized 
to the average of GFP-positive controls.  B: Cell mFI GFP expression analysis for 
30,000 measured events.  Grey bars represent synthetic siFNA and black bars 
represent siRNA. Statistical differences between synthetic siFNA and siRNA for a 




relative to the positive controls measured via flow cytometry were an average of 8.4% 
for the triplicate samples, while the two siFNA averages were 28.3% and 16.8%.  GFP 
mRNA levels are reported as a ratio to GAPDH message measured in triplicate from 
the same cDNA sample.  The positive control illustrates the variability in transfection 





Figure 3.5.  RNAi analysis of antisense RNA and FNA in cell culture.  FACS 
fluorescence analysis of GFP expression in cells transfected with antisense siRNA, 
synthetic antisense siFNA, and transcribed antisense siFNA at various 
concentrations from light to dark, respectively.  Expression was normalized to an 
average of GFP positive controls. The symbol † denotes a significant differences 
between antisense FNA and antisense RNA only.  The symbol ‡ denotes a 
significant difference between antisense FNA and antisense RNA and a significant 
difference between the two antisense FNA populations (Student’s t-test, p < 0.05). 
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GFP:GAPDH).  This ratio is drastically reduced for the siRNA (0.16±0.05 
GFP:GAPDH) and siFNA (5.77±1.61 and 3.36±1.77 GFP:GAPDH) samples.   
 
3.4 Discussion 
In this investigation fully-modified 2’-deoxy-2’fluoro nucleic acids were 
generated through transcription and solid phase synthesis, evaluated for their nuclease 
resistance, and tested for knockdown activity in cell culture.  FNA effectively induced 
gene silencing in the duplex siFNA form but is much less effective as an antisense 
†
 
Figure 3.6:  Semiquantitative PCR analysis of RNAi knockdown of GFP vs GAPDH.  
Levels of mRNA are reported as a ratio of GAPDH to GFP.  Each category shown 
as an individual bar represents three separate cellular experiments, which were 
each measured in triplicate.  The siRNA samples achieved an average GFP 
knockdown of 91.6%.  The two concentrations of synthetic siFNAs evaluated 
reduced GFP expression levels at averages of 77.7% and 83.2%.  The symbol † 
denotes a significant difference between the siRNA and 77.7% siFNA knockdown 
(Student’s t-test, p < 0.05).  No statistical difference was observed between the 
siRNA and 83.2% siFNA knockdown or between the two siFNA populations. 
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single-stranded oligonucleotide.   The findings presented here are in agreement with 
earlier works using partially modified nucleic acids.  The ability to incorporate these 
modifications using standard synthesis techniques allows for the additional inclusion of 
other types of alterations that may aid in drug delivery.  The combined results suggest 
that incorporation of the 2’-fluoro modification may be a useful approach to achieve 
improved stability of RNAi-based therapeutics without sacrificing potency. 
 
3.4.1 FNA Generation 
FNAs for RNAi were successfully generated through both solid phase 
synthesis and transcription.  However, the quality of the product generated from each 
method is markedly different.  Synthetic FNAs were shown to be the proper size 
through mass spectroscopy and PAGE separation.  Elevated melting temperatures of 
these products illustrated strong association with the target sequence, indicating both 
that FNAs form more stable duplexes and that base incorporation errors are not likely 
in the synthetic products. The observed increase in Tm values that occur due to the 2’F 
substitution are in agreement with previous work that evaluated partially and fully 
modified oligonucleotides.  The transcribed FNAs required further purification using 
Microcon YM3 spin filters to remove any fragments under 10 nucleotides in length.  
Approximately 70% of the product was not recovered, which suggests that a large 
portion of the FNAs were shorter than the desired 21 nucleotides due to early 
termination.  This agrees with early characterizations of the Y639F T7 polymerase 
regarding the abortive stage of polymerization, where it was found that the wild-type 
and the mutant polymerase generate a large amount of early termination product in the 
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2-8nt range (Sousa and Padilla 1995).  Despite that the Y639F polymerase is able to 
initiate DNA and RNA primer extension to a limited extent (Sousa and Padilla 1995), 
extending the reaction to 48 hours did not yield a higher percentage of full length FNA 
transcripts.  Melting curve data reveals that the synthetic products have very different 
hybridization behavior than the transcribed FNAs based on the difference in the Tm 
values.  The higher melting temperature of the synthetic FNAs suggests that custom 
synthesis has a much lower error incorporation rate than the transcription method.  
While the error incorporation rate of 2-F-NTPs is not known, Y639F T7 polymerase 
does exhibit miscoding of rNTPs at a similar rate to the wild-type polymerase (Sousa 
and Padilla 1995).  Consequently, transcription base-coupling errors are expected and 
will have a minimum incorporation rate that is equivalent to the wild-type polymerase.  
Homopolymer assays to determine the error-rate of the mutant polymerase showed 
that the incorporation of a complementary NTP was 184-fold greater than that for non-
complementary NTPs on a poly(dC) template (Sousa and Padilla 1995).  Relative to 
the poly(dC) template non-complementary base incorporation was approximately 5-
fold higher using a poly(dT) template (Sousa and Padilla 1995).  Thus errors in base 
incorporation would be expected at relatively high frequency, even if unmodified 
nucleotides were used.  Despite the higher inaccuracy rate, the transcribed FNAs were 
still able to elicit RNAi.  As a result, the products are still useful and possess 
appreciable benefits over custom synthesis techniques.  Although currently the cost to 
generate a given amount of FNA product is nearly equivalent for the two techniques, 
enzymatic generation offers greater flexibility than custom synthesis.  Specifically, 
transcription allows for the generation of several different siFNAs instead of only one 
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sequence.  This provides a technique for siFNA screening, the ability knockdown of an 
array of targets, or the ability to validate the viability of a siFNA sequence before 
pursuing custom synthesis. 
 
3.4.2   Digestion Assays 
Both the single-stranded and the double-stranded FNAs were resistant to 
enzymatic digestion using DNAse I and RNAse One®, while both forms of unmodified 
RNA were degraded completely under the same conditions.  While this does not 
indicate invulnerability to all enzymatic degradation pathways, it does illustrate 
improved nuclease resistance over unmodified RNA and DNA.  Previous work with 
pyrimidine 2’-deoxy 2’fluoro modified RNA has also shown improved stability in cell 
lysate and plasma (Layzer, McCaffrey et al. 2004).  However, since pyrimidine only 
fluoro-modified nucleic acids still contain 2’-hydroxyls, they may still be susceptible to 
sugar-specific endonuclease digestion.  Some evidence of substrate degradation was 
observed in pyrimidine-only 2’F modified RNA that was incubated for 60 minutes in cell 
lysate (Chiu and Rana).  Additionally, partially-modified siRNAs did not extend target 
gene knockdown relative to the unmodified species (Layzer, McCaffrey et al. 2004).  
Incorporating fluorine halides on every nucleotide could eliminate all possibility of 2’-
hydroxyl-mediated enzymatic digestion or degradation through spontaneous 
intramolecular hydrolysis and may further improve the stability of single- and double-
stranded siRNAs.  The current GFP expression system in BHK cells is not conducive 
to long-term suppression analysis due to the fact that the effector is diluted in the 
rapidly proliferating cells.  Future studies will explore the silencing duration of siFNAs 
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using a stably-transfected transient or inducible reporter gene in a system more 
amenable to long-term gene expression analysis. 
  
3.4.3 RNAi of GFP Expression in Cell Cultures  
It was previously shown that RNAi does not require a 2’-hydroxl to be 
present in the nucleic acid species, but it requires an unimpeded minor groove and an 
A-type helical structure (Chiu and Rana 2003).  Since fluorine is small enough to fit in 
the minor groove and the electronegativity of the halide reinforces an A-type helix 
structure through a preferred sugar pucker conformation (Guschlbauer and Jankowski 
1980; Chiu and Rana 2003), fluoro-modifications are particularly well-tolerated by the 
RNAi pathway.  Our results indicate that siFNA can induce RNAi and the silencing 
efficiency is nearly equivalent to the unmodified siRNA species.  In fact, siRNA and 
siFNA efficacy were only significantly different at the 66.7 nM and 133.3 nM 
concentrations (Student’s t-test, p<0.05).  These results correlate well with 
observations regarding RNAi activity of partially or pyrimidine only 2’F-modified 
siRNAs, reported elsewhere (Chiu and Rana 2003; Layzer, McCaffrey et al. 2004).  
One potential reason for the slight decrease in knockdown potency is that FNAs may 
form more stable duplexes relative to RNAs.  This could result in a duplex that is less 
efficiently unwound by RISC.  The melting properties of the synthetic fluorinated 
oligonucleotide duplexes suggest that this hypothesis may have merit.  It is likely that 
the RNAi pathway is able to overcome this obstacle since the dissociation of siRNA is 
an ATP-driven process.  Additionally, it was observed through the course of this 
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investigation that minor variations in the initial siFNA hybridization had a noticeable 
effect on the silencing outcome.  
One concern relating to the observed elevated melting temperatures of FNAs is 
the potential loss of may loose some level of target specificity.  Kawasaki and 
colleagues gave a detailed description of 2’F modifications with respect to increased 
Tm and base pair specificity (Kawasaki, Casper et al. 1993).  In essence, they 
demonstrate that uniformly- modified NAs maintain base-specificity relative to the 
perfect complement.  Since the 2’F modification results in a large Tm increase, the 
annealing temperature may still be elevated with a single nucleotide mismatch point-
mutation.  This could lead to off-target hybridization at physiological temperatures.  
However it is doubtful that even one or two mismatches in a 21-mer oligonucleotide 
would result in better complementarity to an off-target mRNA within the transcriptome 
that has amenable secondary structure for hybridization.  Because the RISC 
machinery must interact with the duplex siRNA and the antisense RNA/mRNA 
complement along the silencing pathway, RNAi might still be disrupted by a single 
mismatch within a siFNA molecule.  Additionally, the improved duplex stability may 
also allow the use of small interfering duplexes with a lower GC content to be used for 
RNAi.  In this study, no changes to cellular morphology, growth rate or housekeeping 
gene expression were observed in response to siFNA treatment.  This suggests that if 
off-target silencing was occurring, the potential effect on the global expression profile 
was not toxic for the sequence studied.  Future endeavors exploring off-target effects 
could test a series of mismatches at several locations on the sense and antisense 
strands of the different effector sequences, and include more global measures of gene 
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expression such as RT-PCR of multiple candidate off-targets or comprehensive 
microarray analysis (Jackson, Burchard et al. 2006). 
Transcribed FNA products displayed the least amount of silencing ability, which 
is likely due to malformed siFNAs that arise from either early termination products or 
more likely polymerase base incorporation errors.  In the future, it may be possible to 
improve the transcription efficiency by using a dual-mutated polymerase which has 
been used to successfully incorporate 2’-O-methyl modified NTPs into full-length 
transcripts (Padilla and Sousa 2002).  Knockdown at higher concentrations of siFNA 
were not evaluated due to potential transfection lipid toxicities.  The upper limit was 
determined in mock RNAi experiments using scrambled sequences over an extended 
range of concentrations.  At the 333.3 nM concentration, GFP expression was 
decreased in response to the scrambled siRNAs, indicating nonspecific effects.  
Additionally, exposing cells to micromolar concentrations of siFNA in the absence of a 
cationic lipid showed no signs of toxicity nor GFP reduction (data not shown).  
Therefore, the observed decrease in GFP mRNA and protein expression by siFNA 
treatment below 333.3 nM is believed to be the result of targeted gene knockdown.   
Despite the typically rigid adherence to the characteristic siRNA structure 
resulting from the processing of dsRNA by Dicer, recent work has demonstrated that 
RNAi can be elicited by single-stranded antisense siRNAs (Martinez, Patkaniowska et 
al. 2002; Schwarz, Hutvagner et al. 2002; Amarzguioui, Holen et al. 2003; Holen, 
Amarzguioui et al. 2003).  Although the pathway of RNAi using single-stranded 
homologues is not well-understood, evidence suggests that at least part of the 
pathway is conserved among the duplex and antisense siRNAs (Holen, Amarzguioui et 
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al. 2003).  It has also been shown that antisense siRNAs are incorporated into RISC, 
resulting in targeted RNA cleavage in mammalian cell extracts (Martinez, 
Patkaniowska et al. 2002; Schwarz, Hutvagner et al. 2002) and in cell culture (Holen, 
Amarzguioui et al. 2003).  In contrast with the apparent similarities, antisense siRNA 
shows lower activity and reaches peak levels earlier than compared to duplex siRNA 
(Holen, Amarzguioui et al. 2003).  Duplex siRNA requires unwinding while still 
associated with RISC, which may explain the delayed onset of gene silencing through 
this RNAi pathway.  The transient nature of the single-stranded knockdown could be 
partially explained by its vulnerability to ribonucleases.  Therefore, nuclease-resistant 
modified antisense siRNA may have potential benefits over native unmodified 
antisense siRNA.  Fully fluorinated nucleic acids were initially thought to have ideal 
properties to achieve single-stranded knockdown while improving stability of the 
effecter molecule. 
Because single-stranded antisense RNA is known to induce RNAi, antisense 
FNA was also evaluated for its silencing ability.  Given that this method does not 
require delivery of a duplex knockdown agent, the negative affects of early termination 
are thought to be lessened.  Surprisingly, the FNA antisense product shows no 
significant silencing ability until higher concentration levels are reached, and in contrast 
to RNA, antisense FNA silencing ability is greatly reduced.  Even though 
misincorporation errors may be present in the transcribed FNAs, antisense products 
may still hybridize to the target mRNA due to the increases the Tm by the 2’F 
substitution.  This FNA:RNA duplex with potential mismatch bulges may still participate 
in translational arrest, which could explain the lack of difference observed between the 
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transcribed and synthetic antisense FNAs shown in figure 3.5.  For the siFNA 
knockdown, these base misincorporation errors may hinder the ability for RISC to 
recognize the duplex form of the transcribed product duplexes, explaining the larger 
difference in silencing ability between transcribed and synthetic FNAs shown in figure 
3.4. Since it is known that 2’-FNA:RNA duplexes do not induce RNAse H1 mediated 
cleavage of the RNA strand (Yazbeck, Min et al. 2002), the slight reduction in GFP 
expression caused by the single-stranded antisense products is likely due to minimal 
levels of antisense translational interruption.  2’-Flouro substitutions in nucleic have 
been shown to increase the melting temperature when hybridized to either DNA or 
RNA complements (Kawasaki, Casper et al. 1993; Yazbeck, Min et al. 2002), and in 
conjunction with improved stability, this supports the idea that some physical disruption 
of protein synthesis in the cytoplasm may be possible.  However, since single-stranded 
antisense FNAs are inefficient in reducing GFP expression relative to siFNAs, the 
mechanism of knockdown by duplex siFNAs is not likely to be simple antisense 
translational arrest or FNA toxicity.  Rather, these results, in conjunction with the 
finding that FNA:RNA duplexes do not act as substrates for RNAse H1, suggest that 
siFNA GFP knockdown is mediated through the RNAi pathway.   
 
3.5 Conclusions and Future Works 
RNAi has quickly become one of the primary methods of genetic knockdown 
and has experienced a rapid expansion in the number of exploited applications and 
synthetic modifications.  In addition to its utility for a wide array of applications 
conserved over a variety of organisms, the RNAi mechanism has proven to be 
 92
remarkably complex.  Previous works have illustrated the flexibility of RNAi to tolerate 
certain chemical modifications into siRNA.  By maintaining efficacy while imparting 
other potentially beneficial properties, such as nuclease resistance and improved 
cellular delivery, the possibility of using RNAi for therapeutic applications is within 
reach.  In fact, pharmaceutical companies have begun incorporating these types of 
modifications into potential siRNA drugs, and some of these chemically-modified 
siRNA therapeutic agents have already reached clinical trials (Sirna Therapeutics, 
Alnylam, Acuity (Bourzac 2007)).  Previous works which have incorporated halides in 
the 2’-region of nucleic acids were limited due to the scarcity of modified guanine and 
adenosine residues.  Therefore this study investigated the efficacy of RNAi knockdown 
using fully-fluorinated nucleic acids as small interfering RNAs.  Despite the fact that 
phosphoramidites which contain these modifications are becoming available with 
increasing frequency, the custom synthesis of fully-fluorinated strands is still cost-
prohibitive.  For this reason, we also investigated the ability to generate FNAs through 
transcription using a mutated polymerase.  While the transcription technique does not 
improve the overall cost effectiveness of FNA generation, it adds flexibility to produce 
many siFNAs of distinctive sequences.  The FNAs showed improved enzymatic 
stability in the presence of nucleases as demonstrated by a digestion assay.  It has 
also been shown here that fully-fluorinated nucleic acids can induce targeted gene 
knockdown.  Since the antisense FNA strand is much less potent than the duplex form, 
the decreased genetic expression resulting from siFNA introduction is likely due to 
enzyme mediated RNAi rather than simple translational blockade.  Conversely, this 
result suggests that single-stranded FNAs are not recognized by RISC due to the lack 
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of antisense silencing.  This may provide some insight into the recognition and binding 
properties associated with RISC.  Synthetic siFNAs resulted in more efficient silencing 
than the corresponding transcribed species.  This is likely due to base-coupling 
inefficiencies during transcription and/or early termination of the desired products.   
Melting curve analysis supports the suggestion that transcribed FNAs contain errors.  It 
is possible that improvements in the transcription conditions or the use of a less error 





Caging 2’-Fluoro Nucleic Acids for RNAi 
 
4.1 Introduction 
RNA interference (RNAi) refers to the post-transcriptional silencing of protein 
expression that is initiated by specific small regulatory RNA molecules (reviewed by 
(Tomari and Zamore 2005)).  Several forms of these molecules have RNAi activity 
including small-interfering RNAs (siRNAs), small-hairpin RNAs (shRNAs), or 
microRNAs (miRNAs), where their classification depends on their origin and specific 
structure (Elbashir, Lendeckel et al. 2001; Matzke and Matzke 2003).  RNAi has 
gained attention in laboratory and therapeutic settings because siRNAs are generally 
more potent regulators of gene expression than traditional antisense compounds 
(Grunweller, Wyszko et al. 2003).   Although siRNAs are highly effective, RNA is 
relatively unstable and susceptible to enzymatic digestion.  In order to develop useful 
RNAi drugs, the siRNA must be efficiently delivered either systemically or directly to 
the intended tissue, exhibit specific knockdown of the target gene, and maximize the 
duration of silencing.  In the common effort of expanding the utility of siRNAs, many 
have explored the use of chemical modifications that optimize RNA lipophilicity, 
increase duplex stability, or impart nuclease resistance to achieve these aims.  
Although improving pharmacological efficacy through chemical modification is 
important for the realization of RNAi therapeutics, less progress has been made with 
respect to spatial and temporal control over gene silencing.  One technique to control 
RNAi is to use a chemically-inducible endogenous expression of hairpin RNA (Gossen 
and Bujard 1995; Gossen, Freundlieb et al. 1995; No, Yao et al. 1996; Gupta, Schoer 
 95
et al. 2004).  While this approach does add a level of temporal control, light-based 
triggers are potentially much faster and may allow for spatial resolution on the 
nanometer scale (Betzig, Patterson et al. 2006).  One way to achieve photo-control is 
to introduce a temporary chemical modification which blocks silencing activity and can 
be removed with an external trigger.  Two research groups have recently explored 
using photolabile protection groups in siRNA toward spatial, temporal, and dosing 
control of gene knockdown using light (Shah, Rangarajan et al. 2005; Nguyen, Chavli 
et al. 2006; Shah and Friedman 2007).  Coupling this light-activation technique with 
chemically-stabilized siRNAs may allow RNAi spatiotemporal targeting in more 
complex biological systems.  
The use of photolabile protection groups for the light induction of a biological 
system was first described by Kaplan in 1978 as caging (Kaplan, Forbush et al. 1978).  
Caged nucleic acids (NAs) have been used for a variety of applications [reviewed by 
(Monroe and Haselton 2004; Mayer and Heckel 2006; Ellis-Davies 2007; Tang and 
Dmochowski 2007; Young and Deiters 2007)].  Photo-caged RNA has been used to 
control ribozyme activity through sugar caging (Chaulk and MacMillan 1998; Chaulk 
and MacMillan 2007), RNA folding through base caging (Hobartner and Silverman 
2005), as well as mRNA translation (Ando, Furuta et al. 2001; Ando, Furuta et al. 
2004) and siRNA silencing through phosphate caging (Shah, Rangarajan et al. 2005; 
Nguyen, Chavli et al. 2006; Shah and Friedman 2007).  However, phosphate caging of 
RNAs may lead to unstable products due to the potential for self-meditated hydrolysis 
of the phosphotriester by the neighboring 2’-hydroxyl in aqueous solution (Breslow and 
Xu).  Additionally, multiple attachment sites of cage groups to siRNAs may be 
necessary to achieve full inactivation. 
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For practical applications of caged RNAi effectors, the combination of 
chemical-stabilization and photoprotection might be advantageous. Chemical 
modifications of the sugar-phosphate backbone of RNAi effectors are widely used to 
increase resistance of the RNA to hydrolytic and enzymatic degradation (reviewed by 
(Manoharan 2004; Zhang, Du et al. 2006)).  In addition to nuclease resistance, some 
of these modifications maintain or improve other desired characteristics such as 
preference for a certain helix formation or increased thermal stability (Kurreck 2003; 
Manoharan 2004).  To achieve RNAi that meets all the desired characteristics, many 
types of modified siRNAs have been evaluated for their ability to elicit target mRNA 
degradation and subsequent gene knockdown.  These studies have yielded highly 
variable results between different modification types and sometimes even among 
siRNAs of differing sequence that have the same chemical modification.  Of all the 
modifications tested, 2’-deoxy-2’-fluoro modifications seem to be the best-tolerated 
alteration for maintaining silencing activity.  Partially flouro-modified siRNA in which the 
2’-F substitutions are limited to pyrimidine moieties are common in the literature, so to 
achieve completely modified siRNAs other chemical substitutions are sometimes used 
in combination with the 2’-halide (Braasch, Jensen et al. 2003; Chiu and Rana 2003; 
Harborth, Elbashir et al. 2003; Layzer, McCaffrey et al. 2004; Soutschek, Akinc et al. 
2004; Allerson, Sioufi et al. 2005; Morrissey, Blanchard et al.). Recent results from our 
group indicate that fully 2’-deoxy-2’-fluoro modified siRNA (siFNA) induces RNAi with 
similar activity to unmodified RNA (chapter 2).  Despite the advances made in 
chemical stability of siRNA, RNAi is still limited with respect to temporal and spatial 
regulation.   
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In this study, statistical (non site-specific) caging of the phosphate backbone 
was performed on a chemically stabilized RNAi effector, using 1-(4,5-dimethoxy-2-
nitrophenyl)diazoethane (DMNPE).  To allow the random attachment of multiple caging 
groups to a single siRNA molecule, the following chapter presents a combination of 
RNA 2’-OH chemical modification with the random attachment of DMNPE to achieve 
siRNA with multiple sites caged.  The nucleic acid has been fully substituted with 2’-
deoxy-2’-fluoro modified nucleotides to eliminate the possibility of 2’-OH mediated self 
hydrolysis of the phosphotriester in aqueous solution.  These caged species were 
evaluated in mammalian cell culture and developing zebrafish embryos for light-
induced RNAi activity. 
 
4.2 Materials and Methods 
4.2.1 2’-Deoxy-2’-Fluoro Nucleic Acid Synthesis and Caging  
Synthetic sense (5’-GGUGAACUUCAAGAUCCGCUU-3’) and antisense (5’-
GCGGAUCAUGAAGUU-CACCUU-3’) 2’-deoxy-2’-fluoro nucleic acids were generated 
through solid phase synthesis as previously described (chapter 3), where the resulting 
chemically-modified siFNAs effectively silenced GFP transgene expression through 
RNAi.  Each FNA strand was suspended in 100 μL of 10 mmol Bis-Tris buffer (pH 5.5) 
at 1 μg/μL, (150 μM).  4,5-Dimethoxy-2-nitroacetophenone hydrazone precursor (5 mg, 
22 μmol) (Molecular Probes, Inc., Eugene, OR) was oxidized with MnO2 (50 mg, 557 
μmol) in 1.0 mL acetonitrile at room temperature under agitation for 20 minutes.  MnO2 
was removed by filtration through an acetonitrile-wetted Celite (Sigma Aldrich, St. 
Louis, MO) syringe filter.  The activated diazo-cage solution was mixed with the FNA 
solution to achieve a 2:1 acetonitrile:aqueous buffer and 300 molar equivalents of the 
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active diazo compound.  A process control sample without nucleic acid and a process 
control sample without active caging compound were simultaneously run with 
experimental samples in order to rule out downstream effects resulting from caging 
reaction processing.  The reaction solutions were agitated at 4°C for 18 hours.  Excess 
cage compound was removed by size exclusion chromatography through a gravity 
column of preswollen (1:2 acetonitrile:water) solvent-resistant LH-20 sephadex (GE 
Healthcare Bio-Sciences Corp., Piscataway, NJ).  The product was further purified by 
4 X 500 μL washes through a YM-3 nitrocellulose spin filter (Millipore, Billerica, MA) to 
remove any residual cage compound, buffer, and organic solvent.  The products were 
dried, and resuspended in TE buffer (10 mM Tris, 1mM EDTA, pH 8.0) or nuclease 
free water.  All products were stored at 4°C and protected from light. 
 
4.2.2 Evaluation of Caged Nucleic Acids In Vitro 
 FNA concentration and degree of cage attachment was determined through 
spectrophotometric analysis.  Absorbance spectra of the caged products were 
measured from 230 nm to 500 nm.  The molar concentrations of the covalently bound 
cage sample and nucleic acid were calculated from the absorbance of incident light at 
260 nm and 355 nm.  Reverse phase high performance liquid chromatography (RP-
HPLC) was used to evaluate the control, caged, and photo-released FNAs.  Each 
sample type was injected (1.25 μg, 25 μL) in HPLC-grade water into a C18 analytical 
column, ODS2 spherisorb 5 μm (Waters Corporation, Milford, MA).  Separation was 
obtained using a gradient of 1% TEAA in HPLC water to 1% TEAA in 80% acetonitrile 
over 20 minutes.  
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4.2.3 Nuclease Digestions 
 Bal-31 nuclease (Promega Corporation, Madison, WI) was used to evaluate 
nuclease resistance of control and caged FNAs.  Final digestion conditions were as 
follows: 2.5 units Bal-31 nuclease, 2 μg 21mer FNA samples, 20 mM Tris-HCl (pH 8.1), 
12.5 mM CaCl2, 12.5 mM MgCl2, 600 mM NaCl, 6.25 nM EDTA, 0.625% (v/v) glycerol, 
50 μL total reaction volume at 30°C.  At various time intervals, 5 μL volumes were 
removed and were heated to 80°C for 10mins to halt digestion and immediately frozen 
at -20°C for subsequent analysis.  These fractions were collected and inactivated at 0, 
5, 10, 20, 40, 80, and 160 minute discrete time intervals.  Digestion of each FNA 
sample was evaluated via PAGE using 15% polyacrylamide precast gel (BioRad, 
Hercules, CA, USA) stained with Sybr Gold (Molecular Probes, Inc., Eugene, OR).  
Band densitometry analysis was performed was using Metaview software (Universal 
Imaging Corporation, West Chester, PA).  Briefly, regions of equal size were drawn 
around each band and band density was recorded as intensity integration over the 
area.  In the cases where no bands were visible, regions were drawn over the 
expected location of the bands.  Background intensities of each gel were measured 
and subtracted from the band measurements and each lane was then normalized to 
the undigested product.      
 
4.2.4 Photoexposure  
 A GreenSpot photocuring system (American Ultraviolet, Lebannon, IN) was 
used for exposing nucleic acids, cell cultures, and zebrafish embryos to UVA light 
doses.  Light was delivered through an inverted liquid-filled light guide for bottom-up 
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exposure of cell-culture wells or microcentrifuge tubes.  Infrared, UVC, and UVB light 
was filtered out using a short bandpass filter (SWP-2502U-400) and an IR-filter (KG-2-
IR) (Lambda Research Optics, Costa Mesa, CA).  Delivered light had a maximum 
output at 365 ± 8 nm with a fluence rate of 0.705 W/cm2 at 4.5 cm or 0.950 W/cm2 at 
3.2 cm (Forman, Dietrich et al. 2007).  Total light delivered was 40 J/cm2 for cell 
cultures and zebrafish and 200 J/cm2 for nucleic acid solutions.  Adjacent wells in a BD 
FalconTM 12-well tissue culture plate (BD Bioscience, Franklin Lakes, NJ) were 
protected from light by using an aluminum mask with a 2.25 cm diameter opening.  
 
4.2.5 Cell Culture and Transfection    
 BHK-21 (Baby Hamster Kidney) cells were cultured in reduced serum 
Dulbecco’s Modified Eagle’s Medium (DMEM-RS) (HyClone, Logan, UT) 
supplemented with 3% heat inactivated fetal bovine serum (HyClone, Logan, UT) at 
37°C under 5% CO2 in a humidified chamber and regularly passaged at 
subconfluence.  Cells were seeded on 12-well plates 18 hours prior to transfection at 
approximately 20K cells/cm2.  Cotransfections of pAcGFP-N1 (Clontech, Carlsbad, CA) 
and process control or caged siFNAs were mediated with lipofectamine (Invitrogen,
Carlsbad, CA).  Transfection mixtures containing 0.1 μg of pAcGFP-N1, 3 pmol siFNA 
sample, and lipid (3:1 ratio of lipid to total nucleic acid) were complexed in 100 μL of 
reduced protein medium (OPTI-MEM®, Invitrogen, Carlsbad, CA) and incubated at 
room temperature for 30 minutes.  Cells were rinsed with 500 μL of OPTI-MEM prior to 
transfection, and the transfection mixtures diluted in 500 μL of OPTI-MEM giving final 
siFNA concentrations of 5 nM in 600 μL and were added to the appropriate wells.  The 
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cells were incubated at 37°C under 5% CO2 for 6 hours, followed by return to normal 
growth media.  For light exposure of cell cultures, media was replaced with OPTI-MEM 
and cells were photoexposed at 4 hours after the end of the transfection period.  To 
ensure that photoexposure did not have an effect on GFP expression in cell culture, 
GFP positive controls and siFNA knockdown controls were exposed 5, 10, 20, 40, 60, 
80 J/cm2 to determine thresholds to UVA light.  After exposure, OPTIMEM was 
replaced with cell culture media and cells harvested at 48 hour post-transfection for 
expression analysis. 
 
4.2.6 Flow Cytometry RNAi Analysis   
 Transfected and control cell culture samples were harvested and fixed in 
PBS suspension with 0.5% paraformaldehyde prior to GFP expression analysis via 
flow cytometry.  GFP fluorescence was collected at 530±15 nm (FL1), and cellular 
auto-fluorescence was collected at a wavelength greater than or equal to 650 nm (FL3) 
on a fluorescence activated cell sorter (FASC-Scan) cytometer (Becton Dickinson, San 
Jose, CA) equipped with 488 nm excitation light source.  For each culture sample, a 
maximum of 30,000 cellular events were collected.  Intact cells were gated on a FSC 
(forward angle light scatter) versus SSC (90 degrees light scatter) dot plot.  An FL1 
versus an FL3 display of a GFP-negative control was gated and applied to all samples 
and analyzed to yield a percentage of cell events in the GFP-positive region.  This 
GFP-positive percentage for each sample was normalized to an average of GFP-
positive controls for the specific set of experiments and expressed as a mean value ± 
standard error  
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4.2.7 Zebrafish Embryo RNAi   
 Wild-type zebrafish purchased from EkkWill Waterlife Resources were kept 
at standard laboratory conditions (28°C on a 14 hr light: 10 hr dark photo-period in a 
recirculating system).  Embryos were collected from group spawns, and rinsed several 
times in embryo medium(Westerfield 2000) prior to microinjection procedures.  
Microinjection of zebrafish embryos was carried out as previously described 
(Westerfield 2000) to deliver plasmid and control or caged siFNAs.  Injection needles 
were pulled on a Flaming/Brown P-97 micropipette puller using fire-polished 
borosilicate glass capillaries with filament (Sutter Instrument Co., Novato, CA).  Briefly, 
a volume of 1-3 nL of a solution containing GFP plasmids (125 ng/μL), process control 
or caged siFNAs (250 ng/μL), Alexa Fluor 546-conjugated 10,000 MW dextran tracking 
dye (Molecular Probes, Eugene, OR), and 0.1% phenol red was injected into the 
embryo by forcing the pipette through the chorion and the yolk cell and then injected 
into the yolk stream at the 1- to 4-cell stage.  After injection, embryos were isolated in a 
transgenic containment facility and incubated at 28°C until photoactivated at 6-7 hpf.  
Embryos were exposed to UVA in 35-mm cell culture dishes containing 1 mL of 
embryo medium. Previous UVA dose-response curves (LD50 of UVA in zebrafish ~800 
J/cm2) in zebrafish embryos indicate their very high tolerance to UVA exposure, 
indicating the safety of these photo-activating light regimens (Dong, Svoboda et al. 
2007).  After the photoactivation, the embryos were raised to 27-30 hpf and further 
analyzed at the behavioral level.  Prior to 27 hpf, mortality and malformation 
identifications were used as initial evaluation criteria for UV or siFNA induced toxicity.  
At 27 hpf, the touch response behavior of each embryo was assayed. Those exhibiting 
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a normal touch response were fixed in 4% paraformaldehyde for three hours at room 
temperature.  
After fixation, individual embryos were placed in a single drop of PBST on 1-
mm-thick slides, coverslipped, and viewed with a Zeiss MOT II inverted microscope 
with a 20Χ objective equipped with GFP and rhodamine filter cubes. Embryos were 
first viewed in bright-field with DIC optics to get a clear view of the trunk region or brain 
region. Once a crisp view was obtained with DIC optics, the brain region, as well as 
rostral and caudal spinal cords were imaged under epi-fluorescence utilizing the GFP 
filter set. Images of the GFP expression were acquired using an ORCA-ER digital 
camera (Hamamatsu Inc, Japan). For each experiment, a minimum exposure setting 
required to obtain a non-saturating image of GFP expression in control embryos was 
first determined. For every experiment, after the control images were acquired, images 
of all the subsequent experimental embryos were acquired using the very same 
exposure times as controls.  To confirm that the embryos were indeed successfully 
injected with the various plasmids and molecular reagents, the distribution of the 
10,000 MW dextran was visualized. Control embryos and experimental embryos that 




4.3.1 Spectrophotometric Evaluation of Caged FNA 
 Absorbance spectroscopy was used to determine level of cage attachment 
to oligonucleotides.  Extinction coefficients for attached cage compounds (1-(4,5-
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dimethoxy-2-nitrophenyl)ethyl phosphoesters) were determined for 260nm (ε260 = 
3064 M-1cm-1) and 355nm (ε355 = 4512 M-1cm-1) and were consistent with previously 
reported values (Walker, Reid et al. 1988; Ghosn, Haselton et al. 2005).  These 
values, accompanied with the known spectral properties of nucleic acids, enabled the 
determination of molar concentrations of the cage compound and nucleic acid in a 
sample to give a measure of cage attachment.  A representative spectrum for a caged 
2’-fluoro-substituted nucleic acid is shown in Figure 4.1.  Caged FNAs exhibit a
 
 characteristic absorbance plateau at 355 nm in addition to an absorbance peak at 260 
nm.  Following UVA light exposure and purification, the photocleaved product 
resembles the control (non-caged) FNA.  The level of cage attachment could be 
altered by adjusting the concentration of the diazo-reactant relative to the nucleic acid 
or increasing the reaction duration.  Oligonucleotide products with an average number 
Wavelength (nm)






1.0 Process Control NA
41% Caged NA
Caged NA + 365 nm Light
 
Figure 4.1:  Spectrophotometic analysis of FNAs.  Processed control ( ), caged 
( ), and photoexposed caged ( ) NAs are overlaid.  All samples were 
processed in parallel.  Following photoexposure, released cage was removed from 
the solution via filtratation.  
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of cage groups of approximately 1, 3, 4, and 8 to 9 were generated reproducibly by 
varying cage reaction stoichiometry.  For all assays reported, a single caging reaction 
was utilized and the level of cage attachment for each strand was an average of 7.9 
and 9.0 cage groups per 21mer oligonucleotide strand for the sense and antisense 
FNA strands, respectively.   
 
4.3.2 HPLC Separation of Caged FNAs.   
 Single stranded 21nt FNAs were characterized using RP-HPLC.  A 
representative HPLC plot is shown in Figure 4.2.  FNA control samples eluted quickly 
with a sharp peak elution profile.  Caged FNAs were retained longer than their process 
Retention Time (minutes)








Caged FNA + 365 nm Light 
 
 
Figure 4.2:  HPLC separation of caged FNAs.  Elution profiles for processed control 
( ), caged ( ), and photoexposed caged ( ) FNAs are shown.  Peak 
broadening of caged sample is indicative of a heterogeneous product mixture of 
various degrees of caging.  Photoexposure restores mobility to resemble the 
process control products. 
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control (non-caged reaction, see methods and Fig. 4.1 results) counterparts and 
exhibited a broadened elution profile.  Upon exposure to 200 J/cm2 of 365 nm light, the 
elution profile of the photo-released species resembled the control FNA elution profile, 
suggesting removal of the cage moieties.   
 
4.3.3 Nuclease Digestions of Caged FNAs.   
 Although FNAs have previously been shown to exhibit nuclease resistance 
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Figure 4.3:  Nuclease digestion (BAL-31) of control and caged FNAs.  Top panel: 
PAGE results show that caged FNAs are much more resistant to sugar non-specific 
nuclease that control FNA.  Bottom panel: graphical representation of band-
densitometry normalized to band intensity at time = 0 minutes. 
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Rana 2003; Layzer, McCaffrey et al. 2004), here we show that BAL-31 nuclease can 
digest the modified oligonucleotides in vitro.  This enzyme is a bidirectional 
exonuclease that is able to hydrolyze RNA and DNA (Wei, Alianell et al. 1983).  Time 
course experiments show improved resistance of caged FNA to BAL-31 nuclease as 
illustrated in Figure 4.3.  The uncaged, process control FNA products were not visible 
after 10 minutes of digestion.  The caged products are still detectable at 160 minutes, 
indicating that the presence of the cage group acts to slow digestion of the nucleic 
acids.   
 
4.3.4 Control of RNAi in Cell Culture with Caged FNAs.  
 Sense and antisense FNA strands were caged in parallel reactions.  A 
process control, in which the caging compound was not added to the reaction with the 
FNA, was also prepared simultaneously for each strand.  These products were 
matched to provide four siFNA caging schemes; 1) non-caged, 2) only antisense stand 
caged, 3) only sense strand caged, and 4) both strands caged.  In all cases, the  
attachment of DMNPE decreased the observed RNAi silencing when compared to the 
activity of the process controls (Fig. 4.4).  Exposure of transfected cell cultures to 365 
nm light partially restored the RNAi activity for all caged samples.  Figure 4.4 illustrates 
that the RNAi is more sensitive to the caged antisense strand than the caged sense 
strand.  Knockdown activities of caged and photoexposed siFNAs were compared to 
process control siFNAs.  The latter represent fully active RNAi effectors, which were 
able to eliminate GFP transgene expression in nearly 90% of the cells at a 5nM dose. 
SiFNAs with a caged antisense strand silenced GFP expression in only 15.3 ± 13.7% 
of the cell population, whereas sense strand caged siFNAs silenced GFP in 41.9 ± 
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14.7 % of cells.  A further reduction in RNAi activity to 9.7 ± 1.4 % was observed when 
both strands were caged.  All caged siFNA species had significantly reduced silencing 
activity compared to controls (p <  0.05). Following photoexposure, each of these 
caged siFNA samples exhibited an increase in the percentage of GFP negative cells to 
57.9 ± 6.9 %, 78.1 ± 4.7 %, and 55.8 ± 3.4 % for the antisense caged, sense caged, 
and dual strand caged siFNAs, respectively.  While these photoactivated expression 
increases are significantly different from the corresponding caged samples (p < 0.05), 
























100 siFNA no light treatment




































Figure 4.4: RNAi using caged siFNAs in cell culture.   Bars represent treatments 
that were protected from light.   Bars represent equivalent treatments as the 
paired black bar followed by delivery of 40 J/cm2 365 nm light.  A significant 
difference exists between all photoexposed and non-photoexposed caged samples 
(denoted by †, p < 0.05).  No statistical deference was seen for the control siFNA 
(left).  
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of siFNA activity.  GFP positive controls were subjected to various doses of 365 nm 
light to ensure that photo-treatment did not have a negative impact on transgene 
expression.  No negative affects on cellular morphology or growth rates were observed 
until light doses reached 80 J/cm2.  Figure 4.5 shows that percent of GFP-positive cells 
in samples treated with only plasmid or by plasmid and siFNA remained nearly 
unchanged through a 80 J/cm2 dose of UVA photoexposure, relative to the 
corresponding non-photo-treated cultures.   
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Figure 4.5:  Response of cells to various doses of 365 nm light.    Represents GFP 
positive controls at various light doses.   Represents siFNA knockdown cultures 
exposed to various light doses.  No statistical difference could be found by 
photoexposing positive controls up to 80 J/cm2 (p < 0.05).  A small decrease in GFP 
expression was significant (denoted with †, p < 0.05) at light doses > 40 J/cm2 
relative to non-photoexposed cultures, but this was the opposite effect observed 
from photolysis of caged siFNA treatments.  These results indicate that light dosing 
in this range does not have noteworthy effect on GFP expression or silencing 
activity.  
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4.3.5 In Vivo Control of RNAi in Zebrafish Embryos.   
 All treatment reagents were co-injected into the yolk stream of zebrafish 
embryos in the 1 to 4-cell stage, and a fluorescently labeled dextran tracking dye 
allowed for the selection of successful injections and delivery to the cells, as illustrated 
Figure 4.6.  Adequate injections exhibited a uniform red-fluorescence signal.  No 
differences in mortality or malformation were observed in response to the dextran 
tracking dye or the GFP plasmid at the concentrations tested.  
 
Gene knockdown activity of control and caged siFNAs, prior to and after light 
exposure, are illustrated in Figures 4.7 and 4.8 with representative fluorescent images.  
Co-injections of process control siFNA and GFP plasmid exhibited less green 
fluorescence  signal than embryos only injected with GFP plasmid, performed in 
parallel.  This pattern held true at all concentrations of plasmid and siFNA investigated.  
GFP expression levels in embryos injected with caged siFNAs were similar to those 
with injections of only GFP plasmid.  GFP expression decreased in embryos injected 
with caged siFNAs and exposed to UVA light at 7 hpf. Doses utilized (40 J/cm2) had no 
effect on zebrafish morphology, plasmid expression, or control siFNA silencing.  
Alexa Fluor Dextran pAcGFP MergedFish Embryo at 28 hpf
 
 
Figure 4.6: Zebrafish injection analysis.  Fish embryo at 28 hpf development depicts 
the region in which image analysis was performed.  Left: Dextran tracking dye (red) 
was observed throughout the region for successful injections.  Middle: GFP positive 
cells resulted in mosaic expression (green).  Right: Overlaid of the signals from the 
labeled dextran and GFP expression in the same fish.  This pattern was typically 





The appropriate concentration of siFNAs used for zebrafish injections was 
determined through titration assays to determine subtoxic treatment levels.  Injections 
with siFNA concentrations of 500 ng/μL or greater resulted in an increased incidence 
of mortality and noticeable delays in embryonic development.  The severity of this 
pAcGFP pAcGFP + light
 
Figure 4.7:  GFP expression is unaffected by UVA light exposure (40 J/cm2) 
GFP-control siFNA + GFP siFNA + GFP 
+ UVA Light 
Caged siFNA + GFP 
+ UVA Light





Figure 4.8:  RNAi of caged versus control siFNA in zebrafish.  Each row represents 
a complete experimental set of treatments for embryos injected on the same day.  
Exposure to 40 J/cm2 UVA light was performed at 7 hpf. A: Uncaged siFNAs reduce 
GFP expression relative to controls, and light exposure has no observable effect on 
GFP expression.  B: Caged siFNA resemble GFP control injections, but light 
exposure reduces GFP expression. 
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developmental delay was proportional to the concentration of siFNA delivered to the 
embryo.  Treatment with single-stranded antisense FNA of the same sequence (500 
Age (hpf)





















































































Fig. 4.9:  Toxicity evaluation of control versus caged siFNAs.  Panel A: siFNA 
concentrations above 250 ng/μL resulted in an increase in mortality.  Panel B: 
Caging of siFNAs protects the developing embryo from the siFNA induced toxicity. 
Panel C: Illustrates a developmental delay at 12 hpf in response to siFNA toxicity at 
a concentration of 500 ng/μL.  Control (no siFNA) and caged siFNA injected 
embryos exhibit a developing tail bud, denoted by white circles.  At the same age, 
the embryos injected with process control siFNA are several hours behind in 
development, and they have not transitioned from gastrulation to the tailbud stage.   
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ng/μL) did not result in a noticeable developmental delay or increased mortality rate 
(data not shown).  Interestingly, caging the siFNA reduced both the motility rate an 
observed delay (Fig. 4.9). 
 
4.4 Discussion 
RNAi is a widely utilized mechanism for gene silencing, but despite being 
highly active and stable in cell culture, challenges still exist for effective silencing in 
vivo.  These challenges include improving nuclease stability and siRNA half-life, 
designing thermodynamically stable effectors with improved target binding affinity, 
achieving efficient biodistribution through idealized pharmacokinetic properties, and 
targeting of diseased tissue.  Most attempts to achieve these goals focus on 
permanent chemical modification, resulting in a siRNA mimic.  These types of siRNA 
manipulation have provided much information regarding structural requirements for 
RNAi and what types of alterations can be made without disrupting gene silencing.  For 
instance, a review of 2’-modified siRNAs suggests that the 2’-OH is not necessary for 
RNAi, but changes at this location that alter either the global duplex structure or disrupt 
the minor groove can abolish interference (Manoharan 2004; Zhang, Du et al. 2006).  
Since halide and o-methyl substitutions maintain A-type helical structure by enforcing a 
C3’-endo sugar pucker confirmation (Guschlbauer and Jankowski 1980; Chiu and 
Rana 2003), and are not large enough to disrupt the major groove, these modifications 
have been extensively utilized for RNAi.  In addition, these substitutions improve 
resistance to sugar-specific enzymatic degradation and have been shown to reduce 
off-target effects normally observed following siRNA delivery (Jackson, Burchard et al. 
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2006; Cekaite, Furset et al. 2007).  Despite the advances in siRNA stability through 
permanent chemical modification, these effectors still lack improved biodistribution and 
tissue specific targeting capabilities. 
One strategy to achieve tissue specific targeting of RNAi is to utilize 
synthetic siRNAs that can be activated by an external inducing agent.  This strategy 
would utilize the trigger to activate at select sites and times.  This has been attempted 
by several groups with photo-caging RNA in order to silence gene expression using 
controlled light exposure.   The first incidence of RNA caging was accomplished by the 
incorporation of a 2’-OH photolabile protecting group into RNA for disruption of the 
hammerhead ribozyme activity (Chaulk and MacMillan 1998).  This system efficiently 
provided light-reversible protection of the substrate RNA.  Although highly efficient, this 
technique required extensive synthetic procedures to produce the protected 
oligonucleotide.  An alternative approach to caging RNA was demonstrated with the 
random attachment of 6-bromo-7-hydroxycourmanrin-4-ylmethyl (Bhc) cage compound 
to exogenous mRNA through a reactive diazo-intermediate (Ando, Furuta et al. 2001).  
This approach was adopted using a similar attachment chemistry to produce 1-(4,5-
dimethoxy-2-nitropheynl)ether (DMNPE) caged siRNAs (Shah, Rangarajan et al. 
2005).  In both incidences the caged RNA effectors demonstrated reduced activity 
relative to their respective controls, which was partially restored by exposure to 350-
365 nm light.  Although not proven, it is presumed that caging of nucleic acids with 
diazo-intermediates results in phosphate attachment.  Therefore, a potential drawback 
of these studies was the potential for phosphotriester-mediated hydrolysis of caged 
species.  RNA phosphotriesters have been shown to be unstable in aqueous solutions 
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where the 2’-OH may play a role in hydrolysis (Breslow and Xu).  Therefore internally 
caged nucleotides might be very susceptible to hydrolytic release of the cage molecule 
itself or scissile bond cleavage and degradation of the RNA.  Our early attempts to 
cage 700bp dsRNA using reactive diazo compounds resulted in fragmentation of the 
RNA in aqueous buffer (Chapter 2).   
In an effort to reduce the leak activity, improve the efficiency of photo-
induction, and avoid RNA hydrolysis, two groups have separately expanded on caged 
siRNA by incorporating a single photolabile group onto the 5’-terminal phosphate of the 
siRNA antisense strand (Nguyen, Chavli et al. 2006; Shah and Friedman 2007).  Each 
exploited a commercially-available NPE-derived linker on the 5’-terminal nucleotide 
during 3’ to 5’ RNA solid phase synthesis.  Based on previous work, this phosphate is 
thought to be critical for siRNA incorporation into RISC (Chiu and Rana 2003; 
Czauderna, Fechtner et al. 2003; Ma, Yuan et al. 2005).  However, the results of these 
studies were mixed.  Nguyen et al. demonstrated that these caged siRNA had very 
little activity and that silencing was efficiently restored with light doses that were 
required to remove all cage linkers, which was determined in vitro.  Observations of 
minute leak activities were explained by N-1 contaminants from RNA synthesis that 
had silencing activity due to the absence of the final caged linker. Shah and Friedman 
disputed this interpretation since their data shows significant leak RNAi activity in the 
caged un-induced state.  Additionally Friedman and colleagues tested highly purified 
antisense RNA strands with non-photolabile linkers at the 5’-phosphate to verify their 
results.  Their interpretation was that the RISC components have the ability to interact 
with the remaining non-bridging oxygen, allowing some RNAi to proceed.  Although the 
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5’-phsophate on the antisense strand is known to be required for RNAi activity 
(Nykanen, Haley et al. 2001; Martinez, Patkaniowska et al. 2002; Schwarz, Hutvagner 
et al. 2002), it has also been shown that various linker modifications to this terminal 
location are tolerated if the 5’-phosphoester bond is intact (Schwarz, Hutvagner et al. 
2002; Harborth, Elbashir et al. 2003).  To avoid this residual activity, light-activated 
RNAi might require an alternate site of cage attachment or caging on multiple sites for 
each siRNA.  Recently the site-specific strategy of caging siRNAs was expanded to 
include internally-caged nucleobases with impressive results(Mikat and Heckel 2007). 
While photo-caging of siRNAs has demonstrated promise in spatially and temporally 
controlling RNAi, this technique does not address some of the other desired 
characteristic for improving pharmacological efficiency of RNAi.  Results shown here 
combine the benefits of 2’F modified siRNAs with DMNPE caging in order to achieve 
stable, light-inducible, RNAi. 
 Fully modified 2’-F RNA was generated through solid-phase synthesis and 
caged using a diazonium nitrobenzyl derivative in a batch-style reaction.  While 
conditions of this reaction could be altered to produce varying degrees of cage 
attachment, the more heavily caged products were used in the model biological 
systems to reduce leak RNAi activity.  Evaluation of the caged products in several in 
vitro characterization assays allowed for qualitative analysis of cage attachment and 
photo-release.  PAGE separation of caged products was carried out as previously 
described (Ghosn, Haselton et al. 2005) and indicated cage attachment (data not 
shown).  In this assay a high incidence of cage attachment markedly diminishes 
visualization using ethidium-like stains.  This phenomenon could be caused by a 
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reduction in the association between the stain and nucleic acid, quenching of the 
fluorescent signal, or a combination of the two factors.  In addition to gel shift assays, 
the products were also evaluated by RP-HLPC, where direct absorbance detection 
does not rely on fluorescent staining.  The chromatography results (Fig. 4.2) clearly 
show separation between the uncaged and caged species.  Differences in affinity for 
the non-polar stationary phase are believed to arise from the elimination of a negative 
charge on the backbone as well as the addition of the non-polar cage moiety.  The 
observed peak broadening of the caged NAs indicates that the solution was a 
heterogeneous mixture of products ranging in the degree of cage attachment.  
Therefore, even in samples that are heavily caged, some strands of nucleic acid may 
still have a limited number of cage compounds attached.  For all assays tested, UVA 
photoexposure restored the NA properties to resemble the process control samples.   
 It has previously been suggested that photo-release of a caged-species with 
n multiple adducts requires an irradiation dose that scales to the nth power for 
equivalent uncaging (Tang and Dmochowski 2007).  However, the observed quantum 
yield of DMNPE-caged FNA (n=9) does not support this hypothesis.  For instance, 
DMNPE-caged ATP quantum yield reported in the literature is between 0.1 and 0.05 
(Goeldner and Givens 2006; Ellis-Davies 2007).  Assuming similar quantum yields for 
DMNPE phosophoesters on FNA, complete photocleavage would require several 
orders of magnitude greater light exposure than we observed was necessary for 
complete photocleavage (Fig. 4.2).   
 Caging also provides resistance to enzymatic digestion.  Fully modified 
FNAs were previously shown to be impervious to several sugar-specific nucleases 
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(chapter 2).  However, these NAs are still susceptible to certain sugar-nonspecific 
nucleases, such as BAL-31.  Figure 4.3 illustrates that single-stranded FNAs were 
rapidly processed by this enzyme at the concentrations tested.  However, the 
attachment of DMNPE drastically decreased the BAL-31 degradation of FNA.  Since 
BAL-31 acts primarily as a bidirectional, single-strand specific, exonuclease (Wei, 
Alianell et al. 1983), the enzyme might be able to easily process uncaged end 
nucleotides.  Once reaching one or multiple adjoining caging sites within the nucleic 
acid, the enzyme might be interrupted from its digestive process, similar to the 
disruption of Bam H1 digestion of DMNPE-caged plasmid DNA (Monroe and Haselton 
2004).  It has previously been demonstrated that the 2’F modification increases siRNA 
stability in serum and plasma but this does not translate to longer silencing in vivo 
(Layzer, McCaffrey et al.).  Therefore, intracellular digestion of these modified NAs 
might be more efficient than under in vitro conditions.  The combination sugar 
modification and backbone caging may provide enough enzymatic resistance to 
increase lifetimes of FNA and the duration of RNAi-mediated gene knockdown.  
Unfortunately, cell culture assays are not amenable to extended time course 
experiments since the RNAi effectors are quickly diluted through cellular proliferation.  
Additionally, delayed activation of the caged siFNA could not be tested in these 
systems since the fluorescent protein is stable, resulting in a persistent signal.  Future 
studies utilizing a destabilized or more transient reporter gene in vivo would be useful 
in exploring prolonged RNAi lifetimes through cage attachment.   
It has been shown above that DMPNE attachment to FNA can affect NA:NA as 
well as NA:enzyme interactions.  Therefore, caging of siFNAs may have the potential 
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to disrupt RNAi in various ways such as: disruption of RISC recognition, helicase 
unwinding of the duplex, mRNA target recognition, ejection of the digested target for 
RISC recycling, localization of RISC to specialized organelles, and downstream 
processing such as chromatin remodeling.    Figure 4.4 demonstrates that caging of 
either strand in a siFNA reduces RNAi activity.  However, the caged antisense strand 
results in greater disruption of RNAi activity even though both strands were evaluated 
with similar degrees of cage attachment.  This is not unexpected since the sense FNA 
strand is discarded early in the RNAi pathway.  Reduction of sense strand caged RNAi 
is likely caused by improper siFNA formation, reduced delivery of the caged species 
through lipid mediated transfection, disruption of RISC recognition, disruption of 
helicase removal of the sense strand, or a combination of these factors.  A parallel 
study carried out by our research group has demonstrated that caging of a 
fluorophore-labeled phosphorothioate oligonucleotide resulted in no observable 
difference in lipid-mediated cellular delivery (Fabion, in preparation).  Additionally, it is 
unlikely that cellular delivery is drastically reduced due the attachment of DMNPE 
since photoexposure of sense-caged siFNA treated cells restores RNAi activity to 
levels that are nearly equivalent to the uncaged-control effectors.  This observation 
also suggests that when only one strand is caged, FNA duplexes are stable prior to 
delivery.  Caging of the antisense strand had the benefit of significantly less leak in 
RNAi activity.  However, only partial restoration using 365 nm light was achieved.  
HPLC evaluation of these products suggests that the caged FNAs may consist of a 
heterogeneous mixture of products that vary in the degree of DMNPE attachment.  
More lightly caged species may allow for residual RNAi activity, while DMNPE might 
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not be fully removed upon photoexposure for heavily caged species.  Compounding 
the issue of varying amounts of the cage molecule, the location of attachment is likely 
variable.  Disruption of RNAi might be highly dependant on the location of the cage 
species.  Since it is carried through the entire RNAi pathway, it is more likely that the 
antisense strand has multiple RISC interaction and critical processing locations along 
its length and, therefore, it is more likely for a randomly attached cage group to disrupt 
silencing.  Several potential critical locations for effective RNAi have been identified 
through siRNA chemical modification studies as well as structural evaluation of RISC 
protein components (Song, Liu et al. 2003; Manoharan 2004; Parker, Roe et al. 2004; 
Zhang, Du et al. 2006).  Together, these investigations support the observation that the 
antisense strand is more sensitive to modification or cage attachment.  
Zebrafish embryos were used as an in vivo model to test photo-induced 
silencing with caged siFNA to support the cell culture results.  The mosaic expression 
pattern of the GFP reporter transgene prevented quantitative analysis.  This mosaic 
expression pattern has been previously reported in other studies (Ando, Furuta et al. 
2001).  The red-fluorescence signal from injected labeled dextran indicates uniform 
delivery by microinjection (Fig. 4.6).  Nevertheless, qualitative observations strongly 
suggested that caging reduces the silencing activity of these molecules and that this 
activity can be restored by photoactivation.  The reduction in GFP expression is not 
likely due to photoexposure, as the GFP controls are unaffected with similar light 
doses.  Additionally, the LD50 of UVA in zebrafish (~800 J/cm2) is several orders of 
magnitude larger than we have observed in cell cultures (Matsuura, Dong et al. 2005; 
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Forman, Dietrich et al. 2007). Thus zebrafish are a particularly appropriate model for 
photoactivated gene expression studies.   
Another observed benefit of caging these RNAi effectors is protection from 
toxicity associated with siFNAs.  Several potential causes of this toxicity include off-
target RNAi gene silencing, innate toxicity of siFNAs and their metabolites, or 
overwhelming of the RNAi machinery with siRNA substrates.  It has been previously 
reported that RNAi in zebrafish has a particularly high incidence of off target effects 
(Oates, Bruce et al. 2000; Zhao, Cao et al. 2001; Giraldez, Mishima et al. 2006).  
Therefore, it is likely that the observed increase in mortality rate and developmental 
delay are related to an RNAi phenomenon, rather than toxicity of breakdown products 
of FNAs.  Additionally, single stranded FNAs injected at high concentrations did not 
result in observable toxicity (data not shown).  RNAi toxicity might be more dramatic in 
a developing system, since endogenous microRNAs are theorized to play a major role 
in genetic regulation(Matzke and Matzke 2003).  This further supports the conclusion 
that caging of the RNAi effector prevents them from entering the RNAi pathway.  If this 
is true, then the fact that these molecules were activated at 7 hpf demonstrated 
intracellular stability of the caged species.  Therefore caging of RNAi effectors would 
allow delivery to the biological system at concentrations that would otherwise be toxic, 
followed by photo-induction of gene silencing at a specific stage of development in a 
manner that could be used to control dosing to sub-toxic levels. 
Chemically stabilized siFNA was successfully controlled through transient 
chemical modifications which can be disassociated with light.  The use of 2’-fluoro 
modification throughout the NA eliminated the possibility of unstable phosphotriester 
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formation.  This allowed for multiple attachments of the photolabile compound to the 
phosphate backbone of each siRNA strand.   These caged species exhibit increased 
resistance to nuclease digestion and reduced RNAi silencing, and these effects were 
partially reversible with the application of 365 nm light.  Although this strategy was 
successful in achieving photo-induced RNAi with chemically stabilized effectors, the 
external trigger was not 100% efficient.  In order to approach this level of efficiency, 
cage groups would likely need to be placed at desired locations, which would need to 
be directed through synthetic methods as opposed to random attachment through co-
incubation with a reactive intermediate.   Despite necessary future improvements, the 
results presented here suggest that caging can be used in conjunction with other 






Base-Caged ATP: an Alternative to γ-Phosphate Caged ATP 
 
5.1 Introduction 
The first example of applying photochemistry to control biological activity of a 
substrate was caged ATP [Kaplan, 1978 #60].  In this study, 2-nitrobenzyl and 1-(2-
nitrophenyl)ethyl groups were attached to the gamma phosphate of ATP to cage its 
biological activity.  These caged ATPs were used to control the activity of a Na:K 
ATPase ion pump.  Since this time, ATP has remained the most frequently caged 
biomolecule, and is often used a model for different photolabile protecting groups 
[Reviewed by Givens review].  For instance, the first biological use of the p-
hydroxyphenacyl demonstrated photo-release of ATP (Givens and Park 1996).  
Similarly, the coumarin-derived family of caging compounds was first used to cage 
phosphates (Givens and Matuszewski 1984).  Nearly a decade later it was used for 
caging cAMP in a simulated physiological environment (Furuta, Torigai et al.) and later 
was used for ATP caging.  Caged-ATP is an excellent model due to the myriad of 
biological processes that are dependant on ATP for energy. 
Although alkylation of the ATP γ-phosphate restricts kinase activity, this 
scheme still has one major flaw.  Most applications of caged ATP require an enzyme 
interaction to process the substrate ATP.  Caging at the phosphate prevents 
dephosphorylation of the ATP, but this does not necessarily prevent protein-ATP 
recognition.  In many cases, caged ATP substrates have been shown to inhibit the 
target systems being studied, as first described by Forbush (Forbush 1984).  Other 
examples of the gamma-phosphate caged ATP inhibition include actomyosin (Thirlwell, 
 124
Corrie et al. 1995], mitochondrial ADP/ATP carrier protein (Broustovetsky 1997), 
kinesin and microtubules (Higuchi 1997), and the classical Na:K ATPase pump 
(Geibel, Barth et al.).  In the case of actomyosin, the competitive inhibition caused by 
the presence of caged ATP slowed the shortening kinetics of muscle fibers.  This is 
particularly unfavorable since caged-ATP was classically used to measure the kinetics 
of this system using a pulse trigger (McCray, Herbette et al.).  Since many of these 
processes are specific to the adenosine nucleotide triphosphate, another potential 
approach would be to cage the nucleobase.  This may eliminate competitive binding 
and still render the caged ATP biologically inert.  Despite the recent advances in 
nucleobase caging of oligonucleotides (Hobartner and Silverman), synthesis and 
utilization of base-caged ATP has not been reported to date. 
One reason why the generation of base-caged ATP might not have been 
attempted is that techniques for caging of a nucleobase often require difficult synthetic 
methods.  A potential solution to this problem is to utilize a reactive base-modified NTP 
as the substrate for caging.  This allows for the direct caging of the adenosine through 
direct attachment schemes.  To avoid the requirement for series of protection and 
deprotection steps, the cage intermediate should not be reactive with the phosphates 
or the hydroxyl groups on the ribose.  A mildly nucleophilic primary amine meets these 
requirements.  Additionally this attachment chemistry should be reactive with the 
modified nucleobase, such as 6-chloropurine riboside. Here, we show 2-
nitrobenzylamine and a custom 4,5-dimethoxy-2-nitrobenzyl amine can be used to 




5.2 Materials and Methods 
Ammonia gas was condensed (60 mL) in a pressure vessel cooled in a dry 
ice propanol bath to -80oC. Meanwhile, 4,5-dimethoxy-2-nitrobenzyl bromide (DMNBB) 
(2.5 gr, 9.06 mMol) was dissolved in acetonitrile (ACN) (24 mL) under continuous 
agitation.  The DMNBB solution was added dropwise over 10 minutes to the 
condensed ammonia liquid with constant stirring.  The pressure vessel was sealed, 
shielded from light, and allowed to equilibrate to room temperature.  The reaction 
proceeded under constant stirring for 69 hours.  The vessel was then re-cooled to -
80oC and opened after equalization to atmospheric pressure.  All ammonia was 
evaporated and the product was solubilized in 100mL of dichloromethane (DCM).  A 
10% w/v sodium carbonate aqueous solution was added to the DCM for phase 
extraction to separate the nitrobenzylamine product from the ammonium bromide salt.  
The aqueous phase was washed 2 more times with DCM.  The collected DCM layers 
were dried over potassium hydroxide and filtered through Whittman paper funnel.  The 
product was further purified via silica gel chromatography (1:9 methanol:DCM, Rf = 
0.05).  The product containing fractions were dried in vacuo, leaving a reddish brown 
solid.  4,5-dimethoxy-2-nitrobenzylamine (DMNB-NH2) was verified through NMR, ESI-
MS, and FTIR spectroscopy. 
For nucleoside model studies, chloropurine riboside (CPR) was purchased 
from TriLink BioTechnologies (San Diego, CA) and 2-nitrobenzylamine (NB-NH2) was 
purchased from Sigma Aldrich (St. Louis, MO).  NB-NH2 or DMNB-NH2 (200 μmol) was 
dissolved in 1-propanol or methanol (58.2 μL) and triethylamine (41.8 μL).  CPR (25 
μmol) was added to the solution and the reaction was gently agitated at 42oC for 18 
hours.  Fractions were taken at various time intervals to monitor the reaction progress 
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via reversed phase HPLC on a C18 column (spherisorb ODS2 5 μm bead Waters 
Corp., Milford, MA).  Separation via HPLC was carried out at a flow rate of 0.5 mL/min 
under the following solvent conditions: 90:100 to 50:100 A:B linear gradient over 30 
minutes, linear increase to 100% B over 20 minutes, and 5 minute hold at 100% B, 
where A is 0.1% triethylammonium acetate (TEAA) in water and B is acetonitrile.  
HPLC was also used to purify products for ESI-MS analysis.  
For ATP caging, a chloropurine riboside triphosphate (CPR-TP) solution 
(100 mM) was purchased from TriLink BioTechnologies.  NB-NH2 or DMNB-NH2 (260 
μmol) was dissolved in methanol (150 μL) by heating to 60oC in a water bath.  
Triethylamine (50 μL) and 16.6 μL of a 100mM CPR-TP aqueous solution (1.66 μmols) 
were added to the solution, and the reaction was rocked at 42oC for 18 hours.  Once 
complete, DCM (500 μL) and deionized water (500 μL) were added to the solution and 
phases were mixed by shaking.  The aqueous layer was collected and washed twice 
more with 500 μL of DCM.  The aqueous layer was passed through an DEAE 
sepharose fast-flow anion exchange column (GE Healthcare), which was prewashed 
with 1 M NaCl solution and copious amounts of water.  The product was eluted using 
step increases in concentration of NaCl solutions up to 1 M.  The resulting fractions 
were dried in vacuo, reconstituted in deionized water, and stored at 4oC and protected 
from light for analysis. 
A luciferin-luciferase ATP reporter kit was purchased for analysis of the base 
caged ATPs (Enliten®, Promega Corp., Madison, WI).  Additionally γ-phosphate caged 
ATPs (NPE and DMNPE) were purchased for comparative analysis (Molecular Probes, 
Eugene, OR).  The luciferin-luciferase reagents were reconstituted using the kit buffer 
according the manufacturer specifications.  These enzyme buffer was further diluted 
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(1:5 or 1:10) with HEPES (20mM, pH 7.5).  Various concentrations of ATP samples or 
mixtures (5 μL total) were added to a 96-well plate.   Photoexposures were performed 
directly in the plate, before adding the luciferase reagent.  The diluted reagent was 
added (45 μL per well, 90% of final volume) to the plate immediately before measuring 
luminescence on a Fluorstar plate reader.  All plates contained several ATP and water 
standards for experiment equilibration. 
 
Photoexposures were performed using either a transilluminator (TFM-20, 
UVP Inc., Upland, CA) (λ = 308 nm, 6.5 mW/cm2) or a GreenSpot Photocuring System 
(λ = 365 nm, 0.95 W/cm2) (American Ultraviolet, Lebannon, IN).  Light was delivered to 





































































Figure 5.1:  Base-caged adenosine scheme.  ATP reaction reaction with 2-
nitrobenzyl amine caging groups (R = H, n-nitrobenzyl amine, R= OCH3, 4,5-
dimethoxy-2-nitrobenzyl amine) 
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liquid-filled light guide for the GreenSpot system.  Infrared, UVC, and UVB light was 
filtered out from the GreenSpot light source using a short bandpass filter (SWP-2502U-
400) and an IR-filter (KG-2-IR) (Lambda Research Optics, Costa Mesa, CA).  Total 
light delivered was 60 J/cm2.  Non-photoexposed samples were added to the 




2-nitrobenzylamine was purchased from Sigma Aldrich (St. Louis, MO), 
however the dimethoxy-analogue was synthesized to have a cage suitable for use in 
cells and tissues.  The amination of DMNBB was separated on thin layer 
















Figure 5.2:  NMR of DMNBNH2.  A labeled chemical structure of the product 
correspond to peak labels for H-peak identification. 
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and stained using ninhydrin plus heat for detection of amines (data not shown).  
Although ammonia was used in vast molar excess, formation of a secondary amine 
was detected.  Column silica chromatography yielded a pure product with mass 
spectroscopy showing a molecular weight of 213, corresponding to DMNB-NH2 + H+.  
The primary amine was difficult to observe using 1H-NMR due to proton exchange with 
the solvent (fig. 5.2, peak f).  However, the presence of the amine resulted in a signal 
shift for the two hydrogen atoms associated with exocyclic carbon (fig.5.2, peak e).  
FTIR was used in conjunction with 1H-NMR and ninhydrin staining to verify the 
presence of the primary amine. 
Both 2-nitrobenzylamine compounds were tested for the ability to convert 6-
chloropurine riboside to caged amine via substitution of the chloro-modification.










































Figure 5.3:  HPLC monitoring of CPR and NB-NH2 cage reaction.  Overlaid elution 
profiles of NBNH2 cage reaction with starting reagents.  Red arrow indicates product 
formation at 4 hours into reaction.  ESI-MS of the product peak correlated to 2-
nitrobenzylamine caged adenosine (MW: 403.3). 
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evaluated by RP-HPLC at hourly intervals.  Caging reactions using NB-NH2 gave a 
clean product that eluted between the two starting reagents.  Figure 5.3 demonstrates 
product formation at 1 hour and the elution of the product relative to the starting 
reagents.  The product peak was collected and verified by ESI-MS (MW = 403.3).  The 
reaction using DMNB-NH2 resulted in the formation of several side products (Fig 5.4). 
 
I 
In this reaction, the cage reagent appears to react with the solvent system (methanol 
and triethyl amine) or simply breaks down.  This results in precipitate formation and a 
loss of signal relating to DMNB-NH2 by 4 hours reaction time.  However, the product of 
















DMNB-NH2 + CPR reaction 1 hour












Figure 5.4:  HPLC monitoring of CPR and DMNB-NH2 cage reaction.  Overlaid 
elution profiles of DMNB-NH2 cage reaction with starting reagents.  Red arrow 
indicates product formation of interest, but a significant number of side-product 
contaminants are present.  ESI-MS of the product peak correlated to 2-
nitrobenzylamine caged adenosine (MW: 463.1). 
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Once the caging reactions with the CPR nucleoside model were verified, the 
same process was used to generate caged ATP from 6-chloropurine riboside 
triphosphate.  After the 18 hour reaction, a liquid-liquid extraction was used to separate 
the unreacted cage from the nucleoside triphosphate products.  Similar to the 
nucleoside model studies, a precipitate formed in the reactions and this effect was 
more pronounced in the DMNB-NH2 reaction.  Additionally, the resulting DMNB-NH2 
aqueous phase contained chromophores causing the solution to appear dark blue.  
Prior to ion exchange chromatography, the aqueous phase for both products 
underwent a colorimetric change during the drying process, suggesting further 
reactions by remaining contaminants. During anion exchange, a yellow and green 
band eluted at low salt concentrations.  However, the fraction corresponding to 
nucleotide triphosphate elution retained a dark blue appearance.  Alternatively, the NB-
NH2 caged yielded in a clear eluent.  The collected fractions were evaluated via 
absorbance spectroscopy to determine caged-ATP yield.  Yields of nucleotide 
triphosphate crude products were 90% and 62.7% for NB-NH2 and DMNB-NH2, 
respectively.  
Since 6-chloropurine riboside triphosphate has negligible activity in the 
luciferase reporter assay (table 5.1), the crude caged-ATP products could be used 
without further purification.  Luminescence was recorded prior to and following 
photoexposure using ATP, NPE and DMNPE γ-phosphate caged ATPs, and NB-NH2 
and DMNB-NH2 base-caged ATPs.  The results using a final ATP concentration of 10 
μM, corresponding to the predetermined mid-concentration in the linear range of the 
assay (data not shown), are summarized in table 5.1.  All caged ATP analogues 
demonstrated photo-activation ability. DMNB-NH2 and γ-phosphate NPE caged ATPs 
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exhibited some leak activity.  This leak activity approached 10% for γ-phosphate NPE 
caged ATP 100 μM and 1 mM concentrations.  Alternatively the DMNB-NH2 caged 
ATP did not exhibit an increase in leak activity with elevated concentrations, 
suggesting this product was free of ATP contamination and/or DMNPE may be more 
effective a reducing leak-activity than NPE.  





















Unreacted CPR-TP 6 ± 10.9 N/A  
 
 
Co-incubation of standard ATP and caged ATP analogues (10 μM final 
concentrations, 50 μL) were performed to assess the competitive inhibition properties 
of the caged species.  Table 3.2 summarizes the percentage of ATP activity of the co-
iincubations, relative to an ATP standard plus buffer that was run in parallel.  Both γ-
Table 5.2          % of RLU from ATP co-incubated with caged effectors
ATP [10 μM] + base-caged ATP [10 μM]
ATP alone [10 μM]















Symbol † denotes statistical difference between caged-ATP and ATP standard 
Symbol ‡ denotes statistical difference between γ-phosphate and base caged ATP 
(Student’s t-test p < 0.05) 
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phosphate caged ATPs reduced the observed luminescent signal.  No statistical 
difference could be drawn between the ATP standard and the co-incubation of ATP 





This work demonstrates the facile synthesis of base-caged ATP analogues 
without requiring multiple protection and deprotection steps (Pitsch, Weiss et al. 1999; 
Hobartner and Silverman 2005).  These products are attractive alternatives to classic 
examples of caged ATPs, which are caged on the γ-phosphate and act by preventing 
enzymatic dephosphorylation(Kaplan, Forbush et al. 1978; McCray, Herbette et al. 
1980; Walker, Reid et al. 1988).  Phosphate caged ATP has consistently demonstrated 
competitive inhibition, which may alter the ATP response of the system being studied 
(Forbush 1984).  For instance, the presence of caged ATP following flash-photolysis 
slows the contraction rate of muscle fibers by transiently blocking the actomyosin 
interaction (Thirlwell, Corrie et al.).   Based-caged ATPs show very little activity prior to 
photo-activation, suggesting that caging on the nucleobase prevents enzyme 
recognition since the phosphates are free for kinase processing. 
Nucleoside models were initially performed to access the feasibility for 
caging CPR on the nucleobase.  This system allows for simple reaction analysis and 
purification by reverse phase HPLC.  For both NB-NH2 and DMNB-NH2, the generation 
of base-caged adenosine was observed.  Since the caged product appears to be 
relatively stable, the formation of several side products in the DMNB-NH2 caging 
reaction is likely the result of interactions between the cage compound and the 
solvent/buffer environment.  However, side-products resulting from depurination, 
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phosphate hydrolysis, and ring opening can not be ruled out.  The conditions of the 
substitution reactions were mildly basic to avoid these phenomena.  Colorimetric 
changes following caged ATP reconstitution in water from a methanolic solution, 
suggests reactivity between 2-nitrobenzylamines and water.  Additionally, breakdown 
products could be more readily formed in a slightly acidic aqueous solution than in 
basic methanol.  Differences between the NB-NH2 and DMNB-NH2 groups were likely 






Conclusions and Future Directions 
 
 
6.1 Conclusions  
 
 The primary goal of this work was to demonstrate photo-induced RNAi by 
caging the effector compounds.  Originally it was hypothesized that statistical 
phosphate backbone caging of a long dsRNA transcript would be an ideal means to 
control RNAi activity.  However, in vitro analysis of these caged products indicated that 
the formation of a phosphotriester from the caging process resulted in strand 
breakage.  This suggests that internal phosphate caging of an otherwise unmodified 
RNA is a not a suitable technique for use in aqueous systems.  Despite our results, 
diazo-mediated cage attachment to RNA has since been used to control mRNA 
expression (Ando, Furuta et al. 2001; Ando, Furuta et al. 2004) and siRNA-mediated 
gene silencing (Shah, Rangarajan et al. 2005).  In the latter case, it is possible that a 
significant fraction of the siRNAs were caged on the terminal phosphates only.  These 
positions may be more readily caged as they have an additional anionic non-bridging 
oxygen.  In an effort to circumvent the issue of phosphotriester RNA hydrolysis, a 
uniform chemically modified RNA mimic was tested to RNAi activity. 
Fully 2’-deoxy-2’fluoro modified NA (FNA) was generated for testing of RNAi 
silencing activity.  Eliminating all 2’-hydroxyls greatly reduces the probability of 
spontaneous intramolecular hydrolysis and protects against 2’-hydroxyl-mediated 
enzymatic digestion.  This modification removes this hydroxyl and allows the NA 
duplex to form the A-type helical structure through a preferred C3-endo sugar pucker 
confirmation without disrupting the major or minor grooves.  Among all the 2’-
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substitutions reported in the literature, the 2’-F modification gives the most consistent 
results of unaffected RNAi ability {reviewed by [(Manoharan 2004; Zhang, Du et al. 
2006)]}.  Fully-modified siFNAs were generated through synthetic methods and by in 
vitro transcription.  Transcription gave a crude product contaminated with early 
termination products and full length strands with base incorporation errors.  Therefore 
this technique is somewhat impractical unless considerable improvements are made to 
reduce polymerase miscoding.  The synthetic technique worked well using the 
corresponding phosphoramidites, which until recently were commercially unavailable 
for the purines.  These products were verified through mass spectrometry and PAGE 
separation.  FNAs demonstrated remarkable resistance to enzymatic digestion by 
sugar-specific nucleases.  However, these products could be digested by BAL-31 
nuclease, which proceeds through a sugar-nonspecific mechanism.  Additionally, NAs 
with this substitution exhibited much stronger hybridization properties, as measured by 
a dramatic increase in thermal stability. 
The observed RNAi ability of siFNA was nearly indistinguishable from 
unmodified siRNAs of the same sequence.  It was found throughout the course of the 
initial cell culture RNAi assay that the hybridization protocol had a significant impact on 
the ability to knockdown the reporter gene.  Since the melting temperature for the FNA 
duplex approached 95oC, it is possible that slightly misaligned siFNAs could be 
generated if annealing was rushed or performed at a lower temperature.  Extended 
annealing times at high temperatures prior to cellular transfection improved the 
silencing ability of the siFNAs.  However, this phenomenon was not observed using 
unmodified siRNAs.  In addition to duplex silencing activity, single-stranded antisense 
FNAs were tested for their ability to reduce target gene expression.  It has previously 
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been shown that antisense RNA that is the proper size for RISC association can enter 
the RNAi pathway  (Martinez, Patkaniowska et al. 2002; Schwarz, Hutvagner et al. 
2002; Amarzguioui, Holen et al. 2003; Holen, Amarzguioui et al. 2003).  However, the 
silencing activity of antisense FNA was much less potent than either duplex siFNA or 
single-stranded antisense RNA.  This suggests that antisense FNA is not recognized 
by RISC, and conversely that duplex siFNA silencing occurs through an enzyme 
mediated process rather than simple translational arrest. 
Once the RNAi activity of siFNA was verified, the ability to cage these effectors 
was revisited.  An activated 4,5-dimethoxy-2-nitrophenyl diazonium cage compound 
could be used the alkylate the phosphate backbone of each FNA strand individually.  
This reaction could easily be adjusted to obtain products with varying degrees of 
alkylation.  All caged samples, prior to and following photoexposure, were evaluated 
using spectroscopy, electrophoresis, and HPLC.  Caging also provided additional 
nuclease stability to the FNAs.  FNA samples that were not caged were susceptible to 
the sugar non-specific nuclease, BAL-31.   However, the attachment of DMNPE 
drastically decreased the ability of BAL-31 to degrade the FNA.  It is likely that once 
this bidirectional exonuclease reaches one or multiple adjoining caging sites, the 
enzyme might be interrupted from its digestion process.  It has previously been shown 
that an increase in serum and plasma stability due to partial 2’-F modification does not 
correlate to prolonged RNAi in vivo (Layzer, McCaffrey et al. 2004).  It is possible that 
these modified nucleic acids are processed either by RNA endonuclease activity or 
sugar-nonspecific nucleases.  Full modification and caging appears to protect against 
both of these possibility. 
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 The ability to trigger RNAi activity using caged siFNA was evaluated in cell 
culture and a zebrafish in vivo model.  Taking into account that caging of NAs has 
been shown to affect hybridization ability (Ordoukhanian and Taylor 1995; Ghosn, 
Haselton et al. 2005) and that it can aide against enzymatic digestion, DMPNE 
attachment to FNA should be able to affect NA:NA as well as NA:enzyme interactions.  
Therefore, caging of siFNAs has the potential to disrupt RNAi in various ways such as: 
disruption of RISC recognition, helicase unwinding of the duplex, mRNA target 
recognition, ejection of the digested target for RISC recycling, localization of RISC to 
specialized organelles, and downstream processing such as chromatin remodeling.  It 
was demonstrated that caging of either strand in a siFNA reduces RNAi activity, 
however, the caged antisense strand results in a more deleterious effect on RNAi 
activity.  This is not unexpected since the sense FNA is discarded early in the RNAi 
pathway.  Reduction of sense strand caged RNAi is likely caused by improper siFNA 
formation, reduced delivery of the caged species through lipid mediated transfection, 
disruption of RISC recognition, disruption of helicase removal of the sense strand, or a 
combination of these factors.  A parallel study carried out by our research group has 
demonstrated that caging of a fluorophore labeled PS oligonucleotide resulted in no 
observable difference in lipid-mediated transfection (Fabion, in preparation).    
Additionally, it is unlikely that cellular delivery is drastically reduced due the attachment 
of DMNPE since photo-exposure of these treatments restores RNAi activity to levels 
that are nearly equivalent to the uncaged-control effectors.  This observation also 
suggests that caged FNA duplexes are stable prior to delivery.  Caging of the 
antisense strand had the benefit of significantly less leak RNAi activity.  However, only 
partial restoration using 365 nm light was achieved.  HPLC evaluation of these 
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products suggests that the caged FNAs may consist of a heterogeneous mixture of 
products that vary in the degree of DMNPE attachment.  More lightly caged species 
may allow for residual RNAi activity, while DMNPE might not be fully removed upon 
photo exposure for heavily caged species.  Compounding the issue of varying amounts 
of the cage molecule, the location of attachment is random and variable.  Disruption of 
RNAi might be highly dependant on the location of the cage species.  Since it is carried 
through the entire RNAi pathway, it is more likely that the antisense strand has multiple 
RISC interactions and critical processing locations along its length, and therefore it is 
more likely for a randomly attached cage group to disrupt silencing.    
Zebrafish embryos were used as an in vivo model to test the photoinduced 
silencing ability caged siFNA in support of the cell culture results.  The mosaic 
expression pattern of the GFP reporter transgene prevented quantitative analysis.  
Nevertheless, qualitative observations strongly suggested that caging reduces the 
silencing activity of these molecules and that this activity can be restored by photo-
activation.  Caging of these effectors also protects the embryo from toxicity associated 
with siFNAs.  It has been previously reported that RNAi in zebrafish has a particularly 
high incidence of off target effects (Oates, Bruce et al. 2000; Zhao, Cao et al. 2001; 
Giraldez, Mishima et al. 2006).  Several potential causes of the observed toxicity 
include off-target RNAi gene silencing, innate toxicity of siFNAs and their metabolites, 
or overwhelming of the RNAi machinery.  Since normal RNAi results in toxicity, it is 
likely that the observed increase in mortality rate and developmental delay are related 
to an RNAi phenomenon, rather than toxicity of breakdown products of FNAs.  
Injection of single-stranded FNAs did not result in equivalent toxicity, suggesting that 
breakdown products of FNA digestion are not the cause of the observed 
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developmental delay.  Overwhelming of the RNAi machinery would more critical for a 
developing system, since endogenous microRNAs are theorized to play a major role in 
genetic regulation (Matzke and Matzke 2003).  This further supports the conclusion 
that caging of the RNAi effector prevents them from entering the RNAi pathway.  If this 
is true, than the fact that these molecules were activated at 7 hpf demonstrated 
remarkable intracellular stability of the caged species.  Therefore caging of RNAi 
effectors would allow delivery to a biological system at concentrations that would 
otherwise be toxic, followed by photo-induction of gene silencing at a specific stage of 
development in a manner that could control dosing to sub-toxic levels. 
In an effort to progress toward site-specifically caged RNAi effectors, we have 
generated a scheme to incorporate a single cage molecule within a full length RNA 
oligonucleotide using the convertible nucleoside approach.  This requires the 
generation and testing of cage precursor containing a primary amine at the site of 
attachment for nucleophilic substitution of the internal convertible base placed during 
custom synthesis.  4,5-dimethoxy(2-nitrobenzyl)bromide was reacted in pure 
condensed ammonia to produce the 4,5-dimethoxy ring substituted 2-nitrobenzylamine 
in sufficient yield and purity.  Additionally, an unsubstituted 2-nitrobenzylamine was 
purchased from a commercial source.  These compounds have been tested for the 
ability to generate a photolabile N6-caged adenosine derivative.  Nucleoside model 
studies were carried out by reacting 6-chloropurine ribose with each amine-containing 
cage compound.  The products were successfully isolated on HPLC and verified by 
MS.  Building on the success of these models, chloropurine riboside triphosphate was 
caged on the nucleobase to generate base-caged ATP.  All previous examples of 
caged ATP have attached the chromophore the γ-phosphate to prevent 
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dephosphorylation.  However, this attachment site does not prevent a NA-protein 
association for many of the systems being studied.  Therefore γ-phosphate caged ATP 
often acts as a competitive inhibitor for uncaged ATP.  Our results demonstrate this 
competitive inhibition using a luciferase ATP reporter system in vitro.  Alternatively, the 
base-caged ATP analogs do not appear to act as competitive inhibitors.  These 
compounds are also effectively activated by photoexposure.  One last additional 
benefit of this system is that the chloropurine riboside reagent is inactive as an ATP in 
this reporter system.  Therefore, contamination from the caging reaction does not 
cause leak ATP activity, which is a major problem when using γ-phosphate caged 
ATP.  This is even true when the caged ATP is purchased from a commercial source. 
 
6.2 Future Directions 
 
 This work successfully demonstrates using chemically modified NAs that 
have been caged to control RNAi-mediated gene silencing.  Also demonstrated is the 
ability to cage ATP on the nucleobase through nucleophilic substitution.  Within each of 
these categories, further chemical and photochemical evaluation would strengthen the 
foundation built in this work.  Additionally, each of these techniques has opened the 
possibility for application based investigations.  Finally, the study of base-caged ATP 
provides a platform toward post-synthetic site-specific caging of oligonucleotides for 
use in RNAi or other nucleic acid applications. 
 This work could readily be extended toward the goal of site-specifically 
caged siRNAs.  As aforementioned, the ATP study presented here demonstrates the 
incorporation of a cage molecule at the N6-position of adenosine.  The mechanism of 
substitution should be amenable toward caging through the convertible nucleotide 
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approach.  In this strategy, a full-length RNA oligonucleotide is synthesized with one or 
multiple convertible-base modifications inserted during solid phase synthesis.  While 
still resin bound and protected, the convertible nucleotide is incubated with a 
nitrobenzylamine derivative (or another aminated cage compound) for substitution of 
the leaving group with the cage compound.  If the primary amine is nucleophilic 
enough, this step should also cleave the RNA from its solid support and deprotect the 
other nucelobases.  However, treatment with concentrated methanolic ammonia 
following the conversion reaction is an alternative to completely cleave the support.  
The caged RNA is then 2’-deprotected per normal protocols.  One of the initial hurdles 
of this study will likely be the removal of unbound cage and side products of the 
conversion reaction prior to 2’-deprotection.  Our initial attempts of RNA conversion 
using NB-NH2 have been unable to circumvent this issue without sacrificing RNA yield.  
Additionally, characterization of the caged RNAi product might be difficult if the 
conversion reaction is of low yield.  Separation techniques will likely be needed to 
isolate the properly caged RNAs. 
 Assuming that site-specific caging of RNA is successful, there are several 
immediate phenomena to evaluate.  Clearly, an analysis of RNAi with point cage 
insertions should be initiated.  This will allow probing into the siRNA to determine the 
optimal site(s) for photocaging.  Ideally a single cage compound could be inserted into 
an siRNA molecule to completely ablate gene silencing activity.  Under these 
conditions, caged RNA photoactivation will likely be marked more efficient.  Our ATP 
studies suggest that some degree of uncaging occurs using a NPE nitrobenzyl with an 
intense 365 nm light.  If only a single cage compound is inserted per siRNA, the 
unsubstituted nitrobenzyl group may be adequately uncaged for photoinduced RNAi 
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using this light that is less harmful to biological systems than 308 nm light typically 
used to photolyze NPE-caged compounds.  The siRNA used in the study was originally 
designed for the purpose of site-specific caging.  The 11th nucleotide from the 5’-end of 
the antisense strand is an adenosine.  This was chosen so that a “convertible A” could 
be incorporated and post-synthetically caged.  Chapter 1 illustrates that this site is 
sensitive to base and sugar modifications, and therefore is hypothesized that this is an 
ideal site for cage incorporation to disrupt RNAi. 
 Site-specific caging may also make 2-photon excitation (TPE) of RNAi 
effectors more feasible.  Currently these compounds require a large number of 
siRNA/siFNA alkylation to prevent significant leak activity.  However, TPE requires a 
very high intensity of incident light for uncaging.  Concentrating the number a 
chromophores in this region by attaching multiple cages per oligonucleotide may push 
the required light intensity for uncaging to unsafe limits.  A comparison of two-photon 
uncaging with discrete increases in the number of attached cage molecules (1, 2, 3, 
etc.) will be a worthwhile endeavor to determine the relationship between required light 
energy and the number of bound cage compounds.  Additionally, the distance between 
two cage molecules within a single strand may also affect the efficiency of TPE.  
Chromophores in close proximity may be able to interact with the excited electron state 
of a neighboring cage compound.  
 Another application for site-specifically caged RNAs is to improve upon 
nuclease resistance assays.  By incorporating a cage compound at a specific location, 
the interruption of catalytic activity can investigated for various nucleases that act 
through different mechanisms.  For example, caging at the 5’-terminus may protect 
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exonucleases that digest in the 5’ to 3’ direction.  However this may be ineffectual 
against 3’ to 5’ exonucleases or endonucleases.   
 One of the more recent observations uncovered in this study was the 
developmental delay caused by high concentrations of siFNA and the associated 
reversal of this phenomenon by effector caging.  The cause of this delay is currently 
unknown, but it likely occurs through either RNAi off-target gene silencing or 
overwhelming the RNAi machinery.  Positional caging may provide a means to explore 
this effect.  For instance, caging at site 11 may inhibit target recognition and 
degradation but still allow for RISC assembly.  If the developmental delay is caused by 
overloading the RISC machinery, caging at this site might result in observed toxicity 
but little reporter-gene silencing.  This would allow for modeling of the optimal locations 
for disrupting hybridization and/or target recognition versus the disruption of RISC 
assembly.  Additionally, this might reveal how many cage molecules are needed to 
disrupt all RNAi processes. 
 Protection from siFNA-induced delayed development in zebrafish highlights 
an important potential application for caging.  Since the degree of uncaging can be 
controlled by adjusting total exposure, dosing of an RNAi effector or some other 
therapeutic agent can be modulated with light.  This is a promising tool for determining 
safe dosing of therapeutic agents.  Initially, this phenomenon could be investigated by 
caging compounds with known upper limits of toxicity and introducing the caged 
analogues in excess of this dose.  If the quantum yield is adequately determined, light 
dosing could be calculated for corresponding therapeutic doses and this could be 
tested against traditional toxicity experiments that can be clouded by transport and 
breakdown of the therapeutic agent. 
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